0001071739-23-000116.txt : 20230425 0001071739-23-000116.hdr.sgml : 20230425 20230424211706 ACCESSION NUMBER: 0001071739-23-000116 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230425 DATE AS OF CHANGE: 20230424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 23841421 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-Q 1 cnc-20230331.htm 10-Q cnc-20230331
0001071739--12-312023Q1FALSEhttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent00010717392023-01-012023-03-3100010717392023-04-21xbrli:shares00010717392023-03-31iso4217:USD00010717392022-12-31iso4217:USDxbrli:shares0001071739us-gaap:HealthCarePremiumMember2023-01-012023-03-310001071739us-gaap:HealthCarePremiumMember2022-01-012022-03-310001071739us-gaap:ServiceMember2023-01-012023-03-310001071739us-gaap:ServiceMember2022-01-012022-03-3100010717392022-01-012022-03-310001071739us-gaap:CommonStockMember2022-12-310001071739us-gaap:CommonStockMember2023-03-310001071739us-gaap:TreasuryStockCommonMember2022-12-310001071739us-gaap:TreasuryStockCommonMember2023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001071739us-gaap:RetainedEarningsMember2022-12-310001071739us-gaap:NoncontrollingInterestMember2022-12-310001071739us-gaap:RetainedEarningsMember2023-01-012023-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001071739us-gaap:CommonStockMember2023-01-012023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001071739us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001071739us-gaap:AdditionalPaidInCapitalMember2023-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001071739us-gaap:RetainedEarningsMember2023-03-310001071739us-gaap:NoncontrollingInterestMember2023-03-310001071739us-gaap:CommonStockMember2021-12-310001071739us-gaap:CommonStockMember2022-03-310001071739us-gaap:TreasuryStockCommonMember2022-03-310001071739us-gaap:TreasuryStockCommonMember2021-12-310001071739us-gaap:AdditionalPaidInCapitalMember2021-12-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001071739us-gaap:RetainedEarningsMember2021-12-310001071739us-gaap:NoncontrollingInterestMember2021-12-3100010717392021-12-310001071739us-gaap:RetainedEarningsMember2022-01-012022-03-310001071739us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001071739us-gaap:CommonStockMember2022-01-012022-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001071739us-gaap:TreasuryStockCommonMember2022-01-012022-03-310001071739us-gaap:AdditionalPaidInCapitalMember2022-03-310001071739us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001071739us-gaap:RetainedEarningsMember2022-03-310001071739us-gaap:NoncontrollingInterestMember2022-03-3100010717392022-03-310001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:CenturionMember2023-01-100001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:MagellanSpecialtyHealthMember2023-01-200001071739us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:MagellanSpecialtyHealthMember2023-01-202023-01-200001071739us-gaap:SubsequentEventMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembercnc:MagellanSpecialtyHealthMember2023-04-012023-04-250001071739us-gaap:USTreasuryAndGovernmentMember2023-03-310001071739us-gaap:USTreasuryAndGovernmentMember2022-12-310001071739us-gaap:CorporateDebtSecuritiesMember2023-03-310001071739us-gaap:CorporateDebtSecuritiesMember2022-12-310001071739cnc:RestrictedCertificatesOfDepositMember2023-03-310001071739cnc:RestrictedCertificatesOfDepositMember2022-12-310001071739cnc:RestrictedCashEquivalentsMember2023-03-310001071739cnc:RestrictedCashEquivalentsMember2022-12-310001071739us-gaap:BankTimeDepositsMember2023-03-310001071739us-gaap:BankTimeDepositsMember2022-12-310001071739us-gaap:MunicipalBondsMember2023-03-310001071739us-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:AssetBackedSecuritiesMember2023-03-310001071739us-gaap:AssetBackedSecuritiesMember2022-12-310001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2023-03-310001071739us-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMember2023-03-310001071739us-gaap:CommercialMortgageBackedSecuritiesMember2022-12-310001071739cnc:InvestmentSecuritiesMembercnc:RatedSecuritiesMemberus-gaap:ExternalCreditRatingInvestmentGradeMember2023-01-012023-03-31xbrli:pure0001071739us-gaap:CommercialMortgageBackedSecuritiesMember2023-01-012023-03-31cnc:position0001071739us-gaap:InvestmentsMember2023-03-310001071739us-gaap:DepositsMember2023-03-310001071739us-gaap:InvestmentsMember2022-12-310001071739us-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Member2023-03-310001071739us-gaap:FairValueInputsLevel2Member2023-03-310001071739us-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:BankTimeDepositsMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2023-03-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:MunicipalBondsMemberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2023-03-310001071739us-gaap:FairValueInputsLevel1Member2022-12-310001071739us-gaap:FairValueInputsLevel2Member2022-12-310001071739us-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:CorporateDebtSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:MunicipalBondsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:BankTimeDepositsMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:AssetBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:ResidentialMortgageBackedSecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:CommercialMortgageBackedSecuritiesMemberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:EquitySecuritiesMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:InvestmentsMember2022-12-310001071739us-gaap:InvestmentsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:CashAndCashEquivalentsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:USTreasuryAndGovernmentMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:CorporateDebtSecuritiesMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:CertificatesOfDepositMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:MunicipalBondsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:MunicipalBondsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:MunicipalBondsMemberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel1Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel2Memberus-gaap:DepositsMember2022-12-310001071739us-gaap:FairValueInputsLevel3Memberus-gaap:DepositsMember2022-12-310001071739cnc:MedicaidSegmentMember2021-12-310001071739cnc:MedicareSegmentMember2021-12-310001071739cnc:CommercialSegmentMember2021-12-310001071739us-gaap:AllOtherSegmentsMember2021-12-310001071739cnc:MedicaidSegmentMember2022-01-012022-12-310001071739cnc:MedicareSegmentMember2022-01-012022-12-310001071739cnc:CommercialSegmentMember2022-01-012022-12-310001071739us-gaap:AllOtherSegmentsMember2022-01-012022-12-3100010717392022-01-012022-12-310001071739cnc:MedicaidSegmentMember2022-12-310001071739cnc:MedicareSegmentMember2022-12-310001071739cnc:CommercialSegmentMember2022-12-310001071739us-gaap:AllOtherSegmentsMember2022-12-310001071739cnc:MedicaidSegmentMember2023-01-012023-03-310001071739cnc:MedicareSegmentMember2023-01-012023-03-310001071739cnc:CommercialSegmentMember2023-01-012023-03-310001071739us-gaap:AllOtherSegmentsMember2023-01-012023-03-310001071739cnc:MedicaidSegmentMember2023-03-310001071739cnc:MedicareSegmentMember2023-03-310001071739cnc:CommercialSegmentMember2023-03-310001071739us-gaap:AllOtherSegmentsMember2023-03-310001071739cnc:MedicaidSegmentMember2022-01-012022-03-310001071739cnc:MedicareSegmentMember2022-01-012022-03-310001071739cnc:CommercialSegmentMember2022-01-012022-03-310001071739us-gaap:AllOtherSegmentsMember2022-01-012022-03-310001071739cnc:MedicaidSegmentMember2022-03-310001071739cnc:MedicareSegmentMember2022-03-310001071739cnc:CommercialSegmentMember2022-03-310001071739us-gaap:AllOtherSegmentsMember2022-03-310001071739us-gaap:SeniorNotesMembercnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember2023-03-310001071739us-gaap:SeniorNotesMembercnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember2022-12-310001071739cnc:A2300Million245SeniorNotsDueJuly2028Memberus-gaap:SeniorNotesMember2023-03-310001071739cnc:A2300Million245SeniorNotsDueJuly2028Memberus-gaap:SeniorNotesMember2022-12-310001071739cnc:A3500Million4625SeniorNotesDueDecember2029Memberus-gaap:SeniorNotesMember2023-03-310001071739cnc:A3500Million4625SeniorNotesDueDecember2029Memberus-gaap:SeniorNotesMember2022-12-310001071739cnc:A2200Million375SeniorNotesDueFebruary2030Memberus-gaap:SeniorNotesMember2023-03-310001071739cnc:A2200Million375SeniorNotesDueFebruary2030Memberus-gaap:SeniorNotesMember2022-12-310001071739us-gaap:SeniorNotesMembercnc:A2200Million300SeniorNotesDueOctober2030Member2023-03-310001071739us-gaap:SeniorNotesMembercnc:A2200Million300SeniorNotesDueOctober2030Member2022-12-310001071739cnc:A2200Million250SeniorNotesDueMarch2031Memberus-gaap:SeniorNotesMember2023-03-310001071739cnc:A2200Million250SeniorNotesDueMarch2031Memberus-gaap:SeniorNotesMember2022-12-310001071739us-gaap:SeniorNotesMembercnc:A1300Million2625SeniorNotesDueAugust2031Member2023-03-310001071739us-gaap:SeniorNotesMembercnc:A1300Million2625SeniorNotesDueAugust2031Member2022-12-310001071739cnc:TermLoanCreditAgreementMember2023-03-310001071739cnc:TermLoanCreditAgreementMember2022-12-310001071739us-gaap:RevolvingCreditFacilityMember2023-03-310001071739us-gaap:RevolvingCreditFacilityMember2022-12-310001071739cnc:LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMembercnc:DebtTotalMemberus-gaap:CreditAvailabilityConcentrationRiskMember2023-01-012023-03-310001071739cnc:DebtTotalMemberus-gaap:CreditAvailabilityConcentrationRiskMemberus-gaap:LondonInterbankOfferedRateLIBORMember2023-01-012023-03-310001071739cnc:SterlingOvernightIndexAverageSONIAMembercnc:DebtTotalMemberus-gaap:CreditAvailabilityConcentrationRiskMember2023-01-012023-03-310001071739cnc:CircleHealthMember2023-03-310001071739cnc:ExcludingCircleHealthMember2023-03-3100010717392022-06-012022-06-3000010717392022-12-012022-12-310001071739us-gaap:SubsequentEventMember2023-04-012023-04-250001071739us-gaap:CommonStockMember2023-01-012023-03-310001071739us-gaap:CommonStockMember2022-01-012022-03-310001071739cnc:EmployeeStockCompensationPlanMember2023-01-012023-03-310001071739cnc:EmployeeStockCompensationPlanMember2022-01-012022-03-310001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMemberus-gaap:HealthCarePremiumMember2023-01-012023-03-310001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2023-01-012023-03-310001071739cnc:CommercialSegmentMemberus-gaap:HealthCarePremiumMember2023-01-012023-03-310001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2023-01-012023-03-310001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-03-310001071739cnc:MedicareSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-01-012023-03-310001071739us-gaap:ServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-03-310001071739cnc:TotalPremiumAndServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-01-012023-03-310001071739cnc:TotalPremiumAndServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739cnc:TotalPremiumAndServiceMember2023-01-012023-03-310001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2023-01-012023-03-310001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739us-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2023-01-012023-03-310001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739us-gaap:OperatingSegmentsMember2023-01-012023-03-310001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2023-01-012023-03-310001071739us-gaap:IntersegmentEliminationMembercnc:MedicareSegmentMember2023-01-012023-03-310001071739us-gaap:IntersegmentEliminationMembercnc:CommercialSegmentMember2023-01-012023-03-310001071739us-gaap:IntersegmentEliminationMemberus-gaap:AllOtherSegmentsMember2023-01-012023-03-310001071739us-gaap:IntersegmentEliminationMember2023-01-012023-03-310001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMemberus-gaap:HealthCarePremiumMember2022-01-012022-03-310001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2022-01-012022-03-310001071739cnc:CommercialSegmentMemberus-gaap:HealthCarePremiumMember2022-01-012022-03-310001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMemberus-gaap:HealthCarePremiumMember2022-01-012022-03-310001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-01-012022-03-310001071739cnc:MedicareSegmentMemberus-gaap:ServiceMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739us-gaap:ServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2022-01-012022-03-310001071739us-gaap:ServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-01-012022-03-310001071739cnc:TotalPremiumAndServiceMembercnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739cnc:TotalPremiumAndServiceMemberus-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2022-01-012022-03-310001071739cnc:TotalPremiumAndServiceMemberus-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739cnc:TotalPremiumAndServiceMember2022-01-012022-03-310001071739us-gaap:OperatingSegmentsMembercnc:MedicaidSegmentMember2022-01-012022-03-310001071739cnc:MedicareSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739us-gaap:OperatingSegmentsMembercnc:CommercialSegmentMember2022-01-012022-03-310001071739us-gaap:AllOtherSegmentsMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739us-gaap:OperatingSegmentsMember2022-01-012022-03-310001071739us-gaap:IntersegmentEliminationMembercnc:MedicaidSegmentMember2022-01-012022-03-310001071739us-gaap:IntersegmentEliminationMembercnc:MedicareSegmentMember2022-01-012022-03-310001071739us-gaap:IntersegmentEliminationMembercnc:CommercialSegmentMember2022-01-012022-03-310001071739us-gaap:IntersegmentEliminationMember2022-01-012022-03-310001071739us-gaap:PendingLitigationMember2021-09-30cnc:claim0001071739us-gaap:PendingLitigationMember2021-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
___________________________________________
FORM 10-Q
____________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to
____________________________________________
Commission file number: 001-31826
____________________________________________
CENTENE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware42-1406317
(State or other jurisdiction of(I.R.S. Employer
incorporation or organization)Identification Number)
7700 Forsyth Boulevard 
St. Louis,Missouri63105
(Address of principal executive offices)(Zip Code)

Registrant's telephone number, including area code: (314) 725-4477 
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s)Name of Each Exchange on Which Registered
Common Stock $0.001 Par ValueCNCNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days ☒ Yes ☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files) ☒ Yes ☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Large accelerated filer☒Accelerated filer☐
Non-accelerated filer ☐Smaller reporting company☐
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statement of the registrant included in the filing reflect the correction of an error to the previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b) ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐     No  ☒
As of April 21, 2023, the registrant had 548,769,258 shares of common stock outstanding.


CENTENE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
 PAGE
  
Part I
Financial Information
Item 1.
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
Part II
Other Information
Item 1.
Item 1A.
Item 2.
Item 6.


CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue," and other similar words or expressions (and the negative thereof). Centene Corporation and its subsidiaries (Centene, the Company, our or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in connection with completed and future acquisitions and dispositions, our investments, and the adequacy of our available cash resources. These statements may be found in the various sections of this filing, such as Part I, Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations," and Part II, Item 1. "Legal Proceedings."

These forward-looking statements reflect our current views with respect to future events and are based on numerous assumptions and assessments made by us in light of our experience and perception of historical trends, current conditions, business strategies, operating environments, future developments, and other factors we believe appropriate. By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive, and other factors that may cause our or our industry's actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions.

All forward-looking statements included in this filing are based on information available to us on the date of this filing. Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events, or otherwise, after the date of this filing. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables, and events including, but not limited to:

•our ability to design and price products that are competitive and/or actuarially sound including but not limited to any impacts resulting from Medicaid redeterminations;
•our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth;
•our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates;
•competition, including our ability to reprocure our contracts and grow organically;
•the timing and extent of benefits from our value creation strategy, including the possibility that the benefits received may be lower than expected, may not occur, or will not be realized within the expected time periods;
•our ability to manage our information systems effectively;
•disruption, unexpected costs, or similar risks from business transactions, including acquisitions, divestitures, and changes in our relationships with third parties;
•impairments to real estate, investments, goodwill, and intangible assets;
•the risk that the election of new directors, changes in senior management, and any inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;
•membership and revenue declines or unexpected trends;
•rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses;
•changes in healthcare practices, new technologies, and advances in medicine;
•increased healthcare costs;
•inflation;
•changes in economic, political, or market conditions;
•changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder;
•tax matters;
•disasters or major epidemics;
i
•changes in expected contract start dates;
•provider, state, federal, foreign, and other contract changes and timing of regulatory approval of contracts;
•the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE, or other customers);
•the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Centene Pharmacy Services (formerly Envolve Pharmacy Solutions, Inc. (Envolve)), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we previously recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations will be brought by states, the federal government or shareholder litigants, or government investigations;
•challenges to our contract awards;
•cyber-attacks or other privacy or data security incidents;
•the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental, or third party consents or approvals for acquisitions or dispositions;
•any changes in expected closing dates, estimated purchase price, or accretion for acquisitions or dispositions;
•restrictions and limitations in connection with our indebtedness;
•a downgrade of the credit rating of our indebtedness;
•the availability of debt and equity financing on terms that are favorable to us; and
•foreign currency fluctuations.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain other factors that may affect our business operations, financial condition, and results of operations, in our filings with the Securities and Exchange Commission (SEC), including our annual report on Form 10-K, other quarterly reports on Form 10-Q and current reports on Form 8-K. Due to these important factors and risks, we cannot give assurances with respect to our future performance, including without limitation our ability to maintain adequate premium levels or our ability to control our future medical and selling, general and administrative costs.


ii

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's performance and for planning purposes, by allowing management to focus on period-to-period changes in the Company's core business operations, and in determining employee incentive compensation. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Specifically, the Company believes the presentation of non-GAAP financial information that excludes amortization of acquired intangible assets and acquisition and divestiture related expenses, as well as other items, allows investors to develop a more meaningful understanding of the Company's core performance over time.

The tables below provide reconciliations of non-GAAP items ($ in millions, except per share data):
Three Months Ended March 31,
20232022
GAAP net earnings attributable to Centene$1,130 $849 
Amortization of acquired intangible assets183 199 
Acquisition and divestiture related expenses23 97 
Other adjustments (1)
(53)2 
Income tax effects of adjustments (2)
(114)(67)
Adjusted net earnings $1,169 $1,080 
GAAP diluted earnings per share (EPS) attributable to Centene$2.04 $1.44 
Amortization of acquired intangible assets0.33 0.34 
Acquisition and divestiture related expenses0.04 0.16 
Other adjustments (1)
(0.09)— 
Income tax effects of adjustments (2)
(0.21)(0.11)
Adjusted diluted EPS$2.11 $1.83 
(1) Other adjustments include the following pre-tax items:
2023:
(a) Magellan Specialty Health divestiture gain of $79 million, or $0.14 per share ($0.12 after-tax) and real estate impairments of $26 million, or $0.05 per share ($0.04 after-tax).

2022:
(b) Costs related to the PBM legal settlement of $2 million, or $0.00 per share ($0.00 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. In addition, the three months ended March 31, 2023, includes a one-time income tax benefit of $69 million, or $0.13 per share, resulting from the distribution of long-term stock awards to the estate of the Company's former CEO.


iii
Three Months Ended March 31,
20232022
GAAP selling, general and administrative expenses$3,011 $2,745 
Less:
Acquisition and divestiture related expenses23 99 
Costs related to the PBM legal settlement— 2 
Real estate optimization6 — 
Adjusted selling, general and administrative expenses$2,982 $2,644 
iv
PART I
FINANCIAL INFORMATION

Item 1. Financial Statements.
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except shares in thousands and per share data in dollars)
March 31, 2023December 31, 2022
(Unaudited)
ASSETS  
Current assets:  
Cash and cash equivalents$15,853 $12,074 
Premium and trade receivables15,210 13,272 
Short-term investments2,135 2,321 
Other current assets1,811 2,461 
Total current assets35,009 30,128 
Long-term investments15,833 14,684 
Restricted deposits1,313 1,217 
Property, software and equipment, net2,478 2,432 
Goodwill18,836 18,812 
Intangible assets, net6,730 6,911 
Other long-term assets2,783 2,686 
Total assets$82,982 $76,870 
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY 
Current liabilities:  
Medical claims liability$17,504 $16,745 
Accounts payable and accrued expenses10,781 9,525 
Return of premium payable2,077 1,634 
Unearned revenue2,398 478 
Current portion of long-term debt97 82 
Total current liabilities32,857 28,464 
Long-term debt18,223 17,938 
Deferred tax liability522 615 
Other long-term liabilities6,194 5,616 
Total liabilities57,796 52,633 
Commitments and contingencies
Redeemable noncontrolling interests20 56 
Stockholders' equity:  
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2023 and December 31, 2022
— — 
Common stock, $0.001 par value; authorized 800,000 shares; 614,355 issued and 551,714 outstanding at March 31, 2023, and 607,847 issued and 550,754 outstanding at December 31, 2022
1 1 
Additional paid-in capital20,121 20,060 
Accumulated other comprehensive earnings (loss)(915)(1,132)
Retained earnings10,471 9,341 
Treasury stock, at cost (62,641 and 57,093 shares, respectively)
(4,636)(4,213)
Total Centene stockholders' equity25,042 24,057 
Nonredeemable noncontrolling interest124 124 
Total stockholders' equity25,166 24,181 
Total liabilities, redeemable noncontrolling interests and stockholders' equity$82,982 $76,870 

The accompanying notes to the consolidated financial statements are an integral part of these statements. 
1
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
 Three Months Ended March 31,
 20232022
Revenues:
Premium$33,825 $31,889 
Service1,127 2,343 
Premium and service revenues34,952 34,232 
Premium tax3,937 2,953 
Total revenues38,889 37,185 
Expenses:
Medical costs29,434 27,838 
Cost of services870 1,988 
Selling, general and administrative expenses3,011 2,745 
Depreciation expense142 156 
Amortization of acquired intangible assets183 199 
Premium tax expense4,011 3,006 
Impairment20 — 
Total operating expenses37,671 35,932 
Earnings from operations1,218 1,253 
Other income (expense):
Investment and other income353 52 
Debt extinguishment— 3 
Interest expense(180)(160)
Earnings before income tax1,391 1,148 
Income tax expense261 296 
Net earnings1,130 852 
(Earnings) loss attributable to noncontrolling interests— (3)
Net earnings attributable to Centene Corporation$1,130 $849 

Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.05 $1.46 
Diluted earnings per common share$2.04 $1.44 

Weighted average number of common shares outstanding:
Basic550,779 583,230 
Diluted553,845 590,658 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
2
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)
(In millions)
(Unaudited)
 Three Months Ended March 31,
 20232022
Net earnings$1,130 $852 
Change in unrealized gain (loss) on investments253 (715)
Change in unrealized gain (loss) on investments, tax effect(61)171 
Change in unrealized gain (loss) on investments, net of tax192 (544)
Reclassification adjustment, net of tax2 2 
Foreign currency translation adjustments, net of tax23 (20)
Other comprehensive earnings (loss)217 (562)
Comprehensive earnings1,347 290 
Comprehensive (earnings) loss attributable to noncontrolling interests— (3)
Comprehensive earnings attributable to Centene Corporation$1,347 $287 

The accompanying notes to the consolidated financial statements are an integral part of these statements.

3
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In millions, except shares in thousands and per share data in dollars)
(Unaudited)
Three Months Ended March 31, 2023
 Centene Stockholders' Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par Value Shares
AmtAdditional Paid-in CapitalAccumulated Other Comprehensive
Earnings (Loss)		Retained Earnings
$0.001 Par Value Shares
AmtNoncontrolling
Interest		Total
Balance, December 31, 2022607,847 $1 $20,060 $(1,132)$9,341 57,093 $(4,213)$124 $24,181 
Net earnings— — — — 1,130 — — — 1,130 
Other comprehensive earnings, net of $61 tax
— — — 217 — — — — 217 
Common stock issued for employee benefit plans6,508 — 12 — — — — — 12 
Common stock repurchases— — — — — 5,548 (423)— (423)
Stock compensation expense— — 61 — — — — — 61 
Purchase of redeemable noncontrolling interest— — (12)— — — — — (12)
Balance, March 31, 2023614,355 $1 $20,121 $(915)$10,471 62,641 $(4,636)$124 $25,166 

Three Months Ended March 31, 2022
 Centene Stockholders' Equity  
 Common Stock   Treasury Stock  
 
$0.001 Par Value Shares
AmtAdditional Paid-in CapitalAccumulated Other Comprehensive
Earnings (Loss)		Retained Earnings
$0.001 Par Value Shares
AmtNoncontrolling
Interest		Total
Balance, December 31, 2021602,704 $1 $19,672 $77 $8,139 20,225 $(1,094)$145 $26,940 
Net earnings (loss)— — — — 849 — — (1)848 
Other comprehensive loss, net of $(171) tax
— — — (562)— — — — (562)
Common stock issued for employee benefit plans3,221 — 28 — — — — — 28 
Fair value of unvested equity awards in connection with acquisition— — 60 — — — — — 60 
Common stock repurchases— — — — — 846 (71)— (71)
Stock compensation expense— — 70 — — — — — 70 
Balance, March 31, 2022605,925 $1 $19,830 $(485)$8,988 21,071 $(1,165)$144 $27,313 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
4
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions, unaudited)
 Three Months Ended March 31,
 20232022
Cash flows from operating activities:  
Net earnings$1,130 $852 
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization346 390 
Stock compensation expense61 70 
Impairment20 — 
(Gain) loss on debt extinguishment— (3)
Deferred income taxes(159)12 
(Gain) on divestiture(79)— 
Other adjustments, net7 22 
Changes in assets and liabilities  
Premium and trade receivables(1,938)(3,099)
Other assets(315)(299)
Medical claims liabilities759 1,767 
Unearned revenue1,919 81 
Accounts payable and accrued expenses1,548 957 
Other long-term liabilities970 401 
Net cash provided by operating activities4,269 1,151 
Cash flows from investing activities:  
Capital expenditures(225)(242)
Purchases of investments(1,619)(1,700)
Sales and maturities of investments1,148 1,047 
Acquisitions, net of cash acquired— (1,504)
Divestiture proceeds, net of divested cash443 — 
Other investing activities, net— (2)
Net cash (used in) investing activities(253)(2,401)
Cash flows from financing activities:  
Proceeds from long-term debt287 100 
Payments and repurchases of long-term debt— (526)
Common stock repurchases(423)(71)
Proceeds from common stock issuances— 27 
Payments for debt extinguishment— (27)
Purchase of noncontrolling interest(58)— 
Other financing activities, net11 (1)
Net cash (used in) financing activities(183)(498)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash2 33 
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents3,835 (1,715)
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period
12,330 13,214 
Cash, cash equivalents, and restricted cash and cash equivalents, end of period
$16,165 $11,499 
Supplemental disclosures of cash flow information:  
Interest paid$144 $139 
Income taxes paid$11 $11 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:
March 31,
20232022
Cash and cash equivalents$15,853 $11,237 
Restricted cash and cash equivalents, included in restricted deposits312 262 
Total cash, cash equivalents, and restricted cash and cash equivalents$16,165 $11,499 

The accompanying notes to the consolidated financial statements are an integral part of these statements.
5
CENTENE CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. Organization and Operations

Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Segment Reporting

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace along with individual, small group, and large group commercial healthcare products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.

2. Acquisitions and Divestitures

On January 5, 2023, the Company completed the divestiture of HealthSmart, its third-party health plan administration business.

On January 10, 2023, the Company signed and closed on a definitive agreement to divest Centurion, its prison healthcare business. During 2022, the Company recorded impairment charges related to goodwill and other current assets associated with the pending divestitures. The Company could receive up to an additional $35 million in cash based on the reprocurements of certain Centurion contracts. The Company will recognize the appropriate amount of contingent consideration related to the additional $35 million when realized or realizable.

On January 20, 2023, the Company completed the divestiture of Magellan Specialty Health for approximately $646 million in cash and stock, including an estimated working capital adjustment and recognized a pre-tax gain of $79 million. The stock consideration was subsequently sold in April 2023 for cash proceeds of $245 million. The Company could also receive up to an additional $150 million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the additional $150 million when realized or realizable.
6

3. Short-term and Long-term Investments, Restricted Deposits

Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 March 31, 2023December 31, 2022
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of U.S. government corporations and agencies$489 $— $(12)$477 $695 $— $(16)$679 
Corporate securities10,523 32 (668)9,887 10,127 12 (778)9,361 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
312 — — 312 256 — — 256 
Short-term time deposits
198 — — 198 204 — — 204 
Municipal securities4,131 15 (213)3,933 4,055 6 (280)3,781 
Asset-backed securities1,492 2 (57)1,437 1,396 — (70)1,326 
Residential mortgage-backed securities1,187 4 (105)1,086 1,165 2 (121)1,046 
Commercial mortgage-backed securities
1,067 1 (87)981 961 — (99)862 
Equity securities (1)
250 — — 250 5 — — 5 
Private equity investments
540 — — 540 529 — — 529 
Life insurance contracts
176 — — 176 169 — — 169 
Total$20,369 $54 $(1,142)$19,281 $19,566 $20 $(1,364)$18,222 
(1) Investments in equity securities as of March 31, 2023 primarily consisted of shares received as part of the Magellan Specialty Health divestiture consideration. These shares were subsequently sold in April 2023.

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of March 31, 2023, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At March 31, 2023, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $141 million and $132 million at March 31, 2023 and December 31, 2022, respectively, and is included in other current assets on the Consolidated Balance Sheets.

The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at March 31, 2023.

7
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 March 31, 2023December 31, 2022
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$(2)$249 $(10)$170 $(5)$342 $(11)$184 
Corporate securities(72)2,755 (596)5,683 (340)5,368 (438)3,400 
Municipal securities(18)1,161 (195)1,945 (142)2,437 (138)995 
Asset-backed securities(5)310 (52)928 (29)786 (41)486 
Residential mortgage-backed securities(10)319 (95)652 (55)629 (66)352 
Commercial mortgage-backed securities(8)188 (79)697 (49)513 (50)330 
Total$(115)$4,982 $(1,027)$10,075 $(620)$10,075 $(744)$5,747 

As of March 31, 2023, the gross unrealized losses were generated from 6,109 positions out of a total of 6,936 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 March 31, 2023December 31, 2022
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,011 $1,981 $570 $569 $2,207 $2,179 $534 $532 
One year through five years8,008 7,556 546 518 7,651 7,147 524 490 
Five years through ten years4,131 3,821 245 224 4,066 3,613 224 195 
Greater than ten years144 140 2 2 135 129 — — 
Asset-backed securities3,746 3,504 — — 3,522 3,234 — — 
Total$18,040 $17,002 $1,363 $1,313 $17,581 $16,302 $1,282 $1,217 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.
8

4. Fair Value Measurements

Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at March 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$15,853 $— $— $15,853 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$156 $— $— $156 
Corporate securities— 9,853 — 9,853 
Municipal securities— 3,291 — 3,291 
Short-term time deposits— 198 — 198 
Asset-backed securities— 1,437 — 1,437 
Residential mortgage-backed securities— 1,086 — 1,086 
Commercial mortgage-backed securities— 981 — 981 
Equity securities248 2 — 250 
Total investments$404 $16,848 $— $17,252 
Restricted deposits:    
Cash and cash equivalents$312 $— $— $312 
U.S. Treasury securities and obligations of U.S. government corporations and agencies321 — — 321 
Corporate securities— 34 — 34 
Certificates of deposit— 4 — 4 
Municipal securities— 642 — 642 
Total restricted deposits$633 $680 $— $1,313 
Total assets at fair value$16,890 $17,528 $— $34,418 

9
The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$12,074 $— $— $12,074 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$366 $5 $— $371 
Corporate securities— 9,328 — 9,328 
Municipal securities— 3,165 — 3,165 
Short-term time deposits— 204 — 204 
Asset backed securities— 1,326 — 1,326 
Residential mortgage backed securities— 1,046 — 1,046 
Commercial mortgage backed securities— 862 — 862 
Equity securities3 2 — 5 
Total investments$369 $15,938 $— $16,307 
Restricted deposits:    
Cash and cash equivalents$256 $— $— $256 
U.S. Treasury securities and obligations of U.S. government corporations and agencies308 — — 308 
Corporate securities— 33 — 33 
Certificates of deposit— 4 — 4 
Municipal securities— 616 — 616 
Total restricted deposits$564 $653 $— $1,217 
Total assets at fair value$13,007 $16,591 $— $29,598 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $716 million and $698 million as of March 31, 2023 and December 31, 2022, respectively.

5. Goodwill and Intangible Assets

As discussed in Note 1. Organization and Operations, in 2023 the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the changes in goodwill by operating segment ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, December 31, 2021$10,194 $1,592 $5,424 $2,561 $19,771 
Acquisition and purchase accounting adjustments— — — 1,077 1,077 
Divestitures— — — (1,533)(1,533)
Reallocation4 — — (4)— 
Impairments— — — (370)(370)
Translation impact— — — (133)(133)
Balance, December 31, 2022$10,198 $1,592 $5,424 $1,598 $18,812 
Translation impact— — — 24 24 
Balance, March 31, 2023$10,198 $1,592 $5,424 $1,622 $18,836 
10
6. Medical Claims Liability

As discussed in Note 1. Organization and Operations, in 2023 the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the change in medical claims liability for the three months ended March 31, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year20,813 5,163 4,177 418 30,571 
Prior years(803)(155)(172)(7)(1,137)
Total incurred20,010 5,008 4,005 411 29,434 
Paid related to:
Current year12,679 2,988 2,541 294 18,502 
Prior years6,834 2,145 1,063 132 10,174 
Total paid19,513 5,133 3,604 426 28,676 
Balance, March 31, 2023, net
11,743 3,306 2,303 125 17,477 
Plus: Reinsurance recoverable9 — 18 — 27 
Balance, March 31, 2023
$11,752 $3,306 $2,321 $125 $17,504 

The following table summarizes the change in medical claims liability for the three months ended March 31, 2022 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2022$9,845 $2,286 $2,014 $98 $14,243 
Less: Reinsurance recoverable23 — — — 23 
Balance, January 1, 2022, net9,822 2,286 2,014 98 14,220 
Acquisitions— — — 249 249 
Incurred related to:
Current year19,289 5,098 3,423 751 28,561 
Prior years(514)(52)(149)(8)(723)
Total incurred18,775 5,046 3,274 743 27,838 
Paid related to:
Current year12,022 2,674 2,012 690 17,398 
Prior years5,643 1,624 1,319 76 8,662 
Total paid17,665 4,298 3,331 766 26,060 
Balance, March 31, 2022, net
10,932 3,034 1,957 324 16,247 
Plus: Reinsurance recoverable12 — — — 12 
Balance, March 31, 2022
$10,944 $3,034 $1,957 $324 $16,259 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum health benefits ratio (HBR) and other return of premium programs, the Company recorded $159 million and $67 million as a reduction to premium revenue in the three months ended March 31, 2023 and 2022, respectively.

11
Incurred but not reported (IBNR) plus expected development on reported claims as of March 31, 2023 was $11,271 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.

7. Affordable Care Act

The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
March 31, 2023December 31, 2022
Risk adjustment receivable$887 $838 
Risk adjustment payable(1,556)(780)
Minimum medical loss ratio(176)(103)
Cost sharing reduction payable(89)(99)

8. Debt
 
Debt consists of the following ($ in millions):
 March 31, 2023December 31, 2022
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,393 $2,393 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,673 15,673 
Term loan facility2,169 2,183 
Revolving credit agreement359 58 
Finance leases and other260 253 
Debt issuance costs(141)(147)
Total debt18,320 18,020 
Less: current portion(97)(82)
 Long-term debt$18,223 $17,938 

Of the Company's total debt, approximately 12% is variable rate debt. Approximately 11% uses the London Interbank Offered Rate (LIBOR) as a reference rate pursuant to the terms of the Company Credit Facility and approximately 1% uses the Sterling Overnight Index Average (SONIA) as a reference rate. The debt agreements that may be impacted by the discontinuation of LIBOR have provisions included that are sufficient for the Company to transition from the existing LIBOR rates to the prevailing successor market rates as necessary. The document governing the Company Credit Facility includes provisions to convert from LIBOR to the Secured Overnight Financing Rate (SOFR) at the time LIBOR ceases to be published.

12
9. Leases

The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):
 March 31, 2023December 31, 2022
Assets
ROU assets (recorded within other long-term assets)$2,578 $2,554 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$177 $180 
Long-term (recorded within other long-term liabilities)3,144 3,133 
Total lease liabilities$3,321 $3,313 

As of March 31, 2023, the weighted average remaining lease term for the Company was 20.5 years. The average remaining lease term of the Circle Health portfolio is 27.0 years. Excluding Circle Health, the company's portfolio average remaining lease term is 8.5 years. The lease liabilities as of March 31, 2023 reflect a weighted average discount rate of 5.7%.

10. Stockholders' Equity

The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million, inclusive of past authorizations. As of March 31, 2023, the Company had a remaining amount of $2,429 million available under the Company's stock repurchase program. In April 2023, the Company repurchased an additional 3 million shares for $200 million.

The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended March 31,
20232022
SharesCostSharesCost
Share buybacks4,852 $377 — $— 
Income tax withholding696 46 846 71 
Total share repurchases5,548 $423 846 $71 

Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.
13

11. Earnings Per Share

The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended March 31,
 20232022
Earnings attributable to Centene Corporation$1,130 $849 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding550,779 583,230 
Common stock equivalents (as determined by applying the treasury stock method) (1)
3,066 7,428 
Weighted average number of common shares and potential dilutive common shares outstanding553,845 590,658 
  
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.05 $1.46 
Diluted earnings per common share$2.04 $1.44 
(1) The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.

The calculation of diluted earnings per common share for the three months ended March 31, 2023 and 2022 excludes 1,606 thousand shares and 923 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.

12. Segment Information

In early 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. Prior year information has been adjusted to reflect the change in segment reporting.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.

14
Segment information for the three months ended March 31, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$22,227 $5,876 $5,252 $470 $33,825 
Service— — — 1,127 1,127 
Premium and service revenues22,227 5,876 5,252 1,597 34,952 
Premium tax3,937 — — — 3,937 
Total external revenues26,164 5,876 5,252 1,597 38,889 
Internal revenues— — — 3,867 3,867 
Eliminations— — — (3,867)(3,867)
Total revenues$26,164 $5,876 $5,252 $1,597 $38,889 
Medical costs$20,010 $5,008 $4,005 $411 $29,434 
Cost of services$— $— $— $870 $870 
Gross margin (1)
$2,217 $868 $1,247 $316 $4,648 
(1) Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended March 31, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,121 $5,757 $4,132 $879 $31,889 
Service— — — 2,343 2,343 
Premium and service revenues21,121 5,757 4,132 3,222 34,232 
Premium tax2,953 — — — 2,953 
Total external revenues24,074 5,757 4,132 3,222 37,185 
Internal revenues— — — 6,450 6,450 
Eliminations— — — (6,450)(6,450)
Total revenues$24,074 $5,757 $4,132 $3,222 $37,185 
Medical costs$18,775 $5,046 $3,274 $743 $27,838 
Cost of services$— $— $— $1,988 $1,988 
Gross margin (1)
$2,346 $711 $858 $491 $4,406 
(1) Gross margin represents premium and service revenues less medical costs and cost of services.
15

13. Contingencies

Overview

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to the Centers for Medicare and Medicaid Services (CMS) related to risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;

•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and

•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the discussion below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.

16
California

On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial condition, results of operations and cash flows.

Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing, and at a mediation in September 2021, the Company reached a settlement with plaintiffs in three of the pending class actions which, if approved by court, should resolve most or all of the pending litigation related to this matter. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations and cash flows.

Pharmacy Benefits Management Matters

On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.

The Company has reached no-fault agreements with the Attorneys General, including Ohio, to resolve claims and/or allegations made by the states related to services previously provided by Envolve. As a result of the settlement, the Ohio Attorney General's litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations and cash flows.
17

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve known and unknown risks and uncertainties.

EXECUTIVE OVERVIEW

General

We are a leading healthcare enterprise, committed to helping people live healthier lives, with an established expertise in lower-income and medically complex populations. We provide access to high-quality healthcare, innovative programs, and a wide range of health solutions that help families and individuals get well, stay well, and be well. We believe that our local approach enables us to provide accessible, quality, culturally sensitive healthcare coverage to our communities.

Results of operations depend on our ability to manage expenses associated with health benefits (including estimated costs incurred) and selling, general and administrative (SG&A) costs. We measure operating performance based upon two key ratios. The health benefits ratio (HBR) represents medical costs as a percentage of premium revenues, excluding premium tax revenues that are separately billed, and reflects the direct relationship between the premiums received and the medical services provided. The SG&A expense ratio represents SG&A costs as a percentage of premium and service revenues, excluding premium taxes separately billed.

Value Creation Plan

We established our Value Creation Plan to drive margin expansion by leveraging our scale and generating sustainable, profitable growth. In addition to creating shareholder value, this plan is an ongoing effort to modernize and improve how we work in order to propel our organization to new levels of success and elevate the member and provider experiences. During the first quarter of 2023, we completed the following key milestones in our Value Creation Plan:

•Completed the divestitures of Magellan Specialty Health, Centurion, our prison healthcare business, and HealthSmart, our third-party health plan administration business.

•Completed $377 million of common stock repurchases in the first quarter of 2023 through our stock repurchase program, which were funded through divestiture proceeds and free cash flow generated from operations. In addition, in April 2023, we completed an additional $200 million of common stock repurchases.

•Completed operating model changes initiated in 2022, including streamlining call center management and utilization management.

•Initiated standardization of our pharmacy operating model.

•Launched our cloud-based, next-gen clinical population health platform.

Segments Update

In early 2023, and in conjunction with our updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, we have revised the way we manage the business, evaluate performance, and allocate resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. We began reporting under this new segment structure in 2023. Prior year information has been adjusted to reflect the change in segment reporting.

Regulatory Trends and Uncertainties

The United States government, policymakers, and healthcare experts continue to discuss and debate various elements of the United States healthcare model. We remain focused on the promise of delivering access to high-quality, affordable healthcare to all of our members and believe we are well positioned to meet the needs of the changing healthcare landscape.

18
In contrast to previous executive and legislative efforts to restrict or limit certain provisions of the Affordable Care Act (ACA), the American Rescue Plan Act (ARPA), enacted in March 2021, contained provisions aimed at leveraging Medicaid and the Health Insurance Marketplace to expand health insurance coverage and affordability to consumers. The ARPA authorized an additional $1.9 trillion in federal spending to address the COVID-19 public health emergency (PHE), and contained several provisions designed to increase coverage of certain healthcare services, expand eligibility and benefits, incentivize state Medicaid expansion, and adjust federal financing for state Medicaid programs, the ultimate impact of which remain uncertain.

The ARPA initially enhanced eligibility for the advance premium tax credit for enrollees in the Health Insurance Marketplace, which was extended through the 2025 tax year by the Inflation Reduction Act, enacted in August 2022.

In October 2022, the Treasury Department issued a final rule to address the family glitch in the ACA, which relates to determining who is eligible for premium subsidies. We see this as a significant step in making Marketplace more affordable for working families.

The COVID-19 pandemic has impacted and may continue to affect our business. The Families First Coronavirus Response Act, enacted in March 2020, increased federal matching rates for state Medicaid programs with a requirement that states suspend Medicaid redeterminations throughout the PHE. As a result, since the onset of the PHE, our Medicaid membership has increased by 3.5 million members (excluding new states North Carolina and Delaware and various state product expansions or managed care organization changes). The Consolidated Appropriations Act, 2023, signed into law on December 29, 2022, delinked the Medicaid continuous coverage requirements from the PHE and, as a result, states began Medicaid disenrollments on April 1, 2023. Per the Act, redeterminations related to the PHE should be initiated within 12 months, by March 31, 2024, and conclude during the second quarter of 2024. We are taking decisive action to help ensure individuals take the state agency requested action to confirm eligibility in their Medicaid coverage or find other appropriate coverage that is best for themselves and their families. Our Ambetter Health product covers the majority of our Medicaid states, and we believe we are among the best positioned in the healthcare market to capture those transitioning coverage through redeterminations. Although Medicaid continuous coverage requirements were decoupled from the PHE, we are working to prepare for other provisions still tied to the end of the PHE which expires May 11, 2023, including COVID costs and coverage requirements, various other payment structures and electronic prescribing of controlled substances.

We have more than three decades of experience, spanning seven presidents from both sides of the aisle, in delivering high-quality healthcare services on behalf of states and the federal government to under-insured and uninsured families, commercial organizations, and military families. This expertise has allowed us to deliver cost-effective services to our government partners and our members. While healthcare experts maintain a focus on personalized healthcare technology, we continue to make strategic decisions to accelerate the development of new software platforms and analytical capabilities. We continue to believe we have both the capacity and capability to successfully navigate industry changes to the benefit of our members, customers, and shareholders.

First Quarter 2023 Highlights

Our financial performance for the first quarter of 2023 is summarized as follows:

•Managed care membership of 28.5 million, an increase of 2.2 million members, or 8% year-over-year.

•Total revenues of $38.9 billion, representing 5% growth year-over-year.

•Premium and service revenues of $35.0 billion, representing 2% growth year-over-year.

•HBR of 87.0%, compared to 87.3% for the first quarter of 2022.

•SG&A expense ratio of 8.6%, compared to 8.0% for the first quarter of 2022.

•Adjusted SG&A expense ratio of 8.5%, compared to 7.7% for the first quarter of 2022.

•Operating cash flows of $4.3 billion for the first quarter of 2023.

•Adjusted diluted earnings per share (EPS) of $2.11, compared to $1.83 for the first quarter of 2022.

19
A reconciliation from GAAP diluted EPS to adjusted diluted EPS is highlighted below, and additional detail is provided above under the heading "Non-GAAP Financial Presentation":
Three Months Ended March 31,
20232022
GAAP diluted EPS attributable to Centene$2.04 $1.44 
Amortization of acquired intangible assets0.33 0.34 
Acquisition and divestiture related expenses0.04 0.16 
Other adjustments (1)
(0.09)— 
Income tax effects of adjustments (2)
(0.21)(0.11)
Adjusted diluted EPS$2.11 $1.83 
(1) Other adjustments include the following pre-tax items:
2023:
(a) Magellan Specialty Health divestiture gain of $79 million, or $0.14 per share ($0.12 after-tax) and real estate impairments of $26 million, or $0.05 per share ($0.04 after-tax).

2022:
(b) Costs related to the PBM legal settlement of $2 million, or $0.00 per share ($0.00 after-tax).

(2) The income tax effects of adjustments are based on the effective income tax rates applicable to each adjustment. In addition, the three months ended March 31, 2023, includes a one-time income tax benefit of $69 million, or $0.13 per share, resulting from the distribution of long-term stock awards to the estate of the Company's former CEO.

Current and Future Operating Drivers

The following items contributed to our results of operations as compared to the previous year:

Medicaid

•In February 2023, our subsidiary, Buckeye Health Plan, commenced the Medicaid contract awarded by the Ohio Department of Medicaid to continue servicing members with quality healthcare, coordinated services, and benefits.

•In January 2023, our subsidiary, Delaware First Health, commenced its contract for the statewide Medicaid managed care programs.

•In January 2023, our subsidiary, Louisiana Healthcare Connections, commenced the Medicaid contract awarded by the Louisiana Department of Health to continue administering quality, integrated healthcare services to members across the state.

•In January 2023, our subsidiary, Managed Health Services, commenced the contract awarded by the Indiana Department of Administration to continue serving Hoosier Healthwise and Health Indiana Plan members with Medicaid and Medicaid alternative managed care and care coordination services.

•In October 2022, the state of Ohio removed pharmacy services in connection with the state's transition from managed care to a single pharmacy benefits management (PBM).

•In July 2022, our subsidiary, Home State Health, commenced the MO HealthNet Managed Care General Plan and Specialty Plan contracts. Under the General Plan, Home State Health continues to serve multiple MO HealthNet programs including Children's Health Insurance members and the state's newly implemented Medicaid expansion population, across all regions of Missouri. Additionally, as the sole provider of the newly awarded Specialty Plan, Home State Health now serves approximately 53,500 foster children and children receiving adoption subsidy assistance.

•Beginning in 2020, the federal government issued a PHE which suspended Medicaid eligibility redeterminations. The ongoing suspensions, which were extended to April 2023, have driven increased membership.
20

Medicare

•Medicare membership declined year-over-year due to lower annual enrollment.

Commercial

•In 2023, our Health Insurance Marketplace product, Ambetter Health, expanded into Alabama and extended its footprint by more than 60 counties across 12 existing states. In total, the Marketplace plan is available in more than 1,500 counties across 28 states. Additionally, Marketplace membership increased year-over-year due to the expanded footprint, strong product positioning and open enrollment results, as well as overall market growth.

Other

•In January 2023, we completed the divestitures of Magellan Specialty Health, Centurion, our prison healthcare business, and HealthSmart, our third-party health plan administration business.

•In December 2022, we completed the divestiture of Magellan Rx, which was part of the Magellan Health, Inc. (Magellan) business acquired in January 2022.

•In November 2022, we completed the divestiture of our ownership stakes in our Spanish and Central European businesses, including Ribera Salud, Torrejón Salud, and Pro Diagnostics Group.

•In July 2022, we completed the divestiture of PANTHERx Rare (PANTHERx).

We expect the following items to impact our future results of operations:

Medicaid

•In April 2023, eligibility redeterminations related to the PHE began. These redeterminations will extend over a 14-month period and are expected to conclude in the second quarter of 2024. In addition to delinking the Medicaid continuous enrollment provision from the PHE, the year-end spending bill also outlines key coverage expansion provisions, including Children’s Health Insurance Program (CHIP) coverage. The provision requires states to provide 12 months of continuous coverage for children under Medicaid and CHIP effective January 2024 and made the state option to extend coverage for postpartum women for up to 12 months permanent.

•In March 2023, the state of North Carolina passed legislation for Medicaid Expansion, presenting a growth opportunity in our existing market.

•In December 2022, our subsidiary, Health Net of California, was selected by the California Department of Health Care Services for direct Medicaid contracts in 10 counties, including Los Angeles (in which a portion will be subcontracted). The contracts are anticipated to begin in January 2024.

•In September 2022, our subsidiary, Nebraska Total Care, was awarded the Nebraska Department of Health and Human Services statewide Medicaid managed care contract. Under the new contract, Nebraska Total Care will continue serving the state's Medicaid Managed Care Program, known as Heritage Health. The new contract term is five years and includes the option for two, one-year renewals. The contract is anticipated to begin in January 2024, subject to the resolution of third-party protests.

•In September 2022, our subsidiary, Superior HealthPlan (Superior), was awarded a new, six-year contract by the Texas Health and Human Services Commission to continue providing youth in foster care with healthcare coverage through the STAR Health Medicaid program. Superior has been the sole provider of STAR Health coverage since the program launched in 2008. The contract is anticipated to begin in September 2023.

•In August 2022, our subsidiary, Magnolia Health Plan (Magnolia), was awarded the Mississippi Division of Medicaid contract. Under the new contract, Magnolia will continue serving the state's Coordinated Care Organization Program, which will consist of the Mississippi Coordinated Access Network and the Mississippi CHIP. The contract is anticipated to begin in July 2023, subject to the resolution of third-party protests.

21
•In August 2021, our subsidiaries, Carolina Complete Health and WellCare of North Carolina, were selected to coordinate physical and/or other health services with Local Management Entities/Managed Care Organizations under the state's new Tailored Plans. The Tailored Plans, which are expected to launch in October 2023, are integrated health plans designed for individuals with significant behavioral health needs and intellectual/developmental disabilities.

Medicare

•In October 2022, the Centers for Medicare and Medicaid Services (CMS) published updated Medicare Star quality ratings for the 2023 rating year, which impacts the 2024 revenue year. The decrease in Star quality ratings is driven by the expiration of certain disaster relief provisions as well as deterioration in select metrics. Over the past year, our leadership team launched a multi-year plan to build and improve quality across the enterprise with a strong focus on enhanced patient experience and access to care. We expect to begin to see the results of these efforts with the 2024 rating year (2025 revenue year).

Other

•We continue to execute on Value Creation Plan initiatives including the award of the new PBM contract commencing in 2024, portfolio review, real estate optimization, stock and debt repurchases, along with an ongoing focus on quality improvement actions. We expect these actions will drive future margin expansion, create shareholder value, and improve the experience for our members and providers.
22

MEMBERSHIP

From March 31, 2022 to March 31, 2023, we increased our managed care membership by 2.2 million, or 8%. The following table sets forth our membership by line of business:
 March 31, 2023December 31, 2022March 31, 2022
Traditional Medicaid (1)
14,521,100 14,264,800 13,590,100 
High Acuity Medicaid (2)
1,801,200 1,710,000 1,682,800 
Total Medicaid (4)
16,322,300 15,974,800 15,272,900 
Commercial Marketplace3,093,600 2,076,100 2,031,000 
Commercial Group437,200 441,100 449,700 
Total Commercial3,530,800 2,517,200 2,480,700 
Medicare (3) (4)
1,343,800 1,511,100 1,452,500 
Medicare PDP4,459,300 4,226,000 4,169,700 
Total at-risk membership25,656,200 24,229,100 23,375,800 
TRICARE eligibles2,799,300 2,832,300 2,862,400 
Total
28,455,500 27,061,400 26,238,200 
(1) Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2) Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals.
(3) Membership includes Medicare Advantage and Medicare Supplement.
(4) Membership includes 1,323,000, 1,291,300, and 1,231,500 Dual Eligible Special Needs Plans (D-SNP) beneficiaries for the periods ending March 31, 2023, December 31, 2022, and March 31, 2022, respectively.
23

RESULTS OF OPERATIONS

The following discussion and analysis is based on our Consolidated Statements of Operations, which reflect our results of operations for the three months ended March 31, 2023 and 2022, prepared in accordance with generally accepted accounting principles in the United States (GAAP). 

Summarized comparative financial data for the three months ended March 31, 2023 and 2022 is as follows ($ in millions, except per share data in dollars):
Three Months Ended March 31,
 20232022% Change
Premium$33,825 $31,889 6 %
Service1,127 2,343 (52)%
Premium and service revenues34,952 34,232 2 %
Premium tax3,937 2,953 33 %
Total revenues38,889 37,185 5 %
Medical costs29,434 27,838 6 %
Cost of services870 1,988 (56)%
Selling, general and administrative expenses3,011 2,745 10 %
Depreciation expense142 156 (9)%
Amortization of acquired intangible assets183 199 (8)%
Premium tax expense4,011 3,006 33 %
Impairment20 — n.m.
Earnings from operations1,218 1,253 (3)%
Investment and other income353 52 n.m.
Debt extinguishment— 3 n.m.
Interest expense(180)(160)(13)%
Earnings before income tax1,391 1,148 21 %
Income tax expense261 296 (12)%
Net earnings1,130 852 33 %
(Earnings) loss attributable to noncontrolling interests— (3)n.m.
Net earnings attributable to Centene Corporation$1,130 $849 33 %
Diluted earnings per common share attributable to Centene Corporation$2.04 $1.44 42 %
n.m.: not meaningful


24
Three Months Ended March 31, 2023 Compared to Three Months Ended March 31, 2022

Total Revenues

The following table sets forth supplemental revenue information for the three months ended March 31, ($ in millions):
20232022% Change
Medicaid$26,164 $24,076 9 %
Commercial5,252 4,132 27 %
Medicare (1)
5,876 5,757 2 %
Other1,597 3,220 (50)%
Total Revenues$38,889 $37,185 5 %
(1) Medicare includes Medicare Advantage, Medicare Supplement, D-SNPs, and Medicare Prescription Drug Plan (PDP).

Total revenues increased 5% in the three months ended March 31, 2023 over the corresponding period in 2022, driven by 52% membership growth in the Marketplace business due to strong product positioning and open enrollment results, as well as overall market growth; organic Medicaid growth, primarily due to the ongoing suspension of eligibility redeterminations; and increased Medicaid premium tax revenue. The decrease in Other revenue was driven by recent divestitures.

Operating Expenses

Medical Costs/HBR

The HBR for the three months ended March 31, 2023, was 87.0%, compared to 87.3% in the same period in 2022. The HBR for the first quarter of 2023 was favorably impacted by continued disciplined Marketplace pricing and lower utilization in Medicare, partially offset by updated Medicaid return of premium payable revenue estimates related to prior periods.

Cost of Services

Cost of services decreased by $1.1 billion in the three months ended March 31, 2023, compared to the corresponding period in 2022. The cost of service ratio for the three months ended March 31, 2023, was 77.2%, compared to 84.8% in the same period in 2022. The decreases were driven by recent divestitures.

Selling, General & Administrative Expenses

The SG&A expense ratio was 8.6% for the first quarter of 2023, compared to 8.0% in the first quarter of 2022. The adjusted SG&A expense ratio was 8.5% for the first quarter of 2023, compared to 7.7% in the first quarter of 2022. The increases were driven by growth in the Marketplace business, which operates at a higher SG&A ratio.

Impairment

During the first quarter of 2023, we recorded impairment charges of $20 million for additional impairments related to our ongoing real estate optimization initiatives, consisting of leased and owned real estate assets and related fixed assets.

25
Other Income (Expense)

The following table summarizes the components of other income (expense) for the three months ended March 31, ($ in millions): 
 20232022
Investment and other income$353 $52 
Debt extinguishment— 3 
Interest expense(180)(160)
Other income (expense), net$173 $(105)

Investment and other income. Investment and other income increased by $301 million in the three months ended March 31, 2023 compared to the corresponding period in 2022, driven by increased interest rates and the $79 million Magellan Specialty Health divestiture gain.

Debt extinguishment. During the first quarter of 2022, we recognized an immaterial gain related to the redemption of Magellan’s outstanding Senior Notes.

Interest expense. Interest expense increased by $20 million in the three months ended March 31, 2023, compared to the corresponding period in 2022. The increase was driven by increased interest rates.

Income Tax Expense

For the three months ended March 31, 2023, we recorded income tax expense of $261 million on pre-tax earnings of $1.4 billion, or an effective tax rate of 18.8%. The effective tax rate for the first quarter of 2023 reflects the tax effects of the distribution of long-term stock awards to the estate of the Company's former CEO as well as the Magellan Specialty Health gain. For the first quarter of 2023, our effective tax rate on adjusted earnings was 24.3%. For the three months ended March 31, 2022, we recorded an income tax expense of $296 million on pre-tax earnings of $1.1 billion, or an effective tax rate of 25.8%. For the first quarter of 2022, our effective tax rate on adjusted earnings was 25.1%.

Segment Results

The following table summarizes our consolidated operating results by segment for the three months ended March 31, ($ in millions):
 20232022% Change
Total Revenues   
Medicaid$26,164 $24,074 9 %
Medicare5,876 5,757 2 %
Commercial5,252 4,132 27 %
Other1,597 3,222 (50)%
Consolidated Total$38,889 $37,185 5 %
Gross Margin (1)
  
Medicaid$2,217 $2,346 (5)%
Medicare868 711 22 %
Commercial1,247 858 45 %
Other316 491 (36)%
Consolidated Total$4,648 $4,406 5 %
(1) Gross margin represents premium and service revenues less medical costs and cost of services.

26
Medicaid

Total revenues increased 9% in the three months ended March 31, 2023, compared to the corresponding period in 2022. The increase was due to organic Medicaid growth, partially due to the ongoing suspension of eligibility redeterminations. Gross margin decreased $129 million between years primarily as a result of updated return of premium payable revenue estimates related to prior periods.

Medicare

Total revenues increased 2% in the three months ended March 31, 2023, compared to the corresponding period in 2022. Gross margin increased $157 million in the three months ended March 31, 2023, compared to the corresponding period in 2022. Increases were primarily due to lower utilization.

Commercial

Total revenues increased 27% in the three months ended March 31, 2023, compared to the corresponding period in 2022. Gross margin increased $389 million in the three months ended March 31, 2023, compared to the corresponding period in 2022. Increases were primarily driven by 52% membership growth in the Marketplace business, resulting from strong product positioning and open enrollment results, overall market growth, and continued disciplined pricing.

Other

Total revenues decreased 50% in the three months ended March 31, 2023, compared to the corresponding period in 2022. Gross margin decreased $175 million in the three months ended March 31, 2023, compared to the corresponding period in 2022. Decreases were primarily due to recent divestitures.

27

LIQUIDITY AND CAPITAL RESOURCES

Shown below is a condensed schedule of cash flows used in the discussion of liquidity and capital resources ($ in millions).
 Three Months Ended March 31,
 20232022
Net cash provided by operating activities$4,269 $1,151 
Net cash (used in) investing activities(253)(2,401)
Net cash (used in) financing activities(183)(498)
Effect of exchange rate changes on cash and cash equivalents2 33 
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents$3,835 $(1,715)

Cash Flows Provided by Operating Activities

Normal operations are funded primarily through operating cash flows and borrowings under our revolving credit facility. Operating activities provided cash of $4.3 billion in the three months ended March 31, 2023, compared to $1.2 billion in the comparable period in 2022. Cash flows provided by operations in 2023 were driven by net earnings, increases in unearned revenue and accounts payable driven by the early receipt of payments from CMS of approximately $2.8 billion, the timing of pass through payments of $1.2 billion, partially offset by a delay in premium payments from one of our state partners of $1.1 billion.

Cash flows provided by operations in 2022 were primarily driven by net earnings.

Cash Flows Used in Investing Activities

Investing activities used cash of $253 million in the three months ended March 31, 2023, and $2.4 billion in the comparable period in 2022. Cash flows used in investing activities in 2023 primarily consisted of net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments) and capital expenditures, partially offset by divestiture proceeds.

In 2022, cash flows used in investing activities primarily related to our acquisition of Magellan and net additions to the investment portfolio of our regulated subsidiaries (including transfers from cash and cash equivalents to long-term investments).

We spent $225 million and $242 million in the three months ended March 31, 2023 and 2022, respectively, on capital expenditures primarily for system enhancements.

As of March 31, 2023, our investment portfolio consisted primarily of fixed-income securities with an average duration of 3.5 years. We had unregulated cash and investments of $1.0 billion at March 31, 2023 compared to $1.4 billion at December 31, 2022.

Cash Flows Used in Financing Activities

Financing activities used cash of $183 million in the three months ended March 31, 2023, compared to using cash of $498 million in the comparable period in 2022. Financing activities in 2023 were driven by stock repurchases of $423 million, partially offset by increased borrowings on our revolving credit facility.

Liquidity Metrics

We have a stock repurchase program authorizing us to repurchase common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized up to a total of $6.0 billion of repurchases under the program.

28
During the quarter, we repurchased 4.9 million shares of common stock for $377 million under the stock repurchase program. We have approximately $2.4 billion remaining under the program for repurchases as of March 31, 2023. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time. Refer to Note 10. Stockholders' Equity for further information on stock repurchases.

As of March 31, 2023, we had an aggregate principal amount of $15.7 billion of senior notes issued and outstanding. The indentures governing our various maturities of senior notes contain restrictive covenants. As of March 31, 2023, we were in compliance with all covenants.

As part of our capital allocation strategy, we may decide to repurchase debt or raise capital through the issuance of debt in the form of senior notes. In June 2022, the Company's Board of Directors also authorized a new $1.0 billion senior note debt repurchase program. No repurchases were made during the quarter ended March 31, 2023. As of March 31, 2023, there was $700 million available under the senior note debt repurchase program. Refer to Note 8. Debt for further information regarding the issuance and redemption of senior notes.

The credit agreement underlying our Revolving Credit Facility and Term Loan Facility contains customary covenants as well as financial covenants including a minimum fixed charge coverage ratio and a maximum debt-to-EBITDA ratio. Our maximum debt-to-EBITDA ratio under the credit agreement may not exceed 4.0 to 1.0. As of March 31, 2023, we had $359 million of borrowings outstanding under our Revolving Credit Facility, $2.2 billion of borrowings under our Term Loan Facility, and we were in compliance with all covenants. As of March 31, 2023, there were no limitations on the availability of our Revolving Credit Facility as a result of the debt-to-EBITDA ratio.

We had outstanding letters of credit of $214 million as of March 31, 2023, which were not part of our revolving credit facility. The letters of credit bore weighted interest of 0.6% as of March 31, 2023. In addition, we had outstanding surety bonds of $1.0 billion as of March 31, 2023.

At March 31, 2023, our debt to capital ratio, defined as total debt divided by the sum of total debt and total equity, was 42.1%, compared to 42.7% at December 31, 2022. The debt to capital ratio decrease was driven by net earnings partially offset by stock repurchases in the quarter. We utilize the debt to capital ratio as a measure, among others, of our leverage and financial flexibility.

At March 31, 2023, we had working capital, defined as current assets less current liabilities, of $2.2 billion, compared to $1.7 billion at December 31, 2022. We manage our short-term and long-term investments with the goal of ensuring that a sufficient portion is held in investments that are highly liquid and can be sold to fund short-term requirements as needed.

2023 Expectations

During the remainder of 2023, we expect to receive net dividends from our insurance subsidiaries of approximately $2.0 billion and spend approximately $620 million in additional capital expenditures. In April 2023, we made additional purchases of $200 million through our stock repurchase program.

Based on our operating plan, we expect that our available cash, cash equivalents and investments, cash from our operations and cash available under our Revolving Credit Facility will be sufficient to finance our general operations and capital expenditures for at least 12 months from the date of this filing. While we are currently in a strong liquidity position and believe we have adequate access to capital, we may elect to increase borrowings on our Revolving Credit Facility. From time to time we may elect to raise additional funds for these and other purposes, either through issuance of debt or equity, the sale of investment securities or otherwise, as appropriate. In addition, we may strategically pursue refinancing or redemption opportunities to extend maturities and/or improve terms of our indebtedness if we believe such opportunities are favorable to us.

We intend to continue to evaluate strategic actions in connection with our Value Creation Plan, targeting initiatives to improve productivity, efficiencies and reduced organizational costs, as well as capital deployment activities, including stock repurchases, portfolio optimization and the evaluation of refinancing opportunities. In addition to creating shareholder value, this plan encompasses a larger organizational mission to enhance our member and provider experience, improve outcomes for our members, and to initiate new ways of doing business that make Centene a great partner in all aspects of our operations.
29
REGULATORY CAPITAL AND DIVIDEND RESTRICTIONS
 
Our operations are conducted through our subsidiaries. As managed care organizations, most of our subsidiaries are subject to state regulations and other requirements that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to us. Generally, the amount of dividend distributions that may be paid by a regulated subsidiary without prior approval by state regulatory authorities is limited based on the entity's level of statutory net income and statutory capital and surplus.

Our regulated subsidiaries are required to maintain minimum capital requirements prescribed by various regulatory authorities in each of the states in which we operate. During the three months ended March 31, 2023, we received dividends of $153 million from and made $87 million of capital contributions to our regulated subsidiaries. For our subsidiaries that file with the National Association of Insurance Commissioners (NAIC), the aggregate risk-based capital (RBC) level as of December 31, 2022, which was the most recent date for which reporting was required, was in excess of 350% of the Authorized Control Level. We intend to continue to maintain an aggregate RBC level in excess of 350% of the Authorized Control Level during 2023.

Under the California Knox-Keene Health Care Service Plan Act of 1975, as amended (Knox-Keene), certain of our California subsidiaries must comply with tangible net equity (TNE) requirements. Under these Knox-Keene TNE requirements, actual net worth less certain unsecured receivables and intangible assets must be more than the greater of (i) a fixed minimum amount, (ii) a minimum amount based on premiums or (iii) a minimum amount based on healthcare expenditures, excluding capitated amounts.

Under the New York State Department of Health Codes, Rules and Regulations Title 10, Part 98, our New York subsidiary must comply with contingent reserve requirements. Under these requirements, net worth based upon admitted assets must equal or exceed a minimum amount based on annual net premium income.

The NAIC has adopted rules which set minimum RBC requirements for insurance companies, managed care organizations and other entities bearing risk for healthcare coverage. As of March 31, 2023, each of our health plans was in compliance with the RBC requirements enacted in those states.

As a result of the above requirements and other regulatory requirements, certain of our subsidiaries are subject to restrictions on their ability to make dividend payments, loans or other transfers of cash to their parent companies. Such restrictions, unless amended or waived or unless regulatory approval is granted, limit the use of any cash generated by these subsidiaries to pay our obligations. The maximum amount of dividends that can be paid by our insurance company subsidiaries without prior approval of the applicable state insurance departments is subject to restrictions relating to statutory surplus, statutory income and unassigned surplus.
30

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

INVESTMENTS AND DEBT

As of March 31, 2023, we had short-term investments of $2.1 billion and long-term investments of $17.2 billion, including restricted deposits of $1.3 billion. The short-term investments generally consist of highly liquid securities with maturities between three and 12 months. The long-term investments consist of municipal, corporate and U.S. Treasury securities, government sponsored obligations, life insurance contracts, asset-backed securities, and equity securities, and have maturities greater than one year. Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. Due to the nature of the states' requirements, these investments are classified as long-term regardless of the contractual maturity date. Substantially all of our investments are subject to interest rate risk and will decrease in value if market rates increase. Assuming a hypothetical and immediate 1% increase in market interest rates at March 31, 2023, the fair value of our fixed income investments would decrease by approximately $617 million.

For a discussion of the interest rate risk that our investments are subject to, refer to our 10-K for the fiscal year ended December 31, 2022, Part 1, Item 1A, "Risk Factors – Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity."

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures - We maintain disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act) that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms; and (ii) accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

In connection with the filing of this Form 10-Q, management evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2023.

Changes in Internal Control Over Financial Reporting - No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended March 31, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

31
PART II
OTHER INFORMATION


Item 1. Legal Proceedings.

A description of the legal proceedings to which the Company and its subsidiaries are a party is contained in Note 13. Contingencies to the consolidated financial statements included in Part I of this Quarterly Report on Form 10-Q, and is incorporated herein by reference.

Item 1A. Risk Factors.

There have been no material changes to the risk factors disclosed in our 2022 Annual Report on Form 10-K.



32

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

In November 2005, the Company's Board of Directors announced a stock repurchase program, which was most recently been increased in December 2022. The Company is authorized to repurchase up to $6.0 billion, inclusive of past authorizations.

The stock repurchase program is effected primarily through regular open-market purchases (which may include repurchase plans designed to comply with Rule 10b5-1 and accelerated share repurchases), the amounts and timing of which are subject to our discretion as part of our capital allocation strategy, and may be based upon general market conditions and the prevailing price and trading volumes of our common stock. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time.

Issuer Purchases of Equity Securities
First Quarter 2023
(shares in thousands)
Period
 
Total Number of Shares Purchased (1)
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs ($ in millions) (2)
January 1, 2023 - January 31, 2023
3,511 $79.44 3,485 $2,529 
February 1, 2023 - February 28, 2023
1,571 72.93 1,367 2,429 
March 1, 2023 - March 31, 2023
503 64.08 — 2,429 
Total5,585 $76.22 4,852 $2,429 
(1) Includes 696 thousand shares relinquished to the Company by certain employees for payment of taxes; open market purchases of 6.8 thousand shares by Andrew Asher, the Company's CFO, at a weighted average price of $71.94 which was previously disclosed on Form 4 filed with the SEC on February 10, 2023; and an open market purchase of 30 thousand shares by Sarah London, the Company's CEO, at a price of $62.60 which was previously disclosed on Form 4 filed with the SEC on March 17, 2023.
(2) A remaining amount of approximately $2.4 billion is available under the stock repurchase program as of March 31, 2023.

33

Item 6. Exhibits.
EXHIBIT
NUMBER		 
DESCRIPTION
10.1
10.2
10.3
31.1
31.2
32.1
32.2
101The following materials from the Centene Corporation Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations; (iii) the Consolidated Statements of Comprehensive Earnings (Loss); (iv) the Consolidated Statements of Stockholders' Equity; (v) the Consolidated Statements of Cash Flows and (vi) related notes.
104Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101.
34
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized as of April 25, 2023.

 CENTENE CORPORATION
      
 By: /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)
 By: /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)
 By: /s/ KATIE N. CASSO
 Senior Vice President, Corporate Controller and Chief Accounting Officer
(principal accounting officer)

35
 EX-10.1 2 a2023033110-qexhibit101.htm EX-10.1 Document

EXHIBIT 10.1
CENTENE CORPORATION

Restricted Stock Unit Agreement Granted Under
2012 Stock Incentive Plan, As Amended

THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <<Participant Name>> (hereinafter the “Participant”).

WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of the Company in connection with the Participant’s relationship with the Company; and

WHEREAS, the Company desires to align the long-term interests of its valued employees with those of the Company by providing the ownership interest granted herein and to prevent former employees whose interest may become adverse to the Company from maintaining an ownership interest in the Company;

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:

1.Grant of RSUs.

This Agreement evidences the grant by the Company on <<Grant Date>> (or the “Grant Date”) to <<Participant Name>> of <<RSU#>> restricted stock units (each an “RSU,” and collectively the “RSUs”) pursuant to the Company’s 2012 Stock Incentive Plan, as Amended (the “Plan”), that will settle in shares of common stock, $.001 par value per share, of the Company (“Common Stock”), as provided in this Agreement. The shares of Common Stock that are issuable upon vesting of the RSUs are referred to in this Agreement as “Shares.”

2.Vesting.

Subject to Section 3 of this Agreement, the table outlined on the last page of this Agreement (the “Appendix”) sets forth each date upon which RSUs shall become vested (each such date, a “Vesting Date”), provided that the Continuous Service of Participant continues through and on the applicable Vesting Date.

#VestingDateandQuantity#

3.Reorganization Event.

The foregoing vesting schedule notwithstanding, if a Change in Control (as defined below) occurs and the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by the Company (or a parent or subsidiary thereof) without Cause (as defined below) or by the Participant for Good Reason (as defined below), and the Participant’s date of termination occurs (or in the case of the Participant’s termination of employment for Good Reason, the event giving rise to Good Reason occurs) within 24 months following the Change in Control, all unvested RSUs shall automatically become 100% vested and shall be paid on the Participant’s date of termination (“CIC Termination Payment”). A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Exchange Act, and as such term is modified in sections



13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent or more of the combined voting power of the Company’s then-outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation. To the extent required to avoid the adverse tax consequences under Section 409A of the Code (“Section 409A”), a Change in Control shall be deemed to have occurred only if it meets the foregoing requirements and meets the requirements for a change in control event under Section 409A. “Cause” shall include acts or omissions that the Company determines, after affording the Participant an opportunity to be heard,  (i) are criminal, dishonest, fraudulent, constitute misconduct, or reflect negatively on the reputation of the Company (including any parent, subsidiary, affiliate or division of the Company); (ii) could expose the Company or any parent, subsidiary, affiliate or division of the Company to claims of illegal harassment or discrimination in employment; (iii) are material breaches of this Agreement or other agreement with the Company; or (iv) reflect continued and repeated failure to perform substantially the duties of his/her employment. “Good Reason” means: (a) if the Participant is a party to an employment or service agreement with the Company or its affiliates and such agreement provides for a definition of Good Reason, the definition contained therein; or (b) if no such agreement exists or if such agreement does not define Good Reason, the occurrence of one or more of the following without the Participant's express written consent, which circumstances are not remedied by the Company within thirty (30) days of its receipt of a written notice from the Participant describing the applicable circumstances (which notice must be provided by the Participant within ninety (90) days of the Participant's knowledge of the applicable circumstances): (i) any material, adverse change in the Participant's responsibilities, authority, title, status or reporting structure; (ii) a material reduction in the Participant's base salary or short-term cash incentive opportunity; or (iii) a geographical relocation of the Participant's principal office location by more than fifty (50) miles; provided that, the Participant in fact terminates employment for Good Reason within one hundred fifty (150) days following the initial existence of the circumstances giving rise to such Good Reason.




4.Distribution of Shares.

(a)Timing of Distribution. The Company will distribute to the Participant (or to the Participant’s beneficiary in the event of the death of the Participant occurring after a Vesting Date but before distribution of the corresponding Shares), as soon as administratively practicable after each Vesting Date, the Shares represented by RSUs that vested on such Vesting Date, except that, payment shall occur earlier and extinguish any further payment on any future Vesting Date in the event that a CIC Termination Payment occurs or payment on death or disability occurs in accordance with Section 4(c).

(b)No Fractional Shares. No fractional Shares shall be issuable pursuant to any RSU. In lieu of any fractional shares to which the Participant would otherwise be entitled, the Company may, in its discretion, determine whether to pay, in lieu of such fractional Share, cash in an amount equal to such fractional Share multiplied by the Fair Market Value (as defined in the Plan) of a share of Common Stock, or whether any such fractional Share should be rounded down to the nearest whole Share, forfeited without consideration therefor, or otherwise eliminated.

(c)Termination of Employment. In the event that the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated for any reason by the Company or by the Participant other than by reason of death or disability (within the meaning of Section 409A(a)(2)(c) of the Internal Revenue Code of 1986, as amended (the “Code”)), the RSUs shall cease vesting as of the date of termination. In the event the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by reason of death or disability (as defined previously in this Section 4(c)), the pro- rata amount of RSUs, attributable to the number of completed months employed between the grant date and the termination date shall immediately vest and be paid on the date of such death or disability (or within 30 days thereafter).

(d)Compliance Restrictions. The Company shall not be obligated to issue to the Participant the Shares upon the vesting of any RSU (or otherwise) unless (i) the Participant has complied with covenants set forth in Section 9 of this Agreement and (ii) the issuance and delivery of such Shares shall comply with all relevant provisions of law and other legal requirements including any applicable federal or state securities laws and the requirements of any stock exchange or quotation system upon which Common Stock may then be listed or quoted.

5.Restrictions on Transfer.

The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except to the Participant's beneficiary as provided in Section 4(a) in the event of the Participant's death. The Participant's beneficiary can be designated and recorded with the Company’s stock plan administrator or, if no election is made with the stock plan administrator, Shares will be distributed to the Participant’s beneficiary under the Centene Management Corporation Retirement Plan. In the absence of any such beneficiary designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s executor, administrator, or legal representative.






6.No Rights as a Stockholder; Dividend Equivalents

Except as set forth in the Plan, neither the Participant nor any person claiming under or through the Participant shall be, or shall have any rights or privileges of, a stockholder of the Company in respect of any Share issuable pursuant to the RSUs granted hereunder until such Share has been delivered to the Participant. Notwithstanding the foregoing or any provision of the Plan to the contrary, to the extent dividends are paid on shares of Common Stock and such dividends have a record date that is on or after the Grant Date but prior to the distribution of the Shares pursuant to the vesting of the RSUs, then the Participant shall be credited with an amount equivalent to the dividends that would have been paid to the Participant for each RSU granted to the Participant pursuant to this Agreement, as determined by the Compensation Committee in its sole discretion (“Dividend Equivalents”), and such Dividend Equivalents shall be subject to the same vesting and forfeiture restrictions as the RSUs to which they are attributable. Any such Dividend Equivalents shall be paid in cash on any Shares delivered in connection with vested RSUs, subject to applicable tax withholding, no later than thirty days after the RSUs to which such Dividend Equivalents are attributable are distributed; provided, that no interest or other earnings will be credited to the Participant with respect to any such Dividend Equivalents.

7.Withholding Taxes; Section 83(b) Election.

(a)No Shares will be delivered pursuant to the vesting of an RSU unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, the amount required or permitted by federal, state, local and/or foreign tax laws to be withheld with respect to the vesting or settlement of such RSU; provided, that, notwithstanding the foregoing, the Participant shall be permitted, with the Company’s consent, to satisfy the applicable tax obligations with respect to any shares of RSUs by net share settlement, pursuant to which the Company shall repurchase the largest whole number of shares of RSUs having a Fair Market Value (as defined in the Plan) equal to the applicable tax obligations.
(b)The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to the RSUs.
8.Provisions of the Plan.

The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.

9.Participant’s Covenants.

For and in consideration of the delivery of this Agreement, the Participant agrees to the provisions of this Section 9.

(a)Confidential Information. As used in this Agreement, “Confidential Information” shall mean the Company’s trade secrets and other non-public proprietary information relating to the Company or the business of the Company, including information relating to financial statements, customer lists and identities, potential customers, customer contacts, employee skills and compensation, employee data, suppliers, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, profit margins, financial, promotional, marketing, training or operational information, and other information



developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Participant.

(b)Non-Disclosure. The Participant agrees that the Confidential Information is a valuable, special and unique asset of the Company’s business, that such Confidential Information is important to the Company and the effective operation of the Company’s business, and that during employment with the Company and at all times thereafter, the Participant shall not, directly or indirectly, disclose to any competitor or other person or entity (other than current employees of the Company) any Confidential Information that the Participant obtains while performing services for the Company, except as may be required in the Participant’s reasonable judgment to fulfill his duties hereunder or to comply with any applicable legal obligation.

(c)Non-Competition; Non-Solicitation.

(i) During Participant’s employment with the Company and for the period of six (6) months (or, if longer, the post-termination period specified in any individual severance or employment agreement, as applicable, to which the Participant is a party) immediately after the termination of Participant’s employment with the Company (including any parent, subsidiary, affiliate or division of the Company) for any reason whatsoever, and whether voluntary or involuntary, Participant shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares), counsel, advise, consult, be employed or otherwise engaged by or with any entity or enterprise (“Competitor”) that competes or that intends or plans to compete with (A) any area of business in which the Company or any affiliate of the Company is engaged, and in which the Participant was engaged, participated in or about which the Participant learned Confidential Information during the Participant’s last thirty-six (36) months of employment, or (B) any other area of business for which the Company or any affiliate of the Company has taken substantial steps towards becoming engaged, and in which the Participant was engaged, participated in or about which the Participant learned Confidential Information during the Participant’s last 36 months of employment. Because the Company and its affiliates engage in business nationwide, the obligations under this Section 9(c)(i) shall apply nationwide (anywhere in the United States). Notwithstanding the foregoing, the Participant shall not violate this provision by providing services to a unit, division, subsidiary or affiliate of a Competitor which otherwise engages in activities competitive with the business activities of the Company if such unit, division, subsidiary or affiliate for which the Participant provides services does not engage in such business activities.

(ii)During the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) and for the period of twelve months immediately after the termination of the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) for any cause whatsoever, and whether voluntary or involuntary (“Restricted Period”), the Participant will not, either directly or indirectly, either for himself or for any other person, firm, company or corporation, call upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, vendors or suppliers of the Company that (at any time during the last three years of the Participant’s employment) the Participant had dealings with, or responsibility for, or as to which the Participant had access to the Company’s (or any affiliate of the Company’s) Confidential Information or such customers’, providers’, vendors’ or suppliers’ confidential information.




(iii)The Participant shall not, at any time during the Restricted Period, without the prior written consent of the Company, (i) directly or indirectly, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six months an employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company); or (ii) take any action to encourage or induce any employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company) to cease their relationship with the Company (or any parent, subsidiary, affiliate or division of the Company) for any reason. Notwithstanding the foregoing, the Participant shall not violate this Section 9(c)(iii) by advertising not specifically targeted at any of the Company’s employees and serving as a reference upon request.

(iv)This Section 9(c) shall not apply if a "Change in Control" (as defined in Section 3) occurs.

(d)Enforcement. If any of the provisions or subparts of this Section 9 shall be held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 9 is held to be overbroad or unreasonable as written, the parties agree that the applicable provision should be considered to be amended to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court and enforced as amended.

(e)Remedy for Breach.

(i)Because the Participant’s services are unique and because the Participant has access to the Company’s Confidential Information, the parties agree that any breach or threatened breach of this Section 9 will cause irreparable harm to the Company and that money damages alone would be an inadequate remedy. The parties therefore agree that, in the event of any breach or threatened breach of this Section 9, and in addition to all other rights and remedies available to it, the Company may apply to any court of competent jurisdiction for specific performance and/or injunctive or other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 9.

(ii)The Participant shall immediately repay to the Company a cash sum in the principal amount equal to all gross proceeds (before-tax) realized by Participant upon the sale or other disposition of the Shares occurring at any time during the period commencing on the date that is three years before the date of termination of the Participant’s employment with the Company and all Subsidiaries of the Company and ending on the date of the Participant’s breach or threatened breach of this Section 9 (the “Refund Period”), together with interest accrued thereon, from the date of such breach or threatened breach, at the prime rate (compounded calendar monthly) as published from time to time in The Wall Street Journal, electronic edition (“Interest”); and

(iii)The Participant shall repay to the Company a cash sum equal to the fair market value of all of the Shares transferred by the Participant as a gift or gifts at any time during the Refund Period, together with Interest, and for which purpose, “fair market value” shall be the Fair Market Value of one share of Common Stock on the date such gift occurs.




(iv)The Participant acknowledges and agrees that nothing contained herein shall be construed to be an excessive remedy to prohibit the Company from pursuing any other remedies available to it for such actual or threatened breach, including the recovery of money damages, proximately caused by the Participant’s breach of this Section 9.

(f)Survival. The provisions of this Section 9 shall survive and continue in full force in accordance with their terms notwithstanding any forfeiture, termination or expiration of this Agreement in accordance with its terms or any termination of the Participant’s employment for any reason (whether voluntary or involuntary).

10.Miscellaneous.

(a)Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.
(b)Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.

(c)Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 5 of this Agreement.

(d)Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after delivery to a United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this paragraph (d).

(e)Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.

(f)Participant’s Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; and (iv) is fully aware of the legal and binding effect of this Agreement.

(g)Unfunded Rights. The right of the Participant to receive Common Stock pursuant to this Agreement is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this Agreement other than those of an unsecured general creditor of the Company.

(h)Deferral. Neither the Company nor the Participant may defer delivery of any Shares issuable under unvested RSUs except to the extent that such deferral complies with the provisions of Section 409A of the Code.




(i)Clawback. By accepting the grant of the RSUs hereunder, the Participant is agreeing to be bound by the Company’s clawback policies and procedures, as in effect or as may be adopted and/or modified from time to time by the Company in its discretion (including, without limitation, to comply with applicable law or stock exchange listing requirements).

(j)Section 409A.

(i)This Agreement is intended to comply with the requirements of Section 409A, including the exceptions thereto, and shall be construed and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. For purposes of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement in connection with a termination of employment shall only be made if such termination of employment constitutes a "separation from service" under Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A.

(ii)If any provision of this Agreement or the Plan shall be invalid or unenforceable, in whole or in part, or as applied to any circumstance, under the laws of any jurisdiction that may govern for such purpose, or if any provision of this Agreement or the Plan needs to be interpreted to comply with the requirements of Section 409A, then such provision shall be deemed to be modified or restricted, or so interpreted, to the extent and in the manner necessary to render the same valid and enforceable, or to the extent and in the manner necessary to be interpreted in compliance with such requirements of the Code, either generally or as applied to such circumstance, or shall be deemed excised from this Agreement or the Plan, as the case may require, and this Agreement or the Plan shall be construed and enforced to the maximum extent permitted by law as if such provision had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated herein, as the case may be.

(iii)Notwithstanding any other provision of this Agreement, if at the time of the Participant’s termination of employment, the Participant is a "specified employee," determined in accordance with Section 409A, any payments and benefits provided under this Agreement that constitute "nonqualified deferred compensation" subject to Section 409A that are provided to the Participant on account of separation from service shall not be paid until the first payroll date to occur following the six-month anniversary of the Participant’s termination date ("Specified Employee Payment Date"). The aggregate amount of any payments that would otherwise have been made during such six-month period shall be paid in a lump sum on the Specified Employee Payment Date without interest. If the Participant dies before the Specified Employee Payment Date, any delayed payments shall be paid to the Participant’s beneficiary in a lump sum within upon the Participant’s death.




(k)Provisions Related to Golden Parachute Excise Tax.

(i)Change in Control When the Shares are Not Publicly Traded. Notwithstanding anything to the contrary contained in this Agreement, to the extent that, upon a Change in Control prior to the time at which the Shares have become publicly traded, any of the payments and benefits provided for under the Plan, any Award Agreement or any other agreement or arrangement between the Company or any of its Affiliates and the Participant (collectively, the “Payments”) would constitute a “parachute payment” within the meaning of section 280G of the Code (a “Parachute Payment”), the amount of such Payments shall be reduced to the amount (the “Safe Harbor Amount”) that would result in no portion of the Payments being treated as an excess parachute payment pursuant to section 280G of the Code (the “Excise Tax”). If, upon a Change in Control prior to the time at which the Shares have become publicly traded, the Parachute Payments that would otherwise be reduced or eliminated, as the case may be, pursuant to this Section 11(k)(i) could be paid without the loss of a deduction under Section 280G of the Code if the shareholder approval exception to treatment as a Parachute Payment can be and is satisfied, then the Company shall use its reasonable best efforts to cause such Parachute Payments to be submitted for such approval in accordance with Section 280G(b)(5)(B) prior to the Change in Control giving rise to such Parachute Payments. If such approval is received, any reduction or forfeiture pursuant to this Section 11(k)(i) shall be reversed, and the subject amount shall be payable to the Participant without regard to this Section 11(k).

(ii)Change in Control When the Shares are Publicly Traded. If upon a Change in Control occurring at any time that the Shares are publicly traded, any Payments would constitute Parachute Payments, then, if and solely to the extent that reducing the benefits payable hereunder would result in the Participant’s receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income, employment and other taxes payable on such amounts, the amounts payable hereunder shall be reduced or eliminated, as the case may be, so that the total amount of Parachute Payments received by the Participant do not exceed the Safe Harbor Amount.

(iii)Order of Reduction in Payments. Any reduction in the amount of compensation or benefits effected pursuant to this Section 11(k) shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to the Participant, then from any other payments which are treated in their entirety as Parachute Payments and then from any other Parachute Payments payable to the Participant with the later possible payment or vesting date being reduced or eliminated before a payment or benefit with an earlier payment or vesting date; provided that if the foregoing order of reduction or elimination would violate Section 409A, then the reduction shall be made pro rata among the payments or benefits otherwise due or payable to the Participant.




(l)Consent to Electronic Delivery; Electronic Signature.

In lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate and agrees that the Participant’s electronic signature is the same as, and shall have the same force and effect as, the Participant’s manual signature.






ELECTRONIC ACCEPTANCE

By the Participant’s electronic acceptance hereof, the Participant and the Company agree that this Award is granted and governed by the terms and conditions of the Plan and this Agreement.

By the Participant’s electronic acceptance hereof, the Participant agrees that in lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate.



 EX-10.2 3 a2023033110-qexhibit102.htm EX-10.2 Document

EXHIBIT 10.2
CENTENE CORPORATION

Restricted Stock Unit Agreement Granted Under
2012 Stock Incentive Plan, As Amended

THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <<Participant Name>> (hereinafter the “Participant”).

WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of the Company in connection with the Participant’s relationship with the Company; and

WHEREAS, the Company desires to align the long-term interests of its valued employees with those of the Company by providing the ownership interest granted herein and to prevent former employees whose interest may become adverse to the Company from maintaining an ownership interest in the Company;

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:

1.Grant of RSUs.

This Agreement evidences the grant by the Company on <<Grant Date>> (or the “Grant Date”) to <<Participant Name>> of <<RSU#>> restricted stock units (each an “RSU,” and collectively the “RSUs”) pursuant to the Company’s 2012 Stock Incentive Plan, as Amended (the “Plan”), that will settle in shares of common stock, $.001 par value per share, of the Company (“Common Stock”), as provided in this Agreement. The shares of Common Stock that are issuable upon vesting of the RSUs are referred to in this Agreement as “Shares.”

2.Vesting.

Subject to Section 3 of this Agreement, the table outlined on the last page of this Agreement (the “Appendix”) sets forth each date upon which RSUs shall become vested (each such date, a “Vesting Date”), provided that the Continuous Service of Participant continues through and on the applicable Vesting Date.

#VestingDateandQuantity#

3.Reorganization Event.

The foregoing vesting schedule notwithstanding, if a Change in Control (as defined below) occurs and the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by the Company (or a parent or subsidiary thereof) without Cause (as defined below) or by the Participant for Good Reason (as defined below), and the Participant’s date of termination occurs (or in the case of the Participant’s termination of employment for Good Reason, the event giving rise to Good Reason occurs) within 24 months following the Change in Control, all unvested RSUs shall automatically become 100% vested and shall be paid on the Participant’s date of termination (“CIC Termination Payment”). A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Exchange Act, and as such term is modified in sections




13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent or more of the combined voting power of the Company’s then-outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation. To the extent required to avoid the adverse tax consequences under Section 409A of the Code (“Section 409A”), a Change in Control shall be deemed to have occurred only if it meets the foregoing requirements and meets the requirements for a change in control event under Section 409A. “Cause” shall include acts or omissions that the Company determines, after affording the Participant an opportunity to be heard,  (i) are criminal, dishonest, fraudulent, constitute misconduct, or reflect negatively on the reputation of the Company (including any parent, subsidiary, affiliate or division of the Company); (ii) could expose the Company or any parent, subsidiary, affiliate or division of the Company to claims of illegal harassment or discrimination in employment; (iii) are material breaches of this Agreement or other agreement with the Company; or (iv) reflect continued and repeated failure to perform substantially the duties of his/her employment. “Good Reason” means: (a) if the Participant is a party to an employment or service agreement with the Company or its affiliates and such agreement provides for a definition of Good Reason, the definition contained therein; or (b) if no such agreement exists or if such agreement does not define Good Reason, the occurrence of one or more of the following without the Participant's express written consent, which circumstances are not remedied by the Company within thirty (30) days of its receipt of a written notice from the Participant describing the applicable circumstances (which notice must be provided by the Participant within ninety (90) days of the Participant's knowledge of the applicable circumstances): (i) any material, adverse change in the Participant's responsibilities, authority, title, status or reporting structure; (ii) a material reduction in the Participant's base salary or short-term cash incentive opportunity; or (iii) a geographical relocation of the Participant's principal office location by more than fifty (50) miles; provided that, the Participant in fact terminates employment for Good Reason within one hundred fifty (150) days following the initial existence of the circumstances giving rise to such Good Reason.







4.Distribution of Shares.

(a)Timing of Distribution. The Company will distribute to the Participant (or to the Participant’s beneficiary in the event of the death of the Participant occurring after a Vesting Date but before distribution of the corresponding Shares), as soon as administratively practicable after each Vesting Date, the Shares represented by RSUs that vested on such Vesting Date, except that, payment shall occur earlier and extinguish any further payment on any future Vesting Date in the event that a CIC Termination Payment occurs or payment on death or disability occurs in accordance with Section 4(c).

(b)No Fractional Shares. No fractional Shares shall be issuable pursuant to any RSU. In lieu of any fractional shares to which the Participant would otherwise be entitled, the Company may, in its discretion, determine whether to pay, in lieu of such fractional Share, cash in an amount equal to such fractional Share multiplied by the Fair Market Value (as defined in the Plan) of a share of Common Stock, or whether any such fractional Share should be rounded down to the nearest whole Share, forfeited without consideration therefor, or otherwise eliminated.

(c)Termination of Employment. In the event that the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated for any reason by the Company or by the Participant other than by reason of death or disability (within the meaning of Section 409A(a)(2)(c) of the Internal Revenue Code of 1986, as amended (the “Code”)) or Qualified Retirement (as defined below), the RSUs shall cease vesting as of the date of termination. In the event the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by reason of death or disability (as defined previously in this Section 4(c)), the pro- rata amount of RSUs, attributable to the number of completed months employed between the grant date and the termination date shall immediately vest and be paid on the date of such death or disability (or within 30 days thereafter). In the event the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by reason of a Qualified Retirement, the RSUs shall cease vesting one year following the date of termination, and any RSUs that vest during such one-year period shall be payable on the applicable Vesting Date on which they otherwise would have been paid in accordance with Section 4(a). A Qualified Retirement is a retirement made pursuant to a bona-fide notice of retirement made 90 days in advance, by a Participant who is at least 55 years old and has been employed at the Company for at least 10 years.

(d)Compliance Restrictions. The Company shall not be obligated to issue to the Participant the Shares upon the vesting of any RSU (or otherwise) unless (i) the Participant has complied with covenants set forth in Section 9 of this Agreement and (ii) the issuance and delivery of such Shares shall comply with all relevant provisions of law and other legal requirements including any applicable federal or state securities laws and the requirements of any stock exchange or quotation system upon which Common Stock may then be listed or quoted.

5.Restrictions on Transfer.

The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except to the Participant's beneficiary as provided in Section 4(a) in the event of the Participant's death. The Participant's beneficiary can




be designated and recorded with the Company’s stock plan administrator or, if no election is made with the stock plan administrator, Shares will be distributed to the Participant’s beneficiary under the Centene Management Corporation Retirement Plan. In the absence of any such beneficiary designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s executor, administrator, or legal representative.

6.No Rights as a Stockholder; Dividend Equivalents

Except as set forth in the Plan, neither the Participant nor any person claiming under or through the Participant shall be, or shall have any rights or privileges of, a stockholder of the Company in respect of any Share issuable pursuant to the RSUs granted hereunder until such Share has been delivered to the Participant. Notwithstanding the foregoing or any provision of the Plan to the contrary, to the extent dividends are paid on shares of Common Stock and such dividends have a record date that is on or after the Grant Date but prior to the distribution of the Shares pursuant to the vesting of the RSUs, then the Participant shall be credited with an amount equivalent to the dividends that would have been paid to the Participant for each RSU granted to the Participant pursuant to this Agreement, as determined by the Compensation Committee in its sole discretion (“Dividend Equivalents”), and such Dividend Equivalents shall be subject to the same vesting and forfeiture restrictions as the RSUs to which they are attributable. Any such Dividend Equivalents shall be paid in cash on any Shares delivered in connection with vested RSUs, subject to applicable tax withholding, no later than thirty days after the RSUs to which such Dividend Equivalents are attributable are distributed; provided, that no interest or other earnings will be credited to the Participant with respect to any such Dividend Equivalents.

7.Withholding Taxes; Section 83(b) Election.

(a)No Shares will be delivered pursuant to the vesting of an RSU unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, the amount required or permitted by federal, state, local and/or foreign tax laws to be withheld with respect to the vesting or settlement of such RSU; provided, that, notwithstanding the foregoing, the Participant shall be permitted, with the Company’s consent, to satisfy the applicable tax obligations with respect to any shares of RSUs by net share settlement, pursuant to which the Company shall repurchase the largest whole number of shares of RSUs having a Fair Market Value (as defined in the Plan) equal to the applicable tax obligations.
(b)The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to the RSUs.
8.Provisions of the Plan.

The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.

9.Participant’s Covenants.

For and in consideration of the delivery of this Agreement, the Participant agrees to the provisions of this Section 9.





(a)Confidential Information. As used in this Agreement, “Confidential Information” shall mean the Company’s trade secrets and other non-public proprietary information relating to the Company or the business of the Company, including information relating to financial statements, customer lists and identities, potential customers, customer contacts, employee skills and compensation, employee data, suppliers, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, profit margins, financial, promotional, marketing, training or operational information, and other information developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Participant.

(b)Non-Disclosure. The Participant agrees that the Confidential Information is a valuable, special and unique asset of the Company’s business, that such Confidential Information is important to the Company and the effective operation of the Company’s business, and that during employment with the Company and at all times thereafter, the Participant shall not, directly or indirectly, disclose to any competitor or other person or entity (other than current employees of the Company) any Confidential Information that the Participant obtains while performing services for the Company, except as may be required in the Participant’s reasonable judgment to fulfill his duties hereunder or to comply with any applicable legal obligation.

(c)Non-Competition; Non-Solicitation.

(i)During Participant’s employment with the Company and for the period of six (6) months (or, if longer, the post-termination period specified in any individual severance or employment agreement, as applicable, to which the Participant is a party) immediately after the termination of Participant’s employment with the Company (including any parent, subsidiary, affiliate or division of the Company) for any reason whatsoever, and whether voluntary or involuntary, Participant shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares), counsel, advise, consult, be employed or otherwise engaged by or with any entity or enterprise (“Competitor”) that competes or that intends or plans to compete with (A) any area of business in which the Company or any affiliate of the Company is engaged, and in which the Participant was engaged, participated in or about which the Participant learned Confidential Information during the Participant’s last thirty-six (36) months of employment, or (B) any other area of business for which the Company or any affiliate of the Company has taken substantial steps towards becoming engaged, and in which the Participant was engaged, participated in or about which the Participant learned Confidential Information during the Participant’s last 36 months of employment. Because the Company and its affiliates engage in business nationwide, the obligations under this Section 9(c)(i) shall apply nationwide (anywhere in the United States). Notwithstanding the foregoing, the Participant shall not violate this provision by providing services to a unit, division, subsidiary or affiliate of a Competitor which otherwise engages in activities competitive with the business activities of the Company if such unit, division, subsidiary or affiliate for which the Participant provides services does not engage in such business activities.

(ii)During the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) and for the period of twelve months immediately after the termination of the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) for any cause whatsoever, and whether voluntary or involuntary (“Restricted Period”), the Participant will not, either directly or




indirectly, either for himself or for any other person, firm, company or corporation, call upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, vendors or suppliers of the Company that (at any time during the last three years of the Participant’s employment) the Participant had dealings with, or responsibility for, or as to which the Participant had access to the Company’s (or any affiliate of the Company’s) Confidential Information or such customers’, providers’, vendors’ or suppliers’ confidential information.

(iii)The Participant shall not, at any time during the Restricted Period, without the prior written consent of the Company, (i) directly or indirectly, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six months an employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company); or (ii) take any action to encourage or induce any employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company) to cease their relationship with the Company (or any parent, subsidiary, affiliate or division of the Company) for any reason. Notwithstanding the foregoing, the Participant shall not violate this Section 9(c)(iii) by advertising not specifically targeted at any of the Company’s employees and serving as a reference upon request.

(iv)This Section 9(c) shall not apply if a "Change in Control" (as defined in Section 3) occurs.

(d)Enforcement. If any of the provisions or subparts of this Section 9 shall be held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 9 is held to be overbroad or unreasonable as written, the parties agree that the applicable provision should be considered to be amended to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court and enforced as amended.

(e)Remedy for Breach.

(i)Because the Participant’s services are unique and because the Participant has access to the Company’s Confidential Information, the parties agree that any breach or threatened breach of this Section 9 will cause irreparable harm to the Company and that money damages alone would be an inadequate remedy. The parties therefore agree that, in the event of any breach or threatened breach of this Section 9, and in addition to all other rights and remedies available to it, the Company may apply to any court of competent jurisdiction for specific performance and/or injunctive or other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 9.

(ii)The Participant shall immediately repay to the Company a cash sum in the principal amount equal to all gross proceeds (before-tax) realized by Participant upon the sale or other disposition of the Shares occurring at any time during the period commencing on the date that is three years before the date of termination of the Participant’s employment with the Company and all Subsidiaries of the Company and ending on the date of the Participant’s breach or threatened breach of this Section 9 (the “Refund Period”), together with interest accrued thereon, from the date of such breach or threatened breach, at the prime rate




(compounded calendar monthly) as published from time to time in The Wall Street Journal, electronic edition (“Interest”); and

(iii)The Participant shall repay to the Company a cash sum equal to the fair market value of all of the Shares transferred by the Participant as a gift or gifts at any time during the Refund Period, together with Interest, and for which purpose, “fair market value” shall be the Fair Market Value of one share of Common Stock on the date such gift occurs.

(iv)The Participant acknowledges and agrees that nothing contained herein shall be construed to be an excessive remedy to prohibit the Company from pursuing any other remedies available to it for such actual or threatened breach, including the recovery of money damages, proximately caused by the Participant’s breach of this Section 9.

(f)Survival. The provisions of this Section 9 shall survive and continue in full force in accordance with their terms notwithstanding any forfeiture, termination or expiration of this Agreement in accordance with its terms or any termination of the Participant’s employment for any reason (whether voluntary or involuntary).

10.Miscellaneous.

(a)Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.
(b)Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.

(c)Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 5 of this Agreement.

(d)Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after delivery to a United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this paragraph (d).

(e)Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.

(f)Participant’s Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; and (iv) is fully aware of the legal and binding effect of this Agreement.





(g)Unfunded Rights. The right of the Participant to receive Common Stock pursuant to this Agreement is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this Agreement other than those of an unsecured general creditor of the Company.

(h)Deferral. Neither the Company nor the Participant may defer delivery of any Shares issuable under unvested RSUs except to the extent that such deferral complies with the provisions of Section 409A of the Code.

(i)Clawback. By accepting the grant of the RSUs hereunder, the Participant is agreeing to be bound by the Company’s clawback policies and procedures, as in effect or as may be adopted and/or modified from time to time by the Company in its discretion (including, without limitation, to comply with applicable law or stock exchange listing requirements).

(j)Section 409A.

(i)This Agreement is intended to comply with the requirements of Section 409A, including the exceptions thereto, and shall be construed and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. For purposes of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement in connection with a termination of employment shall only be made if such termination of employment constitutes a "separation from service" under Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A.

(ii)If any provision of this Agreement or the Plan shall be invalid or unenforceable, in whole or in part, or as applied to any circumstance, under the laws of any jurisdiction that may govern for such purpose, or if any provision of this Agreement or the Plan needs to be interpreted to comply with the requirements of Section 409A, then such provision shall be deemed to be modified or restricted, or so interpreted, to the extent and in the manner necessary to render the same valid and enforceable, or to the extent and in the manner necessary to be interpreted in compliance with such requirements of the Code, either generally or as applied to such circumstance, or shall be deemed excised from this Agreement or the Plan, as the case may require, and this Agreement or the Plan shall be construed and enforced to the maximum extent permitted by law as if such provision had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated herein, as the case may be.

(iii)Notwithstanding any other provision of this Agreement, if at the time of the Participant’s termination of employment, the Participant is a "specified employee," determined in accordance with Section 409A, any payments and benefits provided under this Agreement that constitute "nonqualified deferred compensation" subject to Section 409A that are provided to the Participant on account of separation from service shall not be paid until the first payroll date to occur following the six-month anniversary of the Participant’s termination date ("Specified Employee Payment Date"). The aggregate amount of any payments that would




otherwise have been made during such six-month period shall be paid in a lump sum on the Specified Employee Payment Date without interest. If the Participant dies before the Specified Employee Payment Date, any delayed payments shall be paid to the Participant’s beneficiary in a lump sum within upon the Participant’s death.

(k)Provisions Related to Golden Parachute Excise Tax.

(i)Change in Control When the Shares are Not Publicly Traded. Notwithstanding anything to the contrary contained in this Agreement, to the extent that, upon a Change in Control prior to the time at which the Shares have become publicly traded, any of the payments and benefits provided for under the Plan, any Award Agreement or any other agreement or arrangement between the Company or any of its Affiliates and the Participant (collectively, the “Payments”) would constitute a “parachute payment” within the meaning of section 280G of the Code (a “Parachute Payment”), the amount of such Payments shall be reduced to the amount (the “Safe Harbor Amount”) that would result in no portion of the Payments being treated as an excess parachute payment pursuant to section 280G of the Code (the “Excise Tax”). If, upon a Change in Control prior to the time at which the Shares have become publicly traded, the Parachute Payments that would otherwise be reduced or eliminated, as the case may be, pursuant to this Section 11(k)(i) could be paid without the loss of a deduction under Section 280G of the Code if the shareholder approval exception to treatment as a Parachute Payment can be and is satisfied, then the Company shall use its reasonable best efforts to cause such Parachute Payments to be submitted for such approval in accordance with Section 280G(b)(5)(B) prior to the Change in Control giving rise to such Parachute Payments. If such approval is received, any reduction or forfeiture pursuant to this Section 11(k)(i) shall be reversed, and the subject amount shall be payable to the Participant without regard to this Section 11(k).

(ii)Change in Control When the Shares are Publicly Traded. If upon a Change in Control occurring at any time that the Shares are publicly traded, any Payments would constitute Parachute Payments, then, if and solely to the extent that reducing the benefits payable hereunder would result in the Participant’s receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income, employment and other taxes payable on such amounts, the amounts payable hereunder shall be reduced or eliminated, as the case may be, so that the total amount of Parachute Payments received by the Participant do not exceed the Safe Harbor Amount.

(iii)Order of Reduction in Payments. Any reduction in the amount of compensation or benefits effected pursuant to this Section 11(k) shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to the Participant, then from any other payments which are treated in their entirety as Parachute Payments and then from any other Parachute Payments payable to the Participant with the later possible payment or vesting date being reduced or eliminated before a payment or benefit with an earlier payment or vesting date; provided that if the foregoing order of reduction or elimination would violate Section 409A, then the reduction shall be made pro rata among the payments or benefits otherwise due or payable to the Participant.





(l)Consent to Electronic Delivery; Electronic Signature.

    In lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate and agrees that the Participant’s electronic signature is the same as, and shall have the same force and effect as, the Participant’s manual signature.







ELECTRONIC ACCEPTANCE

By the Participant’s electronic acceptance hereof, the Participant and the Company agree that this Award is granted and governed by the terms and conditions of the Plan and this Agreement.

By the Participant’s electronic acceptance hereof, the Participant agrees that in lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate.



 EX-10.3 4 a2023033110-qexhibit103.htm EX-10.3 Document
EXHIBIT 10.3
CENTENE CORPORATION
Performance-Based Restricted Stock Unit Agreement Granted Under
2012 Stock Incentive Plan, As Amended
THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and <<Participant Name>> (hereinafter the “Participant”).
WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of the Company in connection with the Participant’s relationship with the Company; and
WHEREAS, the Company desires to align the long-term interests of its valued employees with those of the Company by providing the ownership interest granted herein and to prevent former employees whose interest may become adverse to the Company from maintaining an ownership interest in the Company;
    NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:
1.Grant of RSUs.
This Agreement evidences the grant by the Company on the <<Grant Date>> (or the “Grant Date”) to <<Participant Name>> of <<PSU Target $>> restricted stock units (each an “RSU,” and collectively the “RSUs”) pursuant to the Company’s 2012 Stock Incentive Plan, as Amended (the “Plan”), that will settle in shares of common stock, $.001 par value per share, of the Company (“Common Stock”), as provided in this Agreement. The shares of Common Stock that are issuable upon vesting of the RSUs are referred to in this Agreement as “Shares.”
2.Performance Condition and Vesting.
(a) The RSUs vest on <<Vest Date>>, subject to satisfying the performance conditions set forth on Exhibit A and on the Participant’s continued employment with the Company through << Date>>. For each RSU earned as set forth on Exhibit A, the Participant will be entitled to receive between zero and two Shares, based upon the level of achievement of the applicable performance conditions in the manner set forth on Exhibit A.
3.Reorganization Event.
The foregoing vesting schedule notwithstanding, if a Change in Control (as defined below) occurs and the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by the Company (or a parent or subsidiary thereof) without Cause (as defined below) or by the Participant for Good Reason (as defined below), and the Participant’s date of termination occurs (or in the case of the Participant’s termination of employment for Good Reason, the event giving rise to Good Reason occurs) within 24 months following the Change in Control, all of the RSUs that are not vested at the time of the Participant’s termination shall vest at the greater of the actual performance level at the time of the Change in Control event or at target performance level, and other vesting criteria shall be deemed met as of the date of the Participant’s termination. A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of



the following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Exchange Act, and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent or more of the combined voting power of the Company’s then-outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation. To the extent required to avoid the adverse tax consequences under Section 409A of the Code (“Section 409A”), a Change in Control shall be deemed to have occurred only if it meets the foregoing requirements and meets the requirements for a change in control event under Section 409A. “Cause” shall include acts or omissions that the Company determines, after affording the Participant an opportunity to be heard,  (i) are criminal, dishonest, fraudulent, constitute misconduct, or reflect negatively on the reputation of the Company (including any parent, subsidiary, affiliate or division of the Company); (ii) could expose the Company or any parent, subsidiary, affiliate or division of the Company to claims of illegal harassment or discrimination in employment; (iii) are material breaches of this Agreement or other agreement with the Company; or (iv) reflect continued and repeated failure to perform substantially the duties of his/her employment. “Good Reason” means: (a) if the Participant is a party to an employment or service agreement with the Company or its affiliates and such agreement provides for a definition of Good Reason, the definition contained therein; or (b) if no such agreement exists or if such agreement does not define Good Reason, the occurrence of one or more of the following without the Participant's express written consent, which circumstances are not remedied by the Company within thirty (30) days of its receipt of a written notice from the Participant describing the applicable circumstances (which notice must be provided by the Participant within ninety (90) days of the Participant's knowledge of the applicable circumstances): (i) any material, adverse change in the Participant's responsibilities, authority, title, status or reporting structure; (ii) a material reduction in the Participant's base salary or short-term cash incentive opportunity; or (iii) a geographical relocation of the Participant's principal office location by more than fifty (50) miles; provided that, the Participant in fact terminates employment for Good Reason within one hundred fifty (150) days following the initial existence of the circumstances giving rise to such Good Reason.




4.Distribution of Shares.
(a)Timing of Distribution. The Company will distribute to the Participant (or to the Participant’s beneficiary in the event of the death of the Participant occurring after a vesting date but before distribution of the corresponding Shares), as soon as administratively practicable after <<Vest Date>>, the Shares represented by RSUs that vested on such vesting date.
(b)No Fractional Shares. No fractional Shares shall be issuable pursuant to any RSU. In lieu of any fractional shares to which the Participant would otherwise be entitled, the Company may, in its discretion, determine whether to pay, in lieu of such fractional Share, cash in an amount equal to such fractional Share multiplied by the Fair Market Value (as defined in the Plan) of a share of Common Stock, or whether any such fractional Share should be rounded down to the nearest whole Share, forfeited without consideration therefor, or otherwise eliminated.
(c)Termination of Employment. In the event that the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated for any reason by the Company or by the Participant other than by reason of death or disability (within the meaning of Section 409A(a)(2)(c) of the Internal Revenue Code of 1986, as amended (the “Code”)) or Qualified Retirement (as defined below), the RSUs shall cease vesting as of the date of termination. In the event the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by reason of death or disability (as defined previously in this Section 4(c)), the pro-rata amount of RSUs at target performance level, based on the number of full months employed with the Company during the vesting period (as described in Exhibit A), shall immediately vest and be payable. In the event the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by reason of a Qualified Retirement, the pro-rata amount of RSUs, based on the number of full months employed with the Company during the vesting period, shall remain eligible to vest based on the Company’s performance during the performance period compared to the metrics as described in Exhibit A. Any such RSUs which are earned shall be distributed in accordance with Section 4(a) above. A Qualified Retirement is a retirement made pursuant to a bona-fide notice of retirement made 90 days in advance by a Participant who is at least 55 years old and has been employed at the Company for at least 10 years.
(d)Compliance Restrictions. The Company shall not be obligated to issue to the Participant the Shares upon the vesting of any RSU (or otherwise) unless (i) the Participant has complied with covenants set forth in Section 9 of this Agreement and (ii) the issuance and delivery of such Shares shall comply with all relevant provisions of law and other legal requirements including any applicable federal or state securities laws and the requirements of any stock exchange or quotation system upon which Common Stock may then be listed or quoted.
5.Restrictions on Transfer.
The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except to the Participant's beneficiary as provided in Section 4(a) in the event of the Participant's death. The Participant's beneficiary can be designated and recorded with the Company’s stock plan administrator or, if no election is made with the stock plan administrator, Shares will be distributed to the Participant’s beneficiary under the Centene Management Corporation Retirement Plan. In the absence of any such beneficiary



designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s executor, administrator, or legal representative.
6.Rights as a Stockholder; Dividend Equivalents.
Except as set forth in the Plan, neither the Participant nor any person claiming under or through the Participant shall be, or shall have any rights or privileges of, a stockholder of the Company in respect of any Share issuable pursuant to the RSUs granted hereunder until such Share has been delivered to the Participant. Notwithstanding the foregoing or any provision of the Plan to the contrary, to the extent dividends are paid on shares of Common Stock and such dividends have a record date that is on or after the Grant Date but prior to the distribution of the Shares pursuant to the vesting of the RSUs, then the Participant shall be credited with an amount equivalent to the dividends that would have been paid to the Participant for each RSU granted to the Participant pursuant to this Agreement (assuming maximum performance), as determined by the Compensation Committee in its sole discretion (“Dividend Equivalents”), and such Dividend Equivalents shall be subject to the same vesting and forfeiture restrictions as the RSUs to which they are attributable. Any such Dividend Equivalents shall be paid in cash on any Shares delivered in connection with vested RSUs, subject to applicable tax withholding, no later than thirty days after the RSUs to which such Dividend Equivalents are attributable are distributed; provided, that no interest or other earnings will be credited to the Participant with respect to any such Dividend Equivalents.
7.Withholding Taxes; Section 83(b) Election.
(a)No Shares will be delivered pursuant to the vesting of an RSU unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, the amount required or permitted by federal, state, local and/or foreign tax laws to be withheld with respect to the vesting or settlement of such RSU; provided, that, notwithstanding the foregoing, the Participant shall be permitted, with the Company’s consent, to satisfy the applicable tax obligations with respect to any shares of RSUs by net share settlement, pursuant to which the Company shall repurchase the largest whole number of shares of RSUs having a Fair Market Value (as defined in the Plan) equal to the applicable tax obligations.
(b)The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to the RSUs.

8.Provisions of the Plan.
The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.
9.Participant’s Covenants.
For and in consideration of the delivery of this Agreement, the Participant agrees to the provisions of this Section 9.
(a)Confidential Information. As used in this Agreement, “Confidential Information” shall mean the Company’s trade secrets and other non-public proprietary information relating to the



Company or the business of the Company, including information relating to financial statements, customer lists and identities, potential customers, customer contacts, employee skills and compensation, employee data, suppliers, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, profit margins, financial, promotional, marketing, training or operational information, and other information developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Participant.
(b)Non-Disclosure. The Participant agrees that the Confidential Information is a valuable, special and unique asset of the Company’s business, that such Confidential Information is important to the Company and the effective operation of the Company’s business, and that during employment with the Company and at all times thereafter, the Participant shall not, directly or indirectly, disclose to any competitor or other person or entity (other than current employees of the Company) any Confidential Information that the Participant obtains while performing services for the Company, except as may be required in the Participant’s reasonable judgment to fulfill his duties hereunder or to comply with any applicable legal obligation.
(c)Non-Competition; Non-Solicitation.
(i)During Participant’s employment with the Company and for the period of six (6) months (or, if longer, the post-termination period specified in any individual severance or employment agreement, as applicable, to which the Participant is a party) immediately after the termination of Participant’s employment with the Company (including any parent, subsidiary, affiliate or division of the Company) for any reason whatsoever, and whether voluntary or involuntary, Participant shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares), counsel, advise, consult, be employed or otherwise engaged by or with any entity or enterprise (“Competitor”) that competes, or that intends or plans to compete with (A) any area of business in which the Company or any affiliate of the Company is engaged, and in which the Participant was engaged, participated in or about which the Participant learned Confidential Information during the Participant’s last thirty-six (36) months of employment, or (B) any other area of business for which the Company or any affiliate of the Company has taken substantial steps towards becoming engaged, and in which the Participant was engaged, participated in or about which the Participant learned Confidential Information during the Participant’s last 36 months of employment. Because the Company and its affiliates engage in business nationwide, the obligations under this Section 9(c)(i) shall apply nationwide (anywhere in the United States). Notwithstanding the foregoing, the Participant shall not violate this provision by providing services to a unit, division, subsidiary or affiliate of a Competitor which otherwise engages in activities competitive with the business activities of the Company if such unit, division, subsidiary or affiliate for which the Participant provides services does not engage in such business activities.
(ii)During the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) and for the period of twelve months immediately after the termination of the Participant’s employment with the



Company (or any parent, subsidiary, affiliate or division of the Company) for any cause whatsoever, and whether voluntary or involuntary (“Restricted Period”), the Participant will not, either directly or indirectly, either for himself or for any other person, firm, company or corporation, call upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, vendors or suppliers of the Company that (at any time during the last three years of the Participant’s employment) the Participant had dealings with, or responsibility for, or as to which the Participant had access to the Company’s (or any affiliate of the Company’s) Confidential Information or such customers’, providers’, vendors’ or suppliers’ confidential information.
(iii)The Participant shall not, at any time during the Restricted Period, without the prior written consent of the Company, (i) directly or indirectly, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six months an employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company); or (ii) take any action to encourage or induce any employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company) to cease their relationship with the Company (or any parent, subsidiary, affiliate or division of the Company) for any reason. Notwithstanding the foregoing, the Participant shall not violate this Section 9(c)(iii) by advertising not specifically targeted at any of the Company’s employees and serving as a reference upon request.
(iv) If the participant’s employment ends by reason of a Qualified Retirement, the post-employment restrictions set forth in subsections 9(c)(i), (ii) and (iii) above shall continue until the later of (x) the date set forth in 9(c)(i), (ii) and (iii), as applicable, or (y) the expiration of the last performance period for which the Participant is receiving pro-rata vesting; provided that after the date set forth in subsection 9(c)(i), (ii) or (iii), as applicable, the sole remedies for the Company relating to a violation of the applicable post-employment restrictions shall be those set forth in subsections90(e)(ii) and (iii) below.
(v)This Section 9(c) shall not apply if a "Change in Control" (as defined in Section 3) occurs.
(d)Enforcement. If any of the provisions or subparts of this Section 9 shall be held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 9 is held to be overbroad or unreasonable as written, the parties agree that the applicable provision should be considered to be amended to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court and enforced as amended.



(e)Remedy for Breach.
(i)Because the Participant’s services are unique and because the Participant has access to the Company’s Confidential Information, the parties agree that any breach or threatened breach of this Section 9 will cause irreparable harm to the Company and that money damages alone would be an inadequate remedy. The parties therefore agree that, in the event of any breach or threatened breach of this Section 9, and in addition to all other rights and remedies available to it, the Company may apply to any court of competent jurisdiction for specific performance and/or injunctive or other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 9.
(ii)The Participant shall immediately repay to the Company a cash sum in the principal amount equal to all gross proceeds (before-tax) realized by Participant upon the sale or other disposition of the Shares occurring at any time during the period commencing on the date that is three years before the date of termination of the Participant’s employment with the Company and all Subsidiaries of the Company and ending on the date of the Participant’s breach or threatened breach of this Section 9 (the “Refund Period”), together with interest accrued thereon, from the date of such breach or threatened breach, at the prime rate (compounded calendar monthly) as published from time to time in The Wall Street Journal, electronic edition (“Interest”); and
(iii)The Participant shall repay to the Company a cash sum equal to the fair market value of all of the Shares transferred by the Participant as a gift or gifts at any time during the Refund Period, together with Interest, and for which purpose, “fair market value” shall be the Fair Market Value of one share of Common Stock on the date such gift occurs.
(iv)The Participant acknowledges and agrees that nothing contained herein shall be construed to be an excessive remedy to prohibit the Company from pursuing any other remedies available to it for such actual or threatened breach, including the recovery of money damages, proximately caused by the Participant’s breach of this Section 9.
(f)Survival. The provisions of this Section 9 shall survive and continue in full force in accordance with their terms notwithstanding any forfeiture, termination or expiration of this Agreement in accordance with its terms or any termination of the Participant’s employment for any reason (whether voluntary or involuntary).
10.Miscellaneous.
(a)Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.
(b)Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.
(c)Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal



representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 5 of this Agreement.
(d)Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after delivery to a United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this paragraph (d).
(e)Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.
(f)Participant’s Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; and (iv) is fully aware of the legal and binding effect of this Agreement.
(g)Unfunded Rights. The right of the Participant to receive Common Stock pursuant to this Agreement is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this Agreement other than those of an unsecured general creditor of the Company.
(h)Deferral. Neither the Company nor the Participant may defer delivery of any Shares issuable under unvested RSUs except to the extent that such deferral complies with the provisions of Section 409A of the Code.
(i)Clawback. By accepting the grant of the RSUs hereunder, the Participant is agreeing to be bound by the Company’s clawback policies and procedures, as in effect or as may be adopted and/or modified from time to time by the Company in its discretion (including, without limitation, to comply with applicable law or stock exchange listing requirements).
(j)Section 409A.
(i)     This Agreement is intended to comply with the requirements of Section 409A, including the exceptions thereto, and shall be construed and administered in accordance with such intent. Notwithstanding any other provision of this Agreement, payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. For purposes of Section 409A, each installment payment provided under this Agreement shall be treated as a separate payment. Any payments to be made under this Agreement in connection with a termination of employment shall only be made if such termination of employment constitutes a "separation from service" under Section 409A. Notwithstanding the foregoing, the Company makes no representations that the payments and benefits provided under this Agreement comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of non-compliance with Section 409A.



(ii)     If any provision of this Agreement or the Plan shall be invalid or unenforceable, in whole or in part, or as applied to any circumstance, under the laws of any jurisdiction that may govern for such purpose, or if any provision of this Agreement or the Plan needs to be interpreted to comply with the requirements of Section 409A, then such provision shall be deemed to be modified or restricted, or so interpreted, to the extent and in the manner necessary to render the same valid and enforceable, or to the extent and in the manner necessary to be interpreted in compliance with such requirements of the Code, either generally or as applied to such circumstance, or shall be deemed excised from this Agreement or the Plan, as the case may require, and this Agreement or the Plan shall be construed and enforced to the maximum extent permitted by law as if such provision had been originally incorporated herein as so modified or restricted, or as if such provision had not been originally incorporated herein, as the case may be.
(iii)     Notwithstanding any other provision of this Agreement, if at the time of the Participant’s termination of employment, the Participant is a "specified employee," determined in accordance with Section 409A, any payments and benefits provided under this Agreement that constitute "nonqualified deferred compensation" subject to Section 409A that are provided to the Participant on account of separation from service shall not be paid until the first payroll date to occur following the six-month anniversary of the Participant’s termination date ("Specified Employee Payment Date"). The aggregate amount of any payments that would otherwise have been made during such six-month period shall be paid in a lump sum on the Specified Employee Payment Date without interest. If the Participant dies before the Specified Employee Payment Date, any delayed payments shall be paid to the Participant’s beneficiary in a lump sum within upon the Participant’s death.
(k) Provisions Related to Golden Parachute Excise Tax.
(i)     Change in Control When the Shares are Not Publicly Traded. Notwithstanding anything to the contrary contained in this Agreement, to the extent that, upon a Change in Control prior to the time at which the Shares have become publicly traded, any of the payments and benefits provided for under the Plan, any Award Agreement or any other agreement or arrangement between the Company or any of its Affiliates and the Participant (collectively, the “Payments”) would constitute a “parachute payment” within the meaning of section 280G of the Code (a “Parachute Payment”), the amount of such Payments shall be reduced to the amount (the “Safe Harbor Amount”) that would result in no portion of the Payments being treated as an excess parachute payment pursuant to section 280G of the Code (the “Excise Tax”). If, upon a Change in Control prior to the time at which the Shares have become publicly traded, the Parachute Payments that would otherwise be reduced or eliminated, as the case may be, pursuant to this Section 11(k)(i) could be paid without the loss of a deduction under Section 280G of the Code if the shareholder approval exception to treatment as a Parachute Payment can be and is satisfied, then the Company shall use its reasonable best efforts to cause such Parachute Payments to be submitted for such approval in accordance with Section 280G(b)(5)(B) prior to the Change in Control giving rise to such Parachute Payments. If such approval is received, any reduction or



forfeiture pursuant to this Section 11(k)(i) shall be reversed, and the subject amount shall be payable to the Participant without regard to this Section 11(k).
(ii)     Change in Control When the Shares are Publicly Traded. If upon a Change in Control occurring at any time that the Shares are publicly traded, any Payments would constitute Parachute Payments, then, if and solely to the extent that reducing the benefits payable hereunder would result in the Participant’s receiving a greater amount, on an after-tax basis, taking into account any Excise Tax and all applicable income, employment and other taxes payable on such amounts, the amounts payable hereunder shall be reduced or eliminated, as the case may be, so that the total amount of Parachute Payments received by the Participant do not exceed the Safe Harbor Amount.
(iii)     Order of Reduction in Payments. Any reduction in the amount of compensation or benefits effected pursuant to this Section 11(k) shall first come, in order and, in each case, solely to the extent necessary, from any cash severance benefits payable to the Participant, then from any other payments which are treated in their entirety as Parachute Payments and then from any other Parachute Payments payable to the Participant with the later possible payment or vesting date being reduced or eliminated before a payment or benefit with an earlier payment or vesting date; provided that if the foregoing order of reduction or elimination would violate Section 409A, then the reduction shall be made pro rata among the payments or benefits otherwise due or payable to the Participant.
11.Consent to Electronic Delivery; Electronic Signature. In lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate, and agrees that the Participant’s electronic signature is the same as, and shall have the same force and effect as, the Participant’s manual signature.




ELECTRONIC ACCEPTANCE

By the Participant’s electronic acceptance hereof, the Participant and the Company agree that this Award is granted and governed by the terms and conditions of the Plan and this Agreement.

By the Participant’s electronic acceptance hereof, the Participant agrees that in lieu of receiving documents in paper format, the Participant accepts the electronic delivery of any documents by the Company, or any third party involved in administering the Plan that the Company may designate, may deliver in connection with this Award (including the Plan, this Agreement, account statements, or other communications or information) whether via the Company’s intranet or the internet site of such third party or via email or such other means of electronic delivery specified by the Company. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company or any third party involved in administering the Plan that the Company may designate.




 EX-31.1 5 a2023033110-qexhibit311.htm EX-31.1 Document

EXHIBIT 31.1

 
CERTIFICATION
 
I, Sarah M. London, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Dated:April 25, 2023 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-31.2 6 a2023033110-qexhibit312.htm EX-31.2 Document

EXHIBIT 31.2

 
CERTIFICATION
 
I, Andrew L. Asher, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Centene Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:April 25, 2023  /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)

 EX-32.1 7 a2023033110-qexhibit321.htm EX-32.1 Document

EXHIBIT 32.1

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Sarah M. London, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:April 25, 2023 /s/ SARAH M. LONDON
 Chief Executive Officer
(principal executive officer)

 EX-32.2 8 a2023033110-qexhibit322.htm EX-32.2 Document

EXHIBIT 32.2

 
CERTIFICATION PURSUANT TO 18 U.S.C.  SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Centene Corporation (the Company) for the period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Andrew L. Asher, Executive Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
 
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:April 25, 2023  /s/ ANDREW L. ASHER
 Executive Vice President, Chief Financial Officer
(principal financial officer)

 EX-101.SCH 9 cnc-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Organization and Operations link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Acquisitions and Divestitures link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Short-term and Long-term Investments, Restricted Deposits link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Medical Claims Liability link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Affordable Care Act link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Organization and Operations (Policies) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Medical Claims Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Affordable Care Act (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Acquisitions and Divestitures -Divestiture (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Medical Claims Liability - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 cnc-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 cnc-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 cnc-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Securities Debt Securities, Available-for-Sale, Amortized Cost [Abstract] One year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Premium tax expense Premium Tax Expense Premium tax expense, similar assessments and provider pass through payments. Debt Total Debt Total [Member] Debt Total Term loan facility Term Loan Credit Agreement [Member] Term Loan Credit Agreement [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Net earnings Net earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Pending claims Loss Contingency, Pending Claims, Number Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Share buybacks (in shares) Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation Schedule of change in medical claims liability Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block] Total investments Investments, Fair Value Disclosure Debt Instrument [Axis] Debt Instrument [Axis] Other Other/Eliminations Other Segments [Member] Changes in assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract] Medical claims liability Balance, January 1, 2023 Balance, March 31, 2023 Liability for Claims and Claims Adjustment Expense Five years through ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Financial Instruments [Domain] Financial Instruments [Domain] Other investing activities, net Payments for (Proceeds from) Other Investing Activities Depreciation expense Depreciation Weighted-average discount rate for operating leases Operating Lease, Weighted Average Discount Rate, Percent Interest rate Debt Instrument, Interest Rate, Stated Percentage Additional paid-in capital Additional Paid in Capital, Common Stock Risk adjustment payable Affordable Care Act Reinsurance Payable Affordable Care Act Reinsurance, Payable Other adjustments, net Other Noncash Income (Expense) Common stock repurchases Common stock repurchases Common stock repurchases Treasury Stock, Value, Acquired, Cost Method Net earnings attributable to Centene Corporation Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount One year through five years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Subsequent Event Type [Axis] Subsequent Event Type [Axis] Reclassification adjustment, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Total assets at fair value Assets, Fair Value Disclosure Premium tax Premium Tax Revenue Premium tax revenue, similar assessments and provider pass through payments. Leases Lessee, Operating Leases [Text Block] Total debt Debt and Lease Obligation Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Treasury stock, at cost (62,641 and 57,093 shares, respectively) Treasury Stock, Common, Value Plan Name [Axis] Plan Name [Axis] Centurion Centurion [Member] Centurion Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Risk adjustment receivable Affordable Care Act, Risk Adjustment Receivable Affordable Care Act, Risk Adjustment Receivable Lease Contractual Term [Domain] Lease Contractual Term [Domain] Plan Name [Domain] Plan Name [Domain] Share buybacks Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes Goodwill [Line Items] Goodwill [Line Items] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Credit facility Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level I Fair Value, Inputs, Level 1 [Member] Organization and Operations Basis of Presentation and Significant Accounting Policies [Text Block] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Short-term (recorded within accounts payable and accrued expenses) Operating Lease, Liability, Current Proceeds from sale of business Proceeds from Divestiture of Businesses Long-term debt  Long-term debt Long-Term Debt, Excluding Current Maturities Certificates of deposit Certificates of Deposit [Member] Total liabilities Liabilities Short-term time deposits Short-term time deposits Bank Time Deposits [Member] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years $3,500 million 4.625% Senior Notes due December 15, 2029 $3,500 Million 4.625% Senior Notes due December 2029 [Member] $3,500 Million 4.625% Senior Notes due December 2029 Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract] Revolving credit agreement Revolving Credit Facility [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type $2,200 million 3.00% Senior Notes due October 15, 2030 $2,200 Million 3.00% Senior Notes Due October 2030 [Member] $2,200 Million 3.00% Senior Notes Due October 2030 Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Assets Assets, Fair Value Disclosure [Abstract] Segments [Axis] Segments [Axis] Debt Debt Disclosure [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Deferred income taxes Deferred Income Tax Expense (Benefit) Schedule Of Investments And Restricted Deposits By Type [Axis] Financial Instrument [Axis] Financial Instrument [Axis] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Consolidation Items [Domain] Consolidation Items [Domain] Subsequent Event Subsequent Event [Member] Document Period End Date Document Period End Date Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Total assets Assets Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Debt Disclosure [Abstract] Debt Disclosure [Abstract] Fair value of unvested equity awards in connection with acquisition Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture Earnings Per Share [Abstract] Earnings Per Share [Abstract] Change in unrealized gain (loss) on investments OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Equity securities Equity Securities, FV-NI, Current Affordable Care Act [Abstract] Affordable Care Act [Abstract] Affordable Care Act [Abstract] Current portion of long-term debt Less: current portion Long-Term Debt, Current Maturities Net cash (used in) financing activities Net Cash Provided by (Used in) Financing Activities Long-term investments Long-Term Investments Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Premium and service revenues Total Premium and Service [Member] Total Premium and Service Asset-backed securities Asset-Backed Securities [Member] (Gain) on divestiture Gain on disposition of business Gain (Loss) on Disposition of Business Earnings before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Earnings Per Share Earnings Per Share [Text Block] One year through five years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five Employee Stock Compensation Plan Employee Stock Compensation Plan [Member] Employee Stock Compensation Plan Less: Reinsurance recoverable Plus: Reinsurance recoverable Reinsurance Recoverable for Unpaid Claims and Claims Adjustments Municipal securities Municipal Bonds [Member] Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Purchase of redeemable noncontrolling interest Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Change in unrealized gain (loss) on investments, tax effect Other comprehensive earning (loss), tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Residential mortgage-backed securities Residential Mortgage-Backed Securities [Member] (Gain) loss on debt extinguishment Gain (Loss) on Extinguishment of Debt Gross margin Gross Profit Total external revenues Revenue from Contract with Customer, Including Assessed Tax Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block] Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions Entity Registrant Name Entity Registrant Name Total, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost Insurance [Abstract] Insurance [Abstract] Finance leases and other Finance Lease Liability And Other Finance Lease Liability And Other Translation impact Goodwill, Foreign Currency Translation Gain (Loss) Premium and trade receivables Premiums and Other Receivables, Net Entity Address, City or Town Entity Address, City or Town Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value Leases [Abstract] Leases [Abstract] Expenses: Operating Expenses [Abstract] Short-duration insurance contracts, Incurred but not reported and expected development on reported claims Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net Total stockholders' equity Balance Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Eliminations Intersegment Eliminations [Member] Asset Class [Domain] Asset Class [Domain] Nonredeemable noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest One year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Par value (in dollars per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Treasury Stock Treasury Stock, Common [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] Trading Symbol Trading Symbol Entity File Number Entity File Number Aggregate carrying amount of life insurance contracts and equity investments, fair value Life Insurance Contracts And Equity Investments, Fair Value Life Insurance Contracts And Equity Investments, Fair Value Treasury stock (in shares) Treasury stock (in shares) Treasury stock (in shares) Treasury Stock, Common, Shares Comprehensive (earnings) loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Disposal Group Classification [Axis] Disposal Group Classification [Axis] Restricted cash and cash equivalents, included in restricted deposits Restricted Cash and Cash Equivalents Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Premium Health Care, Premium [Member] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure LIBOR London Interbank Offered Rate (LIBOR) [Member] Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations Concentration Risk, Percentage Total revenues Revenues Revenues Short-term and Long-term Investments, Restricted Deposits Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Earnings attributable to Centene Corporation Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Payments for debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost Credit Facility [Domain] Credit Facility [Domain] Fair Value, 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Amortization of acquired intangible assets Amortization of Intangible Assets Schedule of Goodwill Schedule of Goodwill [Table Text Block] Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Basic earnings per common share (in dollars per share) Earnings Per Share, Basic Medical Claims Liability Insurance Disclosure [Text Block] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Purchase of noncontrolling interest Payments to Noncontrolling Interests Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total Centene stockholders' equity Stockholders' Equity Attributable to Parent Five years through ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Lease Contractual Term [Axis] Lease Contractual Term [Axis] Investments Investments [Member] Entity Interactive Data Current Entity Interactive Data Current Commercial mortgage-backed securities Commercial mortgage-backed securities Commercial Mortgage-Backed Securities [Member] Net earnings per common share attributable to Centene Corporation: Earnings attributable to Centene Corporation Net Income (Loss) Attributable to Parent [Abstract] Accrued interest income Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Retained Earnings Retained Earnings [Member] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Litigation Status [Domain] Litigation Status [Domain] Common Stock Common Stock [Member] Common stock issued for employee benefit plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture ROU Assets and Liabilities Lease, Cost [Table Text Block] Common stock repurchases Payments for Repurchase of Common Stock Class of Stock [Axis] Class of Stock [Axis] Statement [Table] Statement [Table] Reallocation Goodwill, Transfers Document Quarterly Report Document Quarterly Report Current assets: Assets, Current [Abstract] Long-term (recorded within other long-term liabilities) Operating Lease, Liability, Noncurrent Class of Treasury Stock Class of Treasury Stock [Table Text Block] Excluding Circle Health Excluding Circle Health [Member] Excluding Circle Health Restricted certificates of deposit Restricted Certificates Of Deposit [Member] Restricted certificates of deposit [member] Common stock repurchases (in shares) Common stock repurchases (in shares) Treasury Stock, Shares, Acquired Retained earnings Retained Earnings (Accumulated Deficit) Disposal Group Name [Axis] Disposal Group Name [Axis] Greater than ten years Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 External Credit Rating by Grouping [Axis] External Credit Rating by Grouping [Axis] U.S. Treasury securities and obligations of U.S. government corporations and agencies US Treasury and Government [Member] Equity Components [Axis] Equity Components [Axis] Segment Reporting Segment Reporting, Policy [Policy Text Block] Fair Value, Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Consideration received on divestiture Disposal Group, Including Discontinued Operation, Consideration Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative expenses Selling, General and Administrative Expense Loss Contingencies [Table] Loss Contingencies [Table] ROU assets (recorded within other long-term assets) Operating Lease, Right-of-Use Asset Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Accumulated Other Comprehensive Earnings (Loss) AOCI Attributable to Parent [Member] $2,000 million 3.375% Senior Notes due February 15, 2030 $2,200 Million 3.75% Senior Notes Due February 2030 [Member] $2,200 Million 3.75% Senior Notes Due February 2030 Document Transition Report Document Transition Report Local Phone Number Local Phone Number Life insurance contracts Life Insurance, Corporate or Bank Owned, Amount Earnings from operations Operating Income (Loss) Accounting Guidance Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Litigation Status [Axis] Litigation Status [Axis] Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Affordable Care Act Affordable Care Act Disclosure [Text Block] Affordable Care Act Disclosure [Text Block] Service Service [Member] Goodwill Goodwill, Balance beginning Goodwill, Balance ending Goodwill Medicare Medicare Segment [Member] Medicare Segment Adjustments to reconcile net earnings to net cash provided by operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Total senior notes Senior Notes, Total Senior Notes, Total Income tax expense Income Tax Expense (Benefit) Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Deferred tax liability Deferred Income Tax Liabilities, Net Restricted deposits Other Restricted Assets, Noncurrent Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Income Statement [Abstract] Income Statement [Abstract] Rated Securities Rated Securities [Member] Rated Securities [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Net earnings per common share attributable to Centene Corporation: Earnings Per Share, Basic [Abstract] Cost of services Cost of Goods and Services Sold Diluted (in shares) Weighted average number of common shares and potential dilutive common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Minimum medical loss ratio Affordable Care Act Minimum Medical Loss Ratio Affordable Care Act, Minimum Medical Loss Ratio Loss Contingencies [Line Items] Loss Contingencies [Line Items] London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA) London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA) [Member] London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA) Schedule Of Investments And Restricted Deposits By Type [Line Items] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Common stock, $0.001 par value; authorized 800,000 shares; 614,355 issued and 551,714 outstanding at March 31, 2023, and 607,847 issued and 550,754 outstanding at December 31, 2022 Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Notes Senior Notes [Member] Total, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Investments, Debt Securities, Equity Securities And Other, Fair Value Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Operating Segments Operating Segments [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period Cash, cash equivalents, and restricted cash and cash equivalents, end of period Total cash, cash equivalents, and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Foreign currency translation adjustments, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Earnings) loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Contingencies Commitments and Contingencies Disclosure [Text Block] Current liabilities: Liabilities, Current [Abstract] Commercial Commercial Segment [Member] Commercial Segment Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Common stock, shares issued (in shares) Common Stock, Shares, Issued Private equity investments Equity Method Investments Unearned revenue Contract with Customer, Liability, Current Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Positions from which gross unrealized losses were generated Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Amendment Flag Amendment Flag Net cash (used in) investing activities Net Cash Provided by (Used in) Investing Activities $1,300 million 2.625% Senior Notes due August 1, 2031 $1,300 Million 2.625% Senior Notes due August 2031 [Member] $1,300 Million 2.625% Senior Notes due August 2031 Debt, face amount Debt Instrument, Face Amount Other comprehensive earnings (loss) Other comprehensive earnings (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Comprehensive earnings attributable to Centene Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Acquisition and purchase accounting adjustments Goodwill, Acquired During Period Acquisitions and Divestitures Mergers, Acquisitions and Dispositions Disclosures [Text Block] Segment Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Other long-term assets Other Assets, Noncurrent Paid related to: Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract] Fair Value Fair Value Debt Securities, Available-for-Sale, Excluding Accrued Interest Acquisitions Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions Medical claims liabilities Increase (Decrease) in Health Care Insurance Liabilities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Liabilities Liabilities [Abstract] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Property, software and equipment, net Property, Plant and Equipment, Net Payments and repurchases of long-term debt Repayments of Long-Term Debt External Credit Rating by Grouping [Domain] External Credit Rating by Grouping [Domain] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Accumulated other comprehensive earnings (loss) Accumulated Other Comprehensive Income (Loss), Net of Tax Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Unearned revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Income taxes paid Income Taxes Paid, Net Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Entity Small Business Entity Small Business Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Senior notes Senior Notes Revenues: Revenues [Abstract] Asset-backed securities Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost Schedule of net receivables (payables) related to the Affordable Care Act Programs Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block] Schedule of Receivables (Payables) Related to the Affordable Care Act Programs Magellan Specialty Health Magellan Specialty Health [Member] Magellan Specialty Health Short-term and long-term investments and restricted deposits by investment type Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block] Short-term and long-term investments and restricted deposits by investment type Title of 12(b) Security Title of 12(b) Security Sales and maturities of investments Proceeds from Sale, Maturity and Collection of Investments Contingent consideration on disposal (up to) Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High Short-term investments Short-Term Investments Total operating expenses Costs and Expenses Class of Treasury Stock [Table] Class of Treasury Stock [Table] $2,500 million 4.25% Senior Notes due December 15, 2027 Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Less Than 12 Months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Common stock issued for employee benefit plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Total lease liabilities Operating Lease, Liability Segment Information Segment Reporting Disclosure [Text Block] $2,200 million 2.50% Senior Notes due March 1, 2031 $2,200 Million 2.50% Senior Notes due March 2031 [Member] $2,200 Million 2.50% Senior Notes due March 2031 Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Circle Health Circle Health [Member] Circle Health 12 Months or More Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY Liabilities and Equity [Abstract] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Current year Current Year Claims and Claims Adjustment Expense Restricted cash equivalents Restricted Cash Equivalents [Member] Restricted Cash Equivalents [Member] Other assets Increase (Decrease) in Other Operating Assets Contractual maturities of short-term and long-term investments and restricted deposits Investments Classified by Contractual Maturity Date [Table Text Block] External Credit Rating, Investment Grade External Credit Rating, Investment Grade [Member] Entity Filer Category Entity Filer Category Proceeds from common stock issuances Proceeds from Issuance of Common Stock Basic (in shares) Weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Stockholders' equity: Stockholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Prior years Prior Year Claims and Claims Adjustment Expense Commitments and contingencies Commitments and Contingencies Security Exchange Name Security Exchange Name Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2023 and December 31, 2022 Preferred Stock, Value, Issued Redeemable noncontrolling interests Redeemable Noncontrolling Interest, Equity, Carrying Amount Schedule of Debt Schedule of Debt [Table Text Block] Premium and service revenues Revenue from Contract with Customer, Excluding Assessed Tax Cash and cash equivalents Cash and Cash Equivalents [Member] Cover [Abstract] Cover [Abstract] Pending Litigation Pending Litigation [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level III Fair Value, Inputs, Level 3 [Member] Impairments Goodwill, Impairment Loss Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Segment Reporting [Abstract] Segment Reporting [Abstract] Incurred related to: Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract] Noncontrolling Interest Noncontrolling Interest [Member] Credit Availability Concentration Risk Credit Availability Concentration Risk [Member] Divestitures Goodwill, Written off Related to Sale of Business Unit Return of premium payable Return of Premium Payable Return of Premium Payable Total liabilities, redeemable noncontrolling interests and stockholders' equity Liabilities and Equity Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Goodwill [Roll Forward] Goodwill [Roll Forward] Restricted Deposits Restricted deposits Deposits [Member] Stock repurchase program, remaining available Stock Repurchase Program, Remaining Authorized Repurchase Amount Common stock equivalents (as determined by applying the treasury stock method) (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Disposal Group Name [Domain] Disposal Group Name [Domain] Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Level II Fair Value, Inputs, Level 2 [Member] Medical costs Policyholder Benefits and Claims Incurred, Net, Health Sterling Overnight Index Average (SONIA) Sterling Overnight Index Average (SONIA) [Member] Sterling Overnight Index Average (SONIA) Purchases of investments Payments to Acquire Investments Current Fiscal Year End Date Current Fiscal Year End Date Diluted earnings per common share (in dollars per share) Earnings Per Share, Diluted Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Stock compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Net earnings (loss) Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Other current assets Other Assets, Current Greater than ten years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Schedule Of Investments And Restricted Deposits By Type [Table] Schedule of Available-for-Sale Securities [Table] Schedule of Available-for-Sale Securities [Table] Balance, January 1, 2023, net Balance, March 31, 2023, net Liability for Unpaid Claims and Claims Adjustment Expense, Net Equity Securities Equity Securities [Member] Corporate securities Corporate Debt Securities [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Weighted average number of common shares outstanding: Shares used in computing per share amounts: Earnings Per Share, Basic, Other Disclosure [Abstract] Entity Address, Address Line One Entity Address, Address Line One Other financing activities, net Proceeds from (Payments for) Other Financing Activities Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Stock repurchase program, increase to authorized amount Stock Repurchase Program, Increase, Authorized Amount Stock Repurchase Program, Increase, Authorized Amount Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Interest expense Interest Expense Investments: Debt Securities, Available-for-Sale [Abstract] Credit Facility [Axis] Credit Facility [Axis] Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration Change in unrealized gain (loss) on investments, net of tax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract] Equity [Abstract] Equity [Abstract] Investment Securities Investment Securities [Member] Investment Securities Entity Tax Identification Number Entity Tax Identification Number Debt issuance costs Unamortized Debt Issuance Expense Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract] Premium and trade receivables Increase (Decrease) in Premiums Receivable Income tax withholding (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Investment and other income Investment Income, Nonoperating Entity Central Index Key Entity Central Index Key Income tax withholding Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Reserve estimate Estimated Litigation Liability Cost sharing reduction payable Affordable Care Act Cost Sharing Reductions, Payable Affordable Care Act Cost Sharing Reductions, Payable City Area Code City Area Code ASSETS Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Debt extinguishment Gain (Loss) on Extinguishment of Debt , Including Cash Portion Gain (Loss) on Extinguishment of Debt , Including Cash Portion $2,300 million 2.45% Senior Notes due July 15, 2028 $2,300 Million 2.45% Senior Nots due July 2028 [Member] $2,300 Million 2.45% Senior Nots due July 2028 Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Fair Value Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Total investment positions Debt Securities, Available -for-Sale, Number of Positions Debt Securities, Available -for-Sale, Number of Positions Asset Class [Axis] Asset Class [Axis] Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Variable Rate [Axis] Variable Rate [Axis] Other long-term liabilities Other Liabilities, Noncurrent Disposal Group Classification [Domain] Disposal Group Classification [Domain] Capital expenditures Payments to Acquire Property, Plant, and Equipment Impairment Asset Impairment Charges Divestiture proceeds, net of divested cash Proceeds from Divestiture of Businesses, Net of Cash Divested Medicaid Medicaid Segment [Member] Medicaid Segment Calculation of Basic and Diluted Net Earnings Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] EX-101.PRE 13 cnc-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 14 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - shares
 3 Months Ended
Mar. 31, 2023
Apr. 21, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2023  
Document Transition Report false  
Entity File Number 001-31826  
Entity Registrant Name CENTENE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 42-1406317  
Entity Address, Address Line One 7700 Forsyth Boulevard  
Entity Address, City or Town St. Louis,  
Entity Address, State or Province MO  
Entity Address, Postal Zip Code 63105  
City Area Code 314  
Local Phone Number 725-4477  
Title of 12(b) Security Common Stock $0.001 Par Value  
Trading Symbol CNC  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   548,769,258
Entity Central Index Key 0001071739  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 15,853 $ 12,074
Premium and trade receivables 15,210 13,272
Short-term investments 2,135 2,321
Other current assets 1,811 2,461
Total current assets 35,009 30,128
Long-term investments 15,833 14,684
Restricted deposits 1,313 1,217
Property, software and equipment, net 2,478 2,432
Goodwill 18,836 18,812
Intangible assets, net 6,730 6,911
Other long-term assets 2,783 2,686
Total assets 82,982 76,870
Current liabilities:    
Medical claims liability 17,504 16,745
Accounts payable and accrued expenses 10,781 9,525
Return of premium payable 2,077 1,634
Unearned revenue 2,398 478
Current portion of long-term debt 97 82
Total current liabilities 32,857 28,464
Long-term debt 18,223 17,938
Deferred tax liability 522 615
Other long-term liabilities 6,194 5,616
Total liabilities 57,796 52,633
Commitments and contingencies
Redeemable noncontrolling interests 20 56
Stockholders' equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 614,355 issued and 551,714 outstanding at March 31, 2023, and 607,847 issued and 550,754 outstanding at December 31, 2022 1 1
Additional paid-in capital 20,121 20,060
Accumulated other comprehensive earnings (loss) (915) (1,132)
Retained earnings 10,471 9,341
Treasury stock, at cost (62,641 and 57,093 shares, respectively) (4,636) (4,213)
Total Centene stockholders' equity 25,042 24,057
Nonredeemable noncontrolling interest 124 124
Total stockholders' equity 25,166 24,181
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 82,982 $ 76,870
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Stockholders' equity    
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 10,000,000 10,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 614,355,000 607,847,000
Common stock, shares outstanding (in shares) 551,714,000 550,754,000
Treasury stock (in shares) 62,641,000 57,093,000
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenues:    
Premium and service revenues $ 34,952 $ 34,232
Premium tax 3,937 2,953
Total revenues 38,889 37,185
Expenses:    
Medical costs 29,434 27,838
Cost of services 870 1,988
Selling, general and administrative expenses 3,011 2,745
Depreciation expense 142 156
Amortization of acquired intangible assets 183 199
Premium tax expense 4,011 3,006
Impairment 20 0
Total operating expenses 37,671 35,932
Earnings from operations 1,218 1,253
Other income (expense):    
Investment and other income 353 52
Debt extinguishment 0 3
Interest expense (180) (160)
Earnings before income tax 1,391 1,148
Income tax expense 261 296
Net earnings 1,130 852
(Earnings) loss attributable to noncontrolling interests 0 (3)
Net earnings attributable to Centene Corporation $ 1,130 $ 849
Net earnings per common share attributable to Centene Corporation:    
Basic earnings per common share (in dollars per share) $ 2.05 $ 1.46
Diluted earnings per common share (in dollars per share) $ 2.04 $ 1.44
Weighted average number of common shares outstanding:    
Basic (in shares) 550,779 583,230
Diluted (in shares) 553,845 590,658
Premium    
Revenues:    
Premium and service revenues $ 33,825 $ 31,889
Service    
Revenues:    
Premium and service revenues $ 1,127 $ 2,343
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Comprehensive Income [Abstract]    
Net earnings $ 1,130 $ 852
Change in unrealized gain (loss) on investments 253 (715)
Change in unrealized gain (loss) on investments, tax effect (61) 171
Change in unrealized gain (loss) on investments, net of tax 192 (544)
Reclassification adjustment, net of tax 2 2
Foreign currency translation adjustments, net of tax 23 (20)
Other comprehensive earnings (loss) 217 (562)
Comprehensive earnings 1,347 290
Comprehensive (earnings) loss attributable to noncontrolling interests 0 (3)
Comprehensive earnings attributable to Centene Corporation $ 1,347 $ 287
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Earnings (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interest
Balance (in shares) at Dec. 31, 2021   602,704          
Treasury stock (in shares) at Dec. 31, 2021           20,225  
Balance at Dec. 31, 2021 $ 26,940 $ 1 $ 19,672 $ 77 $ 8,139 $ (1,094) $ 145
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 848       849   (1)
Other comprehensive earnings (loss), net of tax (562)     (562)      
Common stock issued for employee benefit plans (in shares)   3,221          
Common stock issued for employee benefit plans 28   28        
Fair value of unvested equity awards in connection with acquisition 60   60        
Common stock repurchases (in shares)           846  
Common stock repurchases (71)         $ (71)  
Stock compensation expense 70   70        
Balance (in shares) at Mar. 31, 2022   605,925          
Treasury stock (in shares) at Mar. 31, 2022           21,071  
Balance at Mar. 31, 2022 $ 27,313 $ 1 19,830 (485) 8,988 $ (1,165) 144
Balance (in shares) at Dec. 31, 2022 550,754 607,847          
Treasury stock (in shares) at Dec. 31, 2022 57,093         57,093  
Balance at Dec. 31, 2022 $ 24,181 $ 1 20,060 (1,132) 9,341 $ (4,213) 124
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) 1,130       1,130    
Other comprehensive earnings (loss), net of tax 217     217      
Common stock issued for employee benefit plans (in shares)   6,508          
Common stock issued for employee benefit plans 12   12        
Common stock repurchases (in shares)           5,548  
Common stock repurchases (423)         $ (423)  
Stock compensation expense 61   61        
Purchase of redeemable noncontrolling interest $ (12)   (12)        
Balance (in shares) at Mar. 31, 2023 551,714 614,355          
Treasury stock (in shares) at Mar. 31, 2023 62,641         62,641  
Balance at Mar. 31, 2023 $ 25,166 $ 1 $ 20,121 $ (915) $ 10,471 $ (4,636) $ 124
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Par value (in dollars per share) $ 0.001  
Common Stock    
Par value (in dollars per share) 0.001 $ 0.001
Treasury Stock    
Par value (in dollars per share) $ 0.001 $ 0.001
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net earnings $ 1,130 $ 852
Adjustments to reconcile net earnings to net cash provided by operating activities    
Depreciation and amortization 346 390
Stock compensation expense 61 70
Impairment 20 0
(Gain) loss on debt extinguishment 0 (3)
Deferred income taxes (159) 12
(Gain) on divestiture (79) 0
Other adjustments, net 7 22
Changes in assets and liabilities    
Premium and trade receivables (1,938) (3,099)
Other assets (315) (299)
Medical claims liabilities 759 1,767
Unearned revenue 1,919 81
Accounts payable and accrued expenses 1,548 957
Other long-term liabilities 970 401
Net cash provided by operating activities 4,269 1,151
Cash flows from investing activities:    
Capital expenditures (225) (242)
Purchases of investments (1,619) (1,700)
Sales and maturities of investments 1,148 1,047
Acquisitions, net of cash acquired 0 (1,504)
Divestiture proceeds, net of divested cash 443 0
Other investing activities, net 0 (2)
Net cash (used in) investing activities (253) (2,401)
Cash flows from financing activities:    
Proceeds from long-term debt 287 100
Payments and repurchases of long-term debt 0 (526)
Common stock repurchases (423) (71)
Proceeds from common stock issuances 0 27
Payments for debt extinguishment 0 (27)
Purchase of noncontrolling interest (58) 0
Other financing activities, net 11 (1)
Net cash (used in) financing activities (183) (498)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 2 33
Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents 3,835 (1,715)
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period 12,330 13,214
Cash, cash equivalents, and restricted cash and cash equivalents, end of period 16,165 11,499
Supplemental disclosures of cash flow information:    
Interest paid 144 139
Income taxes paid 11 11
The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:    
Cash and cash equivalents 15,853 11,237
Restricted cash and cash equivalents, included in restricted deposits 312 262
Total cash, cash equivalents, and restricted cash and cash equivalents $ 16,165 $ 11,499
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Operations
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Operations Organization and Operations
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Segment Reporting

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace along with individual, small group, and large group commercial healthcare products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions and Divestitures
 3 Months Ended
Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]  
Acquisitions and Divestitures Acquisitions and Divestitures
On January 5, 2023, the Company completed the divestiture of HealthSmart, its third-party health plan administration business.

On January 10, 2023, the Company signed and closed on a definitive agreement to divest Centurion, its prison healthcare business. During 2022, the Company recorded impairment charges related to goodwill and other current assets associated with the pending divestitures. The Company could receive up to an additional $35 million in cash based on the reprocurements of certain Centurion contracts. The Company will recognize the appropriate amount of contingent consideration related to the additional $35 million when realized or realizable.

On January 20, 2023, the Company completed the divestiture of Magellan Specialty Health for approximately $646 million in cash and stock, including an estimated working capital adjustment and recognized a pre-tax gain of $79 million. The stock consideration was subsequently sold in April 2023 for cash proceeds of $245 million. The Company could also receive up to an additional $150 million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the additional $150 million when realized or realizable.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Short-term and Long-term Investments, Restricted Deposits
 3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Short-term and Long-term Investments, Restricted Deposits Short-term and Long-term Investments, Restricted Deposits
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 March 31, 2023December 31, 2022
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of U.S. government corporations and agencies$489 $— $(12)$477 $695 $— $(16)$679 
Corporate securities10,523 32 (668)9,887 10,127 12 (778)9,361 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
312 — — 312 256 — — 256 
Short-term time deposits
198 — — 198 204 — — 204 
Municipal securities4,131 15 (213)3,933 4,055 6 (280)3,781 
Asset-backed securities1,492 2 (57)1,437 1,396 — (70)1,326 
Residential mortgage-backed securities1,187 4 (105)1,086 1,165 2 (121)1,046 
Commercial mortgage-backed securities
1,067 1 (87)981 961 — (99)862 
Equity securities (1)
250 — — 250 5 — — 5 
Private equity investments
540 — — 540 529 — — 529 
Life insurance contracts
176 — — 176 169 — — 169 
Total$20,369 $54 $(1,142)$19,281 $19,566 $20 $(1,364)$18,222 
(1) Investments in equity securities as of March 31, 2023 primarily consisted of shares received as part of the Magellan Specialty Health divestiture consideration. These shares were subsequently sold in April 2023.

The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of March 31, 2023, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At March 31, 2023, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $141 million and $132 million at March 31, 2023 and December 31, 2022, respectively, and is included in other current assets on the Consolidated Balance Sheets.

The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at March 31, 2023.
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 March 31, 2023December 31, 2022
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$(2)$249 $(10)$170 $(5)$342 $(11)$184 
Corporate securities(72)2,755 (596)5,683 (340)5,368 (438)3,400 
Municipal securities(18)1,161 (195)1,945 (142)2,437 (138)995 
Asset-backed securities(5)310 (52)928 (29)786 (41)486 
Residential mortgage-backed securities(10)319 (95)652 (55)629 (66)352 
Commercial mortgage-backed securities(8)188 (79)697 (49)513 (50)330 
Total$(115)$4,982 $(1,027)$10,075 $(620)$10,075 $(744)$5,747 

As of March 31, 2023, the gross unrealized losses were generated from 6,109 positions out of a total of 6,936 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.

In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.

The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 March 31, 2023December 31, 2022
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,011 $1,981 $570 $569 $2,207 $2,179 $534 $532 
One year through five years8,008 7,556 546 518 7,651 7,147 524 490 
Five years through ten years4,131 3,821 245 224 4,066 3,613 224 195 
Greater than ten years144 140 2 2 135 129 — — 
Asset-backed securities3,746 3,504 — — 3,522 3,234 — — 
Total$18,040 $17,002 $1,363 $1,313 $17,581 $16,302 $1,282 $1,217 
 
Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at March 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$15,853 $— $— $15,853 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$156 $— $— $156 
Corporate securities— 9,853 — 9,853 
Municipal securities— 3,291 — 3,291 
Short-term time deposits— 198 — 198 
Asset-backed securities— 1,437 — 1,437 
Residential mortgage-backed securities— 1,086 — 1,086 
Commercial mortgage-backed securities— 981 — 981 
Equity securities248 2 — 250 
Total investments$404 $16,848 $— $17,252 
Restricted deposits:    
Cash and cash equivalents$312 $— $— $312 
U.S. Treasury securities and obligations of U.S. government corporations and agencies321 — — 321 
Corporate securities— 34 — 34 
Certificates of deposit— 4 — 4 
Municipal securities— 642 — 642 
Total restricted deposits$633 $680 $— $1,313 
Total assets at fair value$16,890 $17,528 $— $34,418 
The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$12,074 $— $— $12,074 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$366 $5 $— $371 
Corporate securities— 9,328 — 9,328 
Municipal securities— 3,165 — 3,165 
Short-term time deposits— 204 — 204 
Asset backed securities— 1,326 — 1,326 
Residential mortgage backed securities— 1,046 — 1,046 
Commercial mortgage backed securities— 862 — 862 
Equity securities3 2 — 5 
Total investments$369 $15,938 $— $16,307 
Restricted deposits:    
Cash and cash equivalents$256 $— $— $256 
U.S. Treasury securities and obligations of U.S. government corporations and agencies308 — — 308 
Corporate securities— 33 — 33 
Certificates of deposit— 4 — 4 
Municipal securities— 616 — 616 
Total restricted deposits$564 $653 $— $1,217 
Total assets at fair value$13,007 $16,591 $— $29,598 
 
The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $716 million and $698 million as of March 31, 2023 and December 31, 2022, respectively.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets
 3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
As discussed in Note 1. Organization and Operations, in 2023 the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the changes in goodwill by operating segment ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, December 31, 2021$10,194 $1,592 $5,424 $2,561 $19,771 
Acquisition and purchase accounting adjustments— — — 1,077 1,077 
Divestitures— — — (1,533)(1,533)
Reallocation4 — — (4)— 
Impairments— — — (370)(370)
Translation impact— — — (133)(133)
Balance, December 31, 2022$10,198 $1,592 $5,424 $1,598 $18,812 
Translation impact— — — 24 24 
Balance, March 31, 2023$10,198 $1,592 $5,424 $1,622 $18,836 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Claims Liability
 3 Months Ended
Mar. 31, 2023
Insurance [Abstract]  
Medical Claims Liability Medical Claims Liability
As discussed in Note 1. Organization and Operations, in 2023 the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.

The following table summarizes the change in medical claims liability for the three months ended March 31, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year20,813 5,163 4,177 418 30,571 
Prior years(803)(155)(172)(7)(1,137)
Total incurred20,010 5,008 4,005 411 29,434 
Paid related to:
Current year12,679 2,988 2,541 294 18,502 
Prior years6,834 2,145 1,063 132 10,174 
Total paid19,513 5,133 3,604 426 28,676 
Balance, March 31, 2023, net
11,743 3,306 2,303 125 17,477 
Plus: Reinsurance recoverable9 — 18 — 27 
Balance, March 31, 2023
$11,752 $3,306 $2,321 $125 $17,504 

The following table summarizes the change in medical claims liability for the three months ended March 31, 2022 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2022$9,845 $2,286 $2,014 $98 $14,243 
Less: Reinsurance recoverable23 — — — 23 
Balance, January 1, 2022, net9,822 2,286 2,014 98 14,220 
Acquisitions— — — 249 249 
Incurred related to:
Current year19,289 5,098 3,423 751 28,561 
Prior years(514)(52)(149)(8)(723)
Total incurred18,775 5,046 3,274 743 27,838 
Paid related to:
Current year12,022 2,674 2,012 690 17,398 
Prior years5,643 1,624 1,319 76 8,662 
Total paid17,665 4,298 3,331 766 26,060 
Balance, March 31, 2022, net
10,932 3,034 1,957 324 16,247 
Plus: Reinsurance recoverable12 — — — 12 
Balance, March 31, 2022
$10,944 $3,034 $1,957 $324 $16,259 

Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum health benefits ratio (HBR) and other return of premium programs, the Company recorded $159 million and $67 million as a reduction to premium revenue in the three months ended March 31, 2023 and 2022, respectively.
Incurred but not reported (IBNR) plus expected development on reported claims as of March 31, 2023 was $11,271 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Affordable Care Act
 3 Months Ended
Mar. 31, 2023
Affordable Care Act [Abstract]  
Affordable Care Act Affordable Care Act
The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions.

The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
March 31, 2023December 31, 2022
Risk adjustment receivable$887 $838 
Risk adjustment payable(1,556)(780)
Minimum medical loss ratio(176)(103)
Cost sharing reduction payable(89)(99)
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Debt
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Debt Debt
 
Debt consists of the following ($ in millions):
 March 31, 2023December 31, 2022
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,393 $2,393 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,673 15,673 
Term loan facility2,169 2,183 
Revolving credit agreement359 58 
Finance leases and other260 253 
Debt issuance costs(141)(147)
Total debt18,320 18,020 
Less: current portion(97)(82)
 Long-term debt$18,223 $17,938 

Of the Company's total debt, approximately 12% is variable rate debt. Approximately 11% uses the London Interbank Offered Rate (LIBOR) as a reference rate pursuant to the terms of the Company Credit Facility and approximately 1% uses the Sterling Overnight Index Average (SONIA) as a reference rate. The debt agreements that may be impacted by the discontinuation of LIBOR have provisions included that are sufficient for the Company to transition from the existing LIBOR rates to the prevailing successor market rates as necessary. The document governing the Company Credit Facility includes provisions to convert from LIBOR to the Secured Overnight Financing Rate (SOFR) at the time LIBOR ceases to be published.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Leases
 3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
Leases Leases
The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):
 March 31, 2023December 31, 2022
Assets
ROU assets (recorded within other long-term assets)$2,578 $2,554 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$177 $180 
Long-term (recorded within other long-term liabilities)3,144 3,133 
Total lease liabilities$3,321 $3,313 

As of March 31, 2023, the weighted average remaining lease term for the Company was 20.5 years. The average remaining lease term of the Circle Health portfolio is 27.0 years. Excluding Circle Health, the company's portfolio average remaining lease term is 8.5 years. The lease liabilities as of March 31, 2023 reflect a weighted average discount rate of 5.7%.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Stockholders' Equity Stockholders' Equity
The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million, inclusive of past authorizations. As of March 31, 2023, the Company had a remaining amount of $2,429 million available under the Company's stock repurchase program. In April 2023, the Company repurchased an additional 3 million shares for $200 million.

The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended March 31,
20232022
SharesCostSharesCost
Share buybacks4,852 $377 — $— 
Income tax withholding696 46 846 71 
Total share repurchases5,548 $423 846 $71 
Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings Per Share
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended March 31,
 20232022
Earnings attributable to Centene Corporation$1,130 $849 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding550,779 583,230 
Common stock equivalents (as determined by applying the treasury stock method) (1)
3,066 7,428 
Weighted average number of common shares and potential dilutive common shares outstanding553,845 590,658 
  
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.05 $1.46 
Diluted earnings per common share$2.04 $1.44 
(1) The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.

The calculation of diluted earnings per common share for the three months ended March 31, 2023 and 2022 excludes 1,606 thousand shares and 923 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
In early 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. Prior year information has been adjusted to reflect the change in segment reporting.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.

Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.
Segment information for the three months ended March 31, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$22,227 $5,876 $5,252 $470 $33,825 
Service— — — 1,127 1,127 
Premium and service revenues22,227 5,876 5,252 1,597 34,952 
Premium tax3,937 — — — 3,937 
Total external revenues26,164 5,876 5,252 1,597 38,889 
Internal revenues— — — 3,867 3,867 
Eliminations— — — (3,867)(3,867)
Total revenues$26,164 $5,876 $5,252 $1,597 $38,889 
Medical costs$20,010 $5,008 $4,005 $411 $29,434 
Cost of services$— $— $— $870 $870 
Gross margin (1)
$2,217 $868 $1,247 $316 $4,648 
(1) Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended March 31, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,121 $5,757 $4,132 $879 $31,889 
Service— — — 2,343 2,343 
Premium and service revenues21,121 5,757 4,132 3,222 34,232 
Premium tax2,953 — — — 2,953 
Total external revenues24,074 5,757 4,132 3,222 37,185 
Internal revenues— — — 6,450 6,450 
Eliminations— — — (6,450)(6,450)
Total revenues$24,074 $5,757 $4,132 $3,222 $37,185 
Medical costs$18,775 $5,046 $3,274 $743 $27,838 
Cost of services$— $— $— $1,988 $1,988 
Gross margin (1)
$2,346 $711 $858 $491 $4,406 
(1) Gross margin represents premium and service revenues less medical costs and cost of services.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Contingencies
 3 Months Ended
Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
Overview

The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:

•periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to the Centers for Medicare and Medicaid Services (CMS) related to risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;

•litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and

•disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.

Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought.

The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices.

As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the discussion below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.
California

On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial condition, results of operations and cash flows.

Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing, and at a mediation in September 2021, the Company reached a settlement with plaintiffs in three of the pending class actions which, if approved by court, should resolve most or all of the pending litigation related to this matter. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations and cash flows.

Pharmacy Benefits Management Matters

On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan.

The Company has reached no-fault agreements with the Attorneys General, including Ohio, to resolve claims and/or allegations made by the states related to services previously provided by Envolve. As a result of the settlement, the Ohio Attorney General's litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations and cash flows.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Organization and Operations (Policies)
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.

Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.
Segment Reporting
Segment Reporting

In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.

The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace along with individual, small group, and large group commercial healthcare products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.
Accounting Guidance Not Yet Adopted
Accounting Guidance Not Yet Adopted

The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Short-term and Long-term Investments, Restricted Deposits (Tables)
 3 Months Ended
Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
Short-term and long-term investments and restricted deposits by investment type
Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):
 March 31, 2023December 31, 2022
 Amortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair ValueAmortized CostGross
Unrealized Gains		Gross
Unrealized Losses		Fair Value
Debt securities:
U.S. Treasury securities and obligations of U.S. government corporations and agencies$489 $— $(12)$477 $695 $— $(16)$679 
Corporate securities10,523 32 (668)9,887 10,127 12 (778)9,361 
Restricted certificates of deposit
4 — — 4 4 — — 4 
Restricted cash equivalents
312 — — 312 256 — — 256 
Short-term time deposits
198 — — 198 204 — — 204 
Municipal securities4,131 15 (213)3,933 4,055 6 (280)3,781 
Asset-backed securities1,492 2 (57)1,437 1,396 — (70)1,326 
Residential mortgage-backed securities1,187 4 (105)1,086 1,165 2 (121)1,046 
Commercial mortgage-backed securities
1,067 1 (87)981 961 — (99)862 
Equity securities (1)
250 — — 250 5 — — 5 
Private equity investments
540 — — 540 529 — — 529 
Life insurance contracts
176 — — 176 169 — — 169 
Total$20,369 $54 $(1,142)$19,281 $19,566 $20 $(1,364)$18,222 
(1) Investments in equity securities as of March 31, 2023 primarily consisted of shares received as part of the Magellan Specialty Health divestiture consideration. These shares were subsequently sold in April 2023.
Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time
The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):
 March 31, 2023December 31, 2022
 Less Than 12 Months12 Months or MoreLess Than 12 Months12 Months or More
 Unrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair ValueUnrealized LossesFair Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$(2)$249 $(10)$170 $(5)$342 $(11)$184 
Corporate securities(72)2,755 (596)5,683 (340)5,368 (438)3,400 
Municipal securities(18)1,161 (195)1,945 (142)2,437 (138)995 
Asset-backed securities(5)310 (52)928 (29)786 (41)486 
Residential mortgage-backed securities(10)319 (95)652 (55)629 (66)352 
Commercial mortgage-backed securities(8)188 (79)697 (49)513 (50)330 
Total$(115)$4,982 $(1,027)$10,075 $(620)$10,075 $(744)$5,747 
Contractual maturities of short-term and long-term investments and restricted deposits
The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):
 March 31, 2023December 31, 2022
 InvestmentsRestricted DepositsInvestmentsRestricted Deposits
 Amortized CostFair ValueAmortized CostFair ValueAmortized CostFair ValueAmortized CostFair Value
One year or less$2,011 $1,981 $570 $569 $2,207 $2,179 $534 $532 
One year through five years8,008 7,556 546 518 7,651 7,147 524 490 
Five years through ten years4,131 3,821 245 224 4,066 3,613 224 195 
Greater than ten years144 140 2 2 135 129 — — 
Asset-backed securities3,746 3,504 — — 3,522 3,234 — — 
Total$18,040 $17,002 $1,363 $1,313 $17,581 $16,302 $1,282 $1,217 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions
Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:
Level Input:Input Definition:
Level IInputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
 
Level IIInputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.
 
Level IIIUnobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.
Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes fair value measurements by level at March 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$15,853 $— $— $15,853 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$156 $— $— $156 
Corporate securities— 9,853 — 9,853 
Municipal securities— 3,291 — 3,291 
Short-term time deposits— 198 — 198 
Asset-backed securities— 1,437 — 1,437 
Residential mortgage-backed securities— 1,086 — 1,086 
Commercial mortgage-backed securities— 981 — 981 
Equity securities248 2 — 250 
Total investments$404 $16,848 $— $17,252 
Restricted deposits:    
Cash and cash equivalents$312 $— $— $312 
U.S. Treasury securities and obligations of U.S. government corporations and agencies321 — — 321 
Corporate securities— 34 — 34 
Certificates of deposit— 4 — 4 
Municipal securities— 642 — 642 
Total restricted deposits$633 $680 $— $1,313 
Total assets at fair value$16,890 $17,528 $— $34,418 
The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):
 Level ILevel IILevel IIITotal
Assets    
Cash and cash equivalents$12,074 $— $— $12,074 
Investments:    
U.S. Treasury securities and obligations of U.S. government corporations and agencies$366 $5 $— $371 
Corporate securities— 9,328 — 9,328 
Municipal securities— 3,165 — 3,165 
Short-term time deposits— 204 — 204 
Asset backed securities— 1,326 — 1,326 
Residential mortgage backed securities— 1,046 — 1,046 
Commercial mortgage backed securities— 862 — 862 
Equity securities3 2 — 5 
Total investments$369 $15,938 $— $16,307 
Restricted deposits:    
Cash and cash equivalents$256 $— $— $256 
U.S. Treasury securities and obligations of U.S. government corporations and agencies308 — — 308 
Corporate securities— 33 — 33 
Certificates of deposit— 4 — 4 
Municipal securities— 616 — 616 
Total restricted deposits$564 $653 $— $1,217 
Total assets at fair value$13,007 $16,591 $— $29,598 
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table summarizes the changes in goodwill by operating segment ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, December 31, 2021$10,194 $1,592 $5,424 $2,561 $19,771 
Acquisition and purchase accounting adjustments— — — 1,077 1,077 
Divestitures— — — (1,533)(1,533)
Reallocation4 — — (4)— 
Impairments— — — (370)(370)
Translation impact— — — (133)(133)
Balance, December 31, 2022$10,198 $1,592 $5,424 $1,598 $18,812 
Translation impact— — — 24 24 
Balance, March 31, 2023$10,198 $1,592 $5,424 $1,622 $18,836 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Claims Liability (Tables)
 3 Months Ended
Mar. 31, 2023
Insurance [Abstract]  
Schedule of change in medical claims liability
The following table summarizes the change in medical claims liability for the three months ended March 31, 2023 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2023$11,253 $3,431 $1,921 $140 $16,745 
Less: Reinsurance recoverable7 — 19 — 26 
Balance, January 1, 2023, net11,246 3,431 1,902 140 16,719 
Incurred related to:
Current year20,813 5,163 4,177 418 30,571 
Prior years(803)(155)(172)(7)(1,137)
Total incurred20,010 5,008 4,005 411 29,434 
Paid related to:
Current year12,679 2,988 2,541 294 18,502 
Prior years6,834 2,145 1,063 132 10,174 
Total paid19,513 5,133 3,604 426 28,676 
Balance, March 31, 2023, net
11,743 3,306 2,303 125 17,477 
Plus: Reinsurance recoverable9 — 18 — 27 
Balance, March 31, 2023
$11,752 $3,306 $2,321 $125 $17,504 

The following table summarizes the change in medical claims liability for the three months ended March 31, 2022 ($ in millions):
 MedicaidMedicareCommercialOtherConsolidated Total
Balance, January 1, 2022$9,845 $2,286 $2,014 $98 $14,243 
Less: Reinsurance recoverable23 — — — 23 
Balance, January 1, 2022, net9,822 2,286 2,014 98 14,220 
Acquisitions— — — 249 249 
Incurred related to:
Current year19,289 5,098 3,423 751 28,561 
Prior years(514)(52)(149)(8)(723)
Total incurred18,775 5,046 3,274 743 27,838 
Paid related to:
Current year12,022 2,674 2,012 690 17,398 
Prior years5,643 1,624 1,319 76 8,662 
Total paid17,665 4,298 3,331 766 26,060 
Balance, March 31, 2022, net
10,932 3,034 1,957 324 16,247 
Plus: Reinsurance recoverable12 — — — 12 
Balance, March 31, 2022
$10,944 $3,034 $1,957 $324 $16,259 
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Affordable Care Act (Tables)
 3 Months Ended
Mar. 31, 2023
Affordable Care Act [Abstract]  
Schedule of net receivables (payables) related to the Affordable Care Act Programs
The Company's net receivables (payables) for each of the programs are as follows ($ in millions):
March 31, 2023December 31, 2022
Risk adjustment receivable$887 $838 
Risk adjustment payable(1,556)(780)
Minimum medical loss ratio(176)(103)
Cost sharing reduction payable(89)(99)
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2023
Debt Disclosure [Abstract]  
Schedule of Debt
Debt consists of the following ($ in millions):
 March 31, 2023December 31, 2022
$2,500 million 4.25% Senior Notes due December 15, 2027
$2,393 $2,393 
$2,300 million 2.45% Senior Notes due July 15, 2028
2,303 2,303 
$3,500 million 4.625% Senior Notes due December 15, 2029
3,277 3,277 
$2,000 million 3.375% Senior Notes due February 15, 2030
2,000 2,000 
$2,200 million 3.00% Senior Notes due October 15, 2030
2,200 2,200 
$2,200 million 2.50% Senior Notes due March 1, 2031
2,200 2,200 
$1,300 million 2.625% Senior Notes due August 1, 2031
1,300 1,300 
Total senior notes15,673 15,673 
Term loan facility2,169 2,183 
Revolving credit agreement359 58 
Finance leases and other260 253 
Debt issuance costs(141)(147)
Total debt18,320 18,020 
Less: current portion(97)(82)
 Long-term debt$18,223 $17,938 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2023
Leases [Abstract]  
ROU Assets and Liabilities
The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):
 March 31, 2023December 31, 2022
Assets
ROU assets (recorded within other long-term assets)$2,578 $2,554 
Liabilities
Short-term (recorded within accounts payable and accrued expenses)$177 $180 
Long-term (recorded within other long-term liabilities)3,144 3,133 
Total lease liabilities$3,321 $3,313 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Class of Treasury Stock
The following represents the Company's share repurchase activity ($ in millions, shares in thousands):
Three Months Ended March 31,
20232022
SharesCostSharesCost
Share buybacks4,852 $377 — $— 
Income tax withholding696 46 846 71 
Total share repurchases5,548 $423 846 $71 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Calculation of Basic and Diluted Net Earnings Per Common Share
The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):
Three Months Ended March 31,
 20232022
Earnings attributable to Centene Corporation$1,130 $849 
Shares used in computing per share amounts: 
Weighted average number of common shares outstanding550,779 583,230 
Common stock equivalents (as determined by applying the treasury stock method) (1)
3,066 7,428 
Weighted average number of common shares and potential dilutive common shares outstanding553,845 590,658 
  
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share$2.05 $1.46 
Diluted earnings per common share$2.04 $1.44 
(1) The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2023
Segment Reporting [Abstract]  
Segment Information
Segment information for the three months ended March 31, 2023, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$22,227 $5,876 $5,252 $470 $33,825 
Service— — — 1,127 1,127 
Premium and service revenues22,227 5,876 5,252 1,597 34,952 
Premium tax3,937 — — — 3,937 
Total external revenues26,164 5,876 5,252 1,597 38,889 
Internal revenues— — — 3,867 3,867 
Eliminations— — — (3,867)(3,867)
Total revenues$26,164 $5,876 $5,252 $1,597 $38,889 
Medical costs$20,010 $5,008 $4,005 $411 $29,434 
Cost of services$— $— $— $870 $870 
Gross margin (1)
$2,217 $868 $1,247 $316 $4,648 
(1) Gross margin represents premium and service revenues less medical costs and cost of services.

Segment information for the three months ended March 31, 2022, is as follows ($ in millions):
 MedicaidMedicareCommercialOther/EliminationsConsolidated Total
Premium$21,121 $5,757 $4,132 $879 $31,889 
Service— — — 2,343 2,343 
Premium and service revenues21,121 5,757 4,132 3,222 34,232 
Premium tax2,953 — — — 2,953 
Total external revenues24,074 5,757 4,132 3,222 37,185 
Internal revenues— — — 6,450 6,450 
Eliminations— — — (6,450)(6,450)
Total revenues$24,074 $5,757 $4,132 $3,222 $37,185 
Medical costs$18,775 $5,046 $3,274 $743 $27,838 
Cost of services$— $— $— $1,988 $1,988 
Gross margin (1)
$2,346 $711 $858 $491 $4,406 
(1) Gross margin represents premium and service revenues less medical costs and cost of services.
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Acquisitions and Divestitures -Divestiture (Details) - USD ($)
$ in Millions
 1 Months Ended 3 Months Ended
Jan. 20, 2023
Apr. 25, 2023
Mar. 31, 2023
Mar. 31, 2022
Jan. 10, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Gain on disposition of business     $ (79) $ 0  
Centurion | Disposal Group, Disposed of by Sale, Not Discontinued Operations          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Contingent consideration on disposal (up to)         $ 35
Magellan Specialty Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Contingent consideration on disposal (up to) $ 150        
Consideration received on divestiture 646        
Gain on disposition of business $ (79)        
Magellan Specialty Health | Disposal Group, Disposed of by Sale, Not Discontinued Operations | Subsequent Event          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from sale of business   $ 245      
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Debt Securities    
Gross Unrealized Gains $ 54 $ 20
Gross Unrealized Losses (1,142) (1,364)
Equity securities 250 5
Private equity investments 540 529
Life insurance contracts 176 169
Total, Amortized Cost 20,369 19,566
Total, Fair Value 19,281 18,222
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Debt Securities    
Amortized Cost 489 695
Gross Unrealized Gains 0 0
Gross Unrealized Losses (12) (16)
Fair Value 477 679
Corporate securities    
Debt Securities    
Amortized Cost 10,523 10,127
Gross Unrealized Gains 32 12
Gross Unrealized Losses (668) (778)
Fair Value 9,887 9,361
Restricted certificates of deposit    
Debt Securities    
Amortized Cost 4 4
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 4 4
Restricted cash equivalents    
Debt Securities    
Amortized Cost 312 256
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 312 256
Short-term time deposits    
Debt Securities    
Amortized Cost 198 204
Gross Unrealized Gains 0 0
Gross Unrealized Losses 0 0
Fair Value 198 204
Municipal securities    
Debt Securities    
Amortized Cost 4,131 4,055
Gross Unrealized Gains 15 6
Gross Unrealized Losses (213) (280)
Fair Value 3,933 3,781
Asset-backed securities    
Debt Securities    
Amortized Cost 1,492 1,396
Gross Unrealized Gains 2 0
Gross Unrealized Losses (57) (70)
Fair Value 1,437 1,326
Residential mortgage-backed securities    
Debt Securities    
Amortized Cost 1,187 1,165
Gross Unrealized Gains 4 2
Gross Unrealized Losses (105) (121)
Fair Value 1,086 1,046
Commercial mortgage-backed securities    
Debt Securities    
Amortized Cost 1,067 961
Gross Unrealized Gains 1 0
Gross Unrealized Losses (87) (99)
Fair Value $ 981 $ 862
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2023
USD ($)
position
Dec. 31, 2022
USD ($)
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Accrued interest income | $ $ 141 $ 132
Positions from which gross unrealized losses were generated 6,109  
Total investment positions 6,936  
Commercial mortgage-backed securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years) 4 years  
Rated Securities | External Credit Rating, Investment Grade | Investment Securities    
Schedule Of Investments And Restricted Deposits By Type [Line Items]    
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 99.00%  
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Unrealized Losses    
Less Than 12 Months $ (115) $ (620)
12 Months or More (1,027) (744)
Fair Value    
Fair Value, Less Than 12 Months 4,982 10,075
Fair Value, 12 Months or More 10,075 5,747
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Unrealized Losses    
Less Than 12 Months (2) (5)
12 Months or More (10) (11)
Fair Value    
Fair Value, Less Than 12 Months 249 342
Fair Value, 12 Months or More 170 184
Corporate securities    
Unrealized Losses    
Less Than 12 Months (72) (340)
12 Months or More (596) (438)
Fair Value    
Fair Value, Less Than 12 Months 2,755 5,368
Fair Value, 12 Months or More 5,683 3,400
Municipal securities    
Unrealized Losses    
Less Than 12 Months (18) (142)
12 Months or More (195) (138)
Fair Value    
Fair Value, Less Than 12 Months 1,161 2,437
Fair Value, 12 Months or More 1,945 995
Asset-backed securities    
Unrealized Losses    
Less Than 12 Months (5) (29)
12 Months or More (52) (41)
Fair Value    
Fair Value, Less Than 12 Months 310 786
Fair Value, 12 Months or More 928 486
Residential mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (10) (55)
12 Months or More (95) (66)
Fair Value    
Fair Value, Less Than 12 Months 319 629
Fair Value, 12 Months or More 652 352
Commercial mortgage-backed securities    
Unrealized Losses    
Less Than 12 Months (8) (49)
12 Months or More (79) (50)
Fair Value    
Fair Value, Less Than 12 Months 188 513
Fair Value, 12 Months or More $ 697 $ 330
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.23.1
Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Investments    
Amortized Cost    
One year or less $ 2,011 $ 2,207
One year through five years 8,008 7,651
Five years through ten years 4,131 4,066
Greater than ten years 144 135
Asset-backed securities 3,746 3,522
Amortized Cost 18,040 17,581
Fair Value    
One year or less 1,981 2,179
One year through five years 7,556 7,147
Five years through ten years 3,821 3,613
Greater than ten years 140 129
Asset-backed securities 3,504 3,234
Fair Value 17,002 16,302
Restricted Deposits    
Amortized Cost    
One year or less 570 534
One year through five years 546 524
Five years through ten years 245 224
Greater than ten years 2 0
Asset-backed securities 0 0
Amortized Cost 1,363 1,282
Fair Value    
One year or less 569 532
One year through five years 518 490
Five years through ten years 224 195
Greater than ten years 2 0
Asset-backed securities 0 0
Fair Value $ 1,313 $ 1,217
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 15,853 $ 12,074
Investments:    
Equity securities 250 5
Total assets at fair value 34,418 29,598
U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 477 679
Corporate securities    
Investments:    
Fair Value 9,887 9,361
Municipal securities    
Investments:    
Fair Value 3,933 3,781
Short-term time deposits    
Investments:    
Fair Value 198 204
Asset-backed securities    
Investments:    
Fair Value 1,437 1,326
Residential mortgage-backed securities    
Investments:    
Fair Value 1,086 1,046
Commercial mortgage-backed securities    
Investments:    
Fair Value 981 862
Investments    
Investments:    
Fair Value 17,002 16,302
Total investments 17,252 16,307
Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 156 371
Investments | Corporate securities    
Investments:    
Fair Value 9,853 9,328
Investments | Municipal securities    
Investments:    
Fair Value 3,291 3,165
Investments | Short-term time deposits    
Investments:    
Fair Value 198 204
Investments | Asset-backed securities    
Investments:    
Fair Value 1,437 1,326
Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 1,086 1,046
Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 981 862
Investments | Equity Securities    
Investments:    
Equity securities 250 5
Restricted deposits    
Investments:    
Fair Value 1,313 1,217
Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 321 308
Restricted deposits | Corporate securities    
Investments:    
Fair Value 34 33
Restricted deposits | Municipal securities    
Investments:    
Fair Value 642 616
Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 312 256
Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 4 4
Level I    
Assets    
Cash and cash equivalents 15,853 12,074
Investments:    
Total assets at fair value 16,890 13,007
Level I | Investments    
Investments:    
Total investments 404 369
Level I | Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 156 366
Level I | Investments | Corporate securities    
Investments:    
Fair Value 0 0
Level I | Investments | Municipal securities    
Investments:    
Fair Value 0 0
Level I | Investments | Short-term time deposits    
Investments:    
Fair Value 0 0
Level I | Investments | Asset-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 0 0
Level I | Investments | Equity Securities    
Investments:    
Equity securities 248 3
Level I | Restricted deposits    
Investments:    
Fair Value 633 564
Level I | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 321 308
Level I | Restricted deposits | Corporate securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits | Municipal securities    
Investments:    
Fair Value 0 0
Level I | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 312 256
Level I | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 0 0
Level II    
Assets    
Cash and cash equivalents 0 0
Investments:    
Total assets at fair value 17,528 16,591
Level II | Investments    
Investments:    
Total investments 16,848 15,938
Level II | Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 5
Level II | Investments | Corporate securities    
Investments:    
Fair Value 9,853 9,328
Level II | Investments | Municipal securities    
Investments:    
Fair Value 3,291 3,165
Level II | Investments | Short-term time deposits    
Investments:    
Fair Value 198 204
Level II | Investments | Asset-backed securities    
Investments:    
Fair Value 1,437 1,326
Level II | Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 1,086 1,046
Level II | Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 981 862
Level II | Investments | Equity Securities    
Investments:    
Equity securities 2 2
Level II | Restricted deposits    
Investments:    
Fair Value 680 653
Level II | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level II | Restricted deposits | Corporate securities    
Investments:    
Fair Value 34 33
Level II | Restricted deposits | Municipal securities    
Investments:    
Fair Value 642 616
Level II | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 0 0
Level II | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value 4 4
Level III    
Assets    
Cash and cash equivalents 0 0
Investments:    
Total assets at fair value 0 0
Level III | Investments    
Investments:    
Total investments 0 0
Level III | Investments | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level III | Investments | Corporate securities    
Investments:    
Fair Value 0 0
Level III | Investments | Municipal securities    
Investments:    
Fair Value 0 0
Level III | Investments | Short-term time deposits    
Investments:    
Fair Value 0 0
Level III | Investments | Asset-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments | Residential mortgage-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments | Commercial mortgage-backed securities    
Investments:    
Fair Value 0 0
Level III | Investments | Equity Securities    
Investments:    
Equity securities 0 0
Level III | Restricted deposits    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | U.S. Treasury securities and obligations of U.S. government corporations and agencies    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Corporate securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Municipal securities    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Cash and cash equivalents    
Investments:    
Fair Value 0 0
Level III | Restricted deposits | Certificates of deposit    
Investments:    
Fair Value $ 0 $ 0
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Fair Value Disclosures [Abstract]    
Aggregate carrying amount of life insurance contracts and equity investments, fair value $ 716 $ 698
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning $ 18,812 $ 19,771
Acquisition and purchase accounting adjustments   1,077
Divestitures   (1,533)
Reallocation   0
Impairments   (370)
Translation impact 24 (133)
Goodwill, Balance ending 18,836 18,812
Medicaid    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 10,198 10,194
Acquisition and purchase accounting adjustments   0
Divestitures   0
Reallocation   4
Impairments   0
Translation impact 0 0
Goodwill, Balance ending 10,198 10,198
Medicare    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 1,592 1,592
Acquisition and purchase accounting adjustments   0
Divestitures   0
Reallocation   0
Impairments   0
Translation impact 0 0
Goodwill, Balance ending 1,592 1,592
Commercial    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 5,424 5,424
Acquisition and purchase accounting adjustments   0
Divestitures   0
Reallocation   0
Impairments   0
Translation impact 0 0
Goodwill, Balance ending 5,424 5,424
Other    
Goodwill and Intangible Assets Disclosure [Abstract]    
Goodwill, Balance beginning 1,598 2,561
Acquisition and purchase accounting adjustments   1,077
Divestitures   (1,533)
Reallocation   (4)
Impairments   (370)
Translation impact 24 (133)
Goodwill, Balance ending $ 1,622 $ 1,598
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1, 2023 $ 16,745 $ 14,243
Less: Reinsurance recoverable 26 23
Balance, January 1, 2023, net 16,719 14,220
Acquisitions   249
Incurred related to:    
Current year 30,571 28,561
Prior years (1,137) (723)
Total incurred 29,434 27,838
Paid related to:    
Current year 18,502 17,398
Prior years 10,174 8,662
Total paid 28,676 26,060
Balance, March 31, 2023, net 17,477 16,247
Plus: Reinsurance recoverable 27 12
Balance, March 31, 2023 17,504 16,259
Medicaid    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1, 2023 11,253 9,845
Less: Reinsurance recoverable 7 23
Balance, January 1, 2023, net 11,246 9,822
Acquisitions   0
Incurred related to:    
Current year 20,813 19,289
Prior years (803) (514)
Total incurred 20,010 18,775
Paid related to:    
Current year 12,679 12,022
Prior years 6,834 5,643
Total paid 19,513 17,665
Balance, March 31, 2023, net 11,743 10,932
Plus: Reinsurance recoverable 9 12
Balance, March 31, 2023 11,752 10,944
Medicare    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1, 2023 3,431 2,286
Less: Reinsurance recoverable 0 0
Balance, January 1, 2023, net 3,431 2,286
Acquisitions   0
Incurred related to:    
Current year 5,163 5,098
Prior years (155) (52)
Total incurred 5,008 5,046
Paid related to:    
Current year 2,988 2,674
Prior years 2,145 1,624
Total paid 5,133 4,298
Balance, March 31, 2023, net 3,306 3,034
Plus: Reinsurance recoverable 0 0
Balance, March 31, 2023 3,306 3,034
Commercial    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1, 2023 1,921 2,014
Less: Reinsurance recoverable 19 0
Balance, January 1, 2023, net 1,902 2,014
Acquisitions   0
Incurred related to:    
Current year 4,177 3,423
Prior years (172) (149)
Total incurred 4,005 3,274
Paid related to:    
Current year 2,541 2,012
Prior years 1,063 1,319
Total paid 3,604 3,331
Balance, March 31, 2023, net 2,303 1,957
Plus: Reinsurance recoverable 18 0
Balance, March 31, 2023 2,321 1,957
Other    
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]    
Balance, January 1, 2023 140 98
Less: Reinsurance recoverable 0 0
Balance, January 1, 2023, net 140 98
Acquisitions   249
Incurred related to:    
Current year 418 751
Prior years (7) (8)
Total incurred 411 743
Paid related to:    
Current year 294 690
Prior years 132 76
Total paid 426 766
Balance, March 31, 2023, net 125 324
Plus: Reinsurance recoverable 0 0
Balance, March 31, 2023 $ 125 $ 324
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Claims Liability - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Insurance [Abstract]    
Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs $ 159 $ 67
Short-duration insurance contracts, Incurred but not reported and expected development on reported claims $ 11,271  
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.23.1
Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Affordable Care Act [Abstract]    
Risk adjustment receivable $ 887 $ 838
Risk adjustment payable (1,556) (780)
Minimum medical loss ratio (176) (103)
Cost sharing reduction payable $ (89) $ (99)
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Schedule of Debt (Details) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Total senior notes $ 15,673,000,000 $ 15,673,000,000
Finance leases and other 260,000,000 253,000,000
Debt issuance costs (141,000,000) (147,000,000)
Total debt 18,320,000,000 18,020,000,000
Less: current portion (97,000,000) (82,000,000)
 Long-term debt 18,223,000,000 17,938,000,000
Revolving credit agreement    
Debt Instrument [Line Items]    
Credit facility 359,000,000 58,000,000
Term loan facility    
Debt Instrument [Line Items]    
Credit facility 2,169,000,000 2,183,000,000
$2,500 million 4.25% Senior Notes due December 15, 2027 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,500,000,000  
Interest rate 4.25%  
Senior notes $ 2,393,000,000 2,393,000,000
$2,300 million 2.45% Senior Notes due July 15, 2028 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,300,000,000  
Interest rate 2.45%  
Senior notes $ 2,303,000,000 2,303,000,000
$3,500 million 4.625% Senior Notes due December 15, 2029 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 3,500,000,000  
Interest rate 4.625%  
Senior notes $ 3,277,000,000 3,277,000,000
$2,000 million 3.375% Senior Notes due February 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,000,000,000  
Interest rate 3.375%  
Senior notes $ 2,000,000,000 2,000,000,000
$2,200 million 3.00% Senior Notes due October 15, 2030 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 3.00%  
Senior notes $ 2,200,000,000 2,200,000,000
$2,200 million 2.50% Senior Notes due March 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 2,200,000,000  
Interest rate 2.50%  
Senior notes $ 2,200,000,000 2,200,000,000
$1,300 million 2.625% Senior Notes due August 1, 2031 | Senior Notes    
Debt Instrument [Line Items]    
Debt, face amount $ 1,300,000,000  
Interest rate 2.625%  
Senior notes $ 1,300,000,000 $ 1,300,000,000
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Debt - Narrative (Details) - Debt Total - Credit Availability Concentration Risk
 3 Months Ended
Mar. 31, 2023
London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)  
Debt Instrument [Line Items]  
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 12.00%
LIBOR  
Debt Instrument [Line Items]  
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 11.00%
Sterling Overnight Index Average (SONIA)  
Debt Instrument [Line Items]  
Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations 1.00%
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Assets    
ROU assets (recorded within other long-term assets) $ 2,578 $ 2,554
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other long-term assets Other long-term assets
Liabilities    
Short-term (recorded within accounts payable and accrued expenses) $ 177 $ 180
Long-term (recorded within other long-term liabilities) 3,144 3,133
Total lease liabilities $ 3,321 $ 3,313
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accounts payable and accrued expenses Accounts payable and accrued expenses
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Other long-term liabilities Other long-term liabilities
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.23.1
Leases - Narrative (Details)
Mar. 31, 2023
Lessee, Lease, Description [Line Items]  
Weighted average remaining lease term 20 years 6 months
Weighted-average discount rate for operating leases 5.70%
Circle Health  
Lessee, Lease, Description [Line Items]  
Weighted average remaining lease term 27 years
Excluding Circle Health  
Lessee, Lease, Description [Line Items]  
Weighted average remaining lease term 8 years 6 months
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Narrative (Details) - USD ($)
shares in Millions, $ in Millions
 1 Months Ended 3 Months Ended
Apr. 25, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2023
Mar. 31, 2022
Equity, Class of Treasury Stock [Line Items]          
Stock repurchase program, increase to authorized amount   $ 2,000 $ 3,000    
Stock repurchase program, authorized amount       $ 6,000  
Stock repurchase program, remaining available       2,429  
Common stock repurchases       $ 423 $ 71
Subsequent Event          
Equity, Class of Treasury Stock [Line Items]          
Common stock repurchases (in shares) 3        
Common stock repurchases $ 200        
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity - Share Repurchase Activity (Details) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Subsidiary, Sale of Stock [Line Items]    
Common stock repurchases $ 423 $ 71
Employee Stock Compensation Plan    
Subsidiary, Sale of Stock [Line Items]    
Income tax withholding (in shares) 696 846
Income tax withholding $ 46 $ 71
Common Stock    
Subsidiary, Sale of Stock [Line Items]    
Share buybacks (in shares) 4,852 0
Common stock repurchases (in shares) 5,548 846
Share buybacks $ 377 $ 0
Common stock repurchases $ 423 $ 71
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.1
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Earnings attributable to Centene Corporation    
Earnings attributable to Centene Corporation $ 1,130 $ 849
Shares used in computing per share amounts:    
Weighted average number of common shares outstanding (in shares) 550,779 583,230
Common stock equivalents (as determined by applying the treasury stock method) (in shares) 3,066 7,428
Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 553,845 590,658
Net earnings per common share attributable to Centene Corporation:    
Basic earnings per common share (in dollars per share) $ 2.05 $ 1.46
Diluted earnings per common share (in dollars per share) $ 2.04 $ 1.44
Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares) 1,606 923
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segment Reporting Information [Line Items]    
Premium and service revenues $ 34,952 $ 34,232
Premium tax 3,937 2,953
Total external revenues 38,889 37,185
Revenues 38,889 37,185
Medical costs 29,434 27,838
Cost of services 870 1,988
Gross margin 4,648 4,406
Operating Segments    
Segment Reporting Information [Line Items]    
Revenues 3,867 6,450
Eliminations    
Segment Reporting Information [Line Items]    
Revenues (3,867) (6,450)
Premium    
Segment Reporting Information [Line Items]    
Premium and service revenues 33,825 31,889
Service    
Segment Reporting Information [Line Items]    
Premium and service revenues 1,127 2,343
Premium and service revenues    
Segment Reporting Information [Line Items]    
Premium and service revenues 34,952 34,232
Medicaid    
Segment Reporting Information [Line Items]    
Revenues 26,164 24,074
Medical costs 20,010 18,775
Cost of services 0 0
Gross margin 2,217 2,346
Medicaid | Operating Segments    
Segment Reporting Information [Line Items]    
Premium tax 3,937 2,953
Total external revenues 26,164 24,074
Revenues 0 0
Medicaid | Eliminations    
Segment Reporting Information [Line Items]    
Revenues 0 0
Medicaid | Premium | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 22,227 21,121
Medicaid | Service | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 0 0
Medicaid | Premium and service revenues | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 22,227 21,121
Medicare    
Segment Reporting Information [Line Items]    
Revenues 5,876 5,757
Medical costs 5,008 5,046
Cost of services 0 0
Gross margin 868 711
Medicare | Operating Segments    
Segment Reporting Information [Line Items]    
Premium tax 0 0
Total external revenues 5,876 5,757
Revenues 0 0
Medicare | Eliminations    
Segment Reporting Information [Line Items]    
Revenues 0 0
Medicare | Premium | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 5,876 5,757
Medicare | Service | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 0 0
Medicare | Premium and service revenues | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 5,876 5,757
Commercial    
Segment Reporting Information [Line Items]    
Revenues 5,252 4,132
Medical costs 4,005 3,274
Cost of services 0 0
Gross margin 1,247 858
Commercial | Operating Segments    
Segment Reporting Information [Line Items]    
Premium tax 0 0
Total external revenues 5,252 4,132
Revenues 0 0
Commercial | Eliminations    
Segment Reporting Information [Line Items]    
Revenues 0 0
Commercial | Premium    
Segment Reporting Information [Line Items]    
Premium and service revenues 5,252 4,132
Commercial | Service | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 0 0
Commercial | Premium and service revenues | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 5,252 4,132
Other/Eliminations    
Segment Reporting Information [Line Items]    
Revenues 1,597 3,222
Medical costs 411 743
Cost of services 870 1,988
Gross margin 316 491
Other/Eliminations | Operating Segments    
Segment Reporting Information [Line Items]    
Premium tax 0 0
Total external revenues 1,597 3,222
Revenues 3,867 6,450
Other/Eliminations | Eliminations    
Segment Reporting Information [Line Items]    
Revenues (3,867)  
Other/Eliminations | Premium | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 470 879
Other/Eliminations | Service | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues 1,127 2,343
Other/Eliminations | Premium and service revenues | Operating Segments    
Segment Reporting Information [Line Items]    
Premium and service revenues $ 1,597 $ 3,222
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.23.1
Contingencies (Details) - Pending Litigation
$ in Millions
Sep. 30, 2021
claim
Jun. 30, 2021
USD ($)
Loss Contingencies [Line Items]    
Pending claims | claim 3  
Reserve estimate | $   $ 1,250
XML 66 cnc-20230331_htm.xml IDEA: XBRL DOCUMENT 0001071739 2023-01-01 2023-03-31 0001071739 2023-04-21 0001071739 2023-03-31 0001071739 2022-12-31 0001071739 us-gaap:HealthCarePremiumMember 2023-01-01 2023-03-31 0001071739 us-gaap:HealthCarePremiumMember 2022-01-01 2022-03-31 0001071739 us-gaap:ServiceMember 2023-01-01 2023-03-31 0001071739 us-gaap:ServiceMember 2022-01-01 2022-03-31 0001071739 2022-01-01 2022-03-31 0001071739 us-gaap:CommonStockMember 2022-12-31 0001071739 us-gaap:CommonStockMember 2023-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-12-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-12-31 0001071739 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001071739 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001071739 us-gaap:RetainedEarningsMember 2023-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2023-03-31 0001071739 us-gaap:CommonStockMember 2021-12-31 0001071739 us-gaap:CommonStockMember 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2021-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2021-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2021-12-31 0001071739 2021-12-31 0001071739 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001071739 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-03-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001071739 us-gaap:RetainedEarningsMember 2022-03-31 0001071739 us-gaap:NoncontrollingInterestMember 2022-03-31 0001071739 2022-03-31 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:CenturionMember 2023-01-10 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanSpecialtyHealthMember 2023-01-20 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanSpecialtyHealthMember 2023-01-20 2023-01-20 0001071739 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember cnc:MagellanSpecialtyHealthMember us-gaap:SubsequentEventMember 2023-04-01 2023-04-25 0001071739 us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2023-03-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2022-12-31 0001071739 cnc:RestrictedCashEquivalentsMember 2023-03-31 0001071739 cnc:RestrictedCashEquivalentsMember 2022-12-31 0001071739 us-gaap:BankTimeDepositsMember 2023-03-31 0001071739 us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 cnc:RatedSecuritiesMember cnc:InvestmentSecuritiesMember us-gaap:ExternalCreditRatingInvestmentGradeMember 2023-01-01 2023-03-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2023-01-01 2023-03-31 0001071739 us-gaap:InvestmentsMember 2023-03-31 0001071739 us-gaap:DepositsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember 2022-12-31 0001071739 us-gaap:DepositsMember 2022-12-31 0001071739 us-gaap:FairValueInputsLevel1Member 2023-03-31 0001071739 us-gaap:FairValueInputsLevel2Member 2023-03-31 0001071739 us-gaap:FairValueInputsLevel3Member 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:BankTimeDepositsMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:AssetBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2023-03-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2023-03-31 0001071739 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001071739 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001071739 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:BankTimeDepositsMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:AssetBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:CommercialMortgageBackedSecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001071739 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:CashAndCashEquivalentsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:USTreasuryAndGovernmentMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:CorporateDebtSecuritiesMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:CertificatesOfDepositMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:MunicipalBondsMember 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel2Member 2022-12-31 0001071739 us-gaap:DepositsMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2021-12-31 0001071739 cnc:MedicareSegmentMember 2021-12-31 0001071739 cnc:CommercialSegmentMember 2021-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2021-12-31 0001071739 cnc:MedicaidSegmentMember 2022-01-01 2022-12-31 0001071739 cnc:MedicareSegmentMember 2022-01-01 2022-12-31 0001071739 cnc:CommercialSegmentMember 2022-01-01 2022-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-12-31 0001071739 2022-01-01 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2022-12-31 0001071739 cnc:MedicareSegmentMember 2022-12-31 0001071739 cnc:CommercialSegmentMember 2022-12-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-12-31 0001071739 cnc:MedicaidSegmentMember 2023-01-01 2023-03-31 0001071739 cnc:MedicareSegmentMember 2023-01-01 2023-03-31 0001071739 cnc:CommercialSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001071739 cnc:MedicaidSegmentMember 2023-03-31 0001071739 cnc:MedicareSegmentMember 2023-03-31 0001071739 cnc:CommercialSegmentMember 2023-03-31 0001071739 us-gaap:AllOtherSegmentsMember 2023-03-31 0001071739 cnc:MedicaidSegmentMember 2022-01-01 2022-03-31 0001071739 cnc:MedicareSegmentMember 2022-01-01 2022-03-31 0001071739 cnc:CommercialSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001071739 cnc:MedicaidSegmentMember 2022-03-31 0001071739 cnc:MedicareSegmentMember 2022-03-31 0001071739 cnc:CommercialSegmentMember 2022-03-31 0001071739 us-gaap:AllOtherSegmentsMember 2022-03-31 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:A2300Million245SeniorNotsDueJuly2028Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:A3500Million4625SeniorNotesDueDecember2029Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:A2200Million375SeniorNotesDueFebruary2030Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:A2200Million300SeniorNotesDueOctober2030Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:A2200Million250SeniorNotesDueMarch2031Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2023-03-31 0001071739 cnc:A1300Million2625SeniorNotesDueAugust2031Member us-gaap:SeniorNotesMember 2022-12-31 0001071739 cnc:TermLoanCreditAgreementMember 2023-03-31 0001071739 cnc:TermLoanCreditAgreementMember 2022-12-31 0001071739 us-gaap:RevolvingCreditFacilityMember 2023-03-31 0001071739 us-gaap:RevolvingCreditFacilityMember 2022-12-31 0001071739 cnc:DebtTotalMember us-gaap:CreditAvailabilityConcentrationRiskMember cnc:LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember 2023-01-01 2023-03-31 0001071739 cnc:DebtTotalMember us-gaap:CreditAvailabilityConcentrationRiskMember us-gaap:LondonInterbankOfferedRateLIBORMember 2023-01-01 2023-03-31 0001071739 cnc:DebtTotalMember us-gaap:CreditAvailabilityConcentrationRiskMember cnc:SterlingOvernightIndexAverageSONIAMember 2023-01-01 2023-03-31 0001071739 cnc:CircleHealthMember 2023-03-31 0001071739 cnc:ExcludingCircleHealthMember 2023-03-31 0001071739 2022-06-01 2022-06-30 0001071739 2022-12-01 2022-12-31 0001071739 us-gaap:SubsequentEventMember 2023-04-01 2023-04-25 0001071739 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001071739 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001071739 cnc:EmployeeStockCompensationPlanMember 2023-01-01 2023-03-31 0001071739 cnc:EmployeeStockCompensationPlanMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001071739 cnc:TotalPremiumAndServiceMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember 2023-01-01 2023-03-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2023-01-01 2023-03-31 0001071739 us-gaap:IntersegmentEliminationMember us-gaap:AllOtherSegmentsMember 2023-01-01 2023-03-31 0001071739 us-gaap:IntersegmentEliminationMember 2023-01-01 2023-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicaidSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember cnc:MedicareSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:HealthCarePremiumMember cnc:CommercialSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:HealthCarePremiumMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicaidSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:MedicareSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember cnc:CommercialSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:ServiceMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicaidSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:MedicareSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember cnc:CommercialSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:TotalPremiumAndServiceMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001071739 cnc:TotalPremiumAndServiceMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicaidSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:MedicareSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember cnc:CommercialSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember us-gaap:AllOtherSegmentsMember 2022-01-01 2022-03-31 0001071739 us-gaap:OperatingSegmentsMember 2022-01-01 2022-03-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicaidSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:MedicareSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:CommercialSegmentMember 2022-01-01 2022-03-31 0001071739 us-gaap:IntersegmentEliminationMember 2022-01-01 2022-03-31 0001071739 us-gaap:PendingLitigationMember 2021-09-30 0001071739 us-gaap:PendingLitigationMember 2021-06-30 shares iso4217:USD iso4217:USD shares pure cnc:position cnc:claim 0001071739 --12-31 2023 Q1 false http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent 10-Q true 2023-03-31 false 001-31826 CENTENE CORPORATION DE 42-1406317 7700 Forsyth Boulevard St. Louis, MO 63105 314 725-4477 Common Stock $0.001 Par Value CNC NYSE Yes Yes Large Accelerated Filer false false false 548769258 15853000000 12074000000 15210000000 13272000000 2135000000 2321000000 1811000000 2461000000 35009000000 30128000000 15833000000 14684000000 1313000000 1217000000 2478000000 2432000000 18836000000 18812000000 6730000000 6911000000 2783000000 2686000000 82982000000 76870000000 17504000000 16745000000 10781000000 9525000000 2077000000 1634000000 2398000000 478000000 97000000 82000000 32857000000 28464000000 18223000000 17938000000 522000000 615000000 6194000000 5616000000 57796000000 52633000000 20000000 56000000 0.001 0.001 10000000 10000000 0 0 0 0 0 0 0.001 0.001 800000000 800000000 614355000 551714000 607847000 550754000 1000000 1000000 20121000000 20060000000 -915000000 -1132000000 10471000000 9341000000 62641000 57093000 4636000000 4213000000 25042000000 24057000000 124000000 124000000 25166000000 24181000000 82982000000 76870000000 33825000000 31889000000 1127000000 2343000000 34952000000 34232000000 3937000000 2953000000 38889000000 37185000000 29434000000 27838000000 870000000 1988000000 3011000000 2745000000 142000000 156000000 183000000 199000000 4011000000 3006000000 20000000 0 37671000000 35932000000 1218000000 1253000000 353000000 52000000 0 3000000 180000000 160000000 1391000000 1148000000 261000000 296000000 1130000000 852000000 0 3000000 1130000000 849000000 2.05 1.46 2.04 1.44 550779000 583230000 553845000 590658000 1130000000 852000000 253000000 -715000000 61000000 -171000000 192000000 -544000000 -2000000 -2000000 23000000 -20000000 217000000 -562000000 1347000000 290000000 0 3000000 1347000000 287000000 0.001 0.001 0.001 0.001 607847000 1000000 20060000000 -1132000000 9341000000 57093000 -4213000000 124000000 24181000000 1130000000 1130000000 61000000 217000000 217000000 6508000 12000000 12000000 5548000 423000000 423000000 61000000 61000000 12000000 12000000 614355000 1000000 20121000000 -915000000 10471000000 62641000 -4636000000 124000000 25166000000 0.001 0.001 0.001 0.001 602704000 1000000 19672000000 77000000 8139000000 20225000 -1094000000 145000000 26940000000 849000000 -1000000 848000000 -171000000 -562000000 -562000000 3221000 28000000 28000000 60000000 60000000 846000 71000000 71000000 70000000 70000000 605925000 1000000 19830000000 -485000000 8988000000 21071000 -1165000000 144000000 27313000000 1130000000 852000000 346000000 390000000 61000000 70000000 20000000 0 0 3000000 -159000000 12000000 79000000 0 -7000000 -22000000 1938000000 3099000000 315000000 299000000 759000000 1767000000 1919000000 81000000 1548000000 957000000 970000000 401000000 4269000000 1151000000 225000000 242000000 1619000000 1700000000 1148000000 1047000000 0 1504000000 443000000 0 0 2000000 -253000000 -2401000000 287000000 100000000 0 526000000 423000000 71000000 0 27000000 0 27000000 58000000 0 11000000 -1000000 -183000000 -498000000 2000000 33000000 3835000000 -1715000000 12330000000 13214000000 16165000000 11499000000 144000000 139000000 11000000 11000000 15853000000 11237000000 312000000 262000000 16165000000 11499000000 Organization and Operations <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace along with individual, small group, and large group commercial healthcare products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim financial statements have been prepared under the presumption that users of the interim financial information have either read or have access to the audited financial statements included in the Form 10-K for the fiscal year ended December 31, 2022. The unaudited interim financial statements herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, footnote disclosures that would substantially duplicate the disclosures contained in the December 31, 2022 audited financial statements have been omitted from these interim financial statements, where appropriate. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the results of the interim periods presented.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain 2022 amounts in the consolidated financial statements and notes to the consolidated financial statements have been reclassified to conform to the 2023 presentation, including reclassifications related to the Company's new segment reporting structure as outlined below. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment, and (4) an Other segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind, or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans (D-SNPs), and Medicare Prescription Drug Plans (PDPs), also known as Medicare Part D. The Commercial segment includes the Health Insurance Marketplace along with individual, small group, and large group commercial healthcare products. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Guidance Not Yet Adopted</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that there are no recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations, or cash flows.</span></div> Acquisitions and Divestitures<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2023, the Company completed the divestiture of HealthSmart, its third-party health plan administration business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2023, the Company signed and closed on a definitive agreement to divest Centurion, its prison healthcare business. During 2022, the Company recorded impairment charges related to goodwill and other current assets associated with the pending divestitures. The Company could receive up to an additional $35 million in cash based on the reprocurements of certain Centurion contracts. The Company will recognize the appropriate amount of contingent consideration related to the additional $35 million when realized or realizable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2023, the Company completed the divestiture of Magellan Specialty Health for approximately $646 million in cash and stock, including an estimated working capital adjustment and recognized a pre-tax gain of $79 million. The stock consideration was subsequently sold in April 2023 for cash proceeds of $245 million. The Company could also receive up to an additional $150 million in cash and stock in 2024 based on certain 2023 performance metrics. The Company will recognize the appropriate amount of contingent consideration related to the additional $150 million when realized or realizable.</span></div> 35000000 35000000 646000000 79000000 245000000 150000000 150000000 Short-term and Long-term Investments, Restricted Deposits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">477 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,887 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,369 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,281 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,566 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,364)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,222 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of March 31, 2023 primarily consisted of shares received as part of the Magellan Specialty Health divestiture consideration. These shares were subsequently sold in April 2023.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are debt securities classified as available-for-sale with the exception of equity securities, certain private equity investments and life insurance contracts. The Company's investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. As of March 31, 2023, 99% of the Company's investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations. At March 31, 2023, the Company held certificates of deposit, equity securities, private equity investments, and life insurance contracts, which did not carry a credit rating. Accrued interest income on available-for-sale debt securities was $141 million and $132 million at March 31, 2023 and December 31, 2022, respectively, and is included in other current assets on the Consolidated Balance Sheets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's residential mortgage-backed securities are primarily issued by the Federal National Mortgage Association, Government National Mortgage Association, or Federal Home Loan Mortgage Corporation, which carry implicit or explicit guarantees of the U.S. government. The Company's commercial mortgage-backed securities are primarily senior tranches with a weighted average rating of AAA and a weighted average duration of 4 years at March 31, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the gross unrealized losses were generated from 6,109 positions out of a total of 6,936 positions. The change in fair value of available-for-sale debt securities is primarily a result of movement in interest rates subsequent to the purchase of the security.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual, or regulatory purposes. If the security meets this criterion, the decline in fair value is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, the Company did not record an impairment for these securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company monitors available-for-sale debt securities for credit losses. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates, and/or general economic conditions. The Company recognizes an allowance when evidence demonstrates that the decline in fair value is credit related. Evidence of a credit related loss may include rating agency actions, adverse conditions specifically related to the security, or failure of the issuer of the security to make scheduled payments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,011 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,821 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,040 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,002 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,302 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual maturities may differ from contractual maturities due to call or prepayment options. Equity securities, private equity investments and life insurance contracts are excluded from the table above because they do not have a contractual maturity. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term and long-term investments and restricted deposits by investment type consist of the following ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:22.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.378%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.284%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">477 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,523 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(668)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,887 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(778)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,361 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted certificates of deposit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(280)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,396 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,187 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Life insurance contracts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,369 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,281 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,566 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,364)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,222 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments in equity securities as of March 31, 2023 primarily consisted of shares received as part of the Magellan Specialty Health divestiture consideration. These shares were subsequently sold in April 2023.</span></div></td></tr></table></div> 489000000 0 12000000 477000000 695000000 0 16000000 679000000 10523000000 32000000 668000000 9887000000 10127000000 12000000 778000000 9361000000 4000000 0 0 4000000 4000000 0 0 4000000 312000000 0 0 312000000 256000000 0 0 256000000 198000000 0 0 198000000 204000000 0 0 204000000 4131000000 15000000 213000000 3933000000 4055000000 6000000 280000000 3781000000 1492000000 2000000 57000000 1437000000 1396000000 0 70000000 1326000000 1187000000 4000000 105000000 1086000000 1165000000 2000000 121000000 1046000000 1067000000 1000000 87000000 981000000 961000000 0 99000000 862000000 250000000 250000000 5000000 5000000 540000000 540000000 529000000 529000000 176000000 176000000 169000000 169000000 20369000000 54000000 1142000000 19281000000 19566000000 20000000 1364000000 18222000000 0.99 141000000 132000000 P4Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of available-for-sale debt securities with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less Than 12 Months</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12 Months or More</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,755 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(596)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,400 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,161 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,027)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(620)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,075 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(744)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,747 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2000000 249000000 10000000 170000000 5000000 342000000 11000000 184000000 72000000 2755000000 596000000 5683000000 340000000 5368000000 438000000 3400000000 18000000 1161000000 195000000 1945000000 142000000 2437000000 138000000 995000000 5000000 310000000 52000000 928000000 29000000 786000000 41000000 486000000 10000000 319000000 95000000 652000000 55000000 629000000 66000000 352000000 8000000 188000000 79000000 697000000 49000000 513000000 50000000 330000000 115000000 4982000000 1027000000 10075000000 620000000 10075000000 744000000 5747000000 6109 6936 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of short-term and long-term debt securities and restricted deposits are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.514%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Deposits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year or less</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,011 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,981 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,207 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,179 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,651 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,147 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,821 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,613 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,504 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,522 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,040 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,002 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,581 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,302 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div> 2011000000 1981000000 570000000 569000000 2207000000 2179000000 534000000 532000000 8008000000 7556000000 546000000 518000000 7651000000 7147000000 524000000 490000000 4131000000 3821000000 245000000 224000000 4066000000 3613000000 224000000 195000000 144000000 140000000 2000000 2000000 135000000 129000000 0 0 3746000000 3504000000 0 0 3522000000 3234000000 0 0 18040000000 17002000000 1363000000 1313000000 17581000000 16302000000 1282000000 1217000000 Fair Value Measurements <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at March 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,890 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,528 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,418 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes matrix-pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. In addition, the aggregate carrying amount of the Company's private equity investments and life insurance contracts, which approximates fair value, was $716 million and $698 million as of March 31, 2023 and December 31, 2022, respectively.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities recorded at fair value in the Consolidated Balance Sheets are categorized based upon observable or unobservable inputs used to estimate fair value. Level inputs are as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:11.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level Input:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Input Definition:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability at the measurement date.</span></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at March 31, 2023, for assets and liabilities measured at fair value on a recurring basis ($ in millions): </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,853 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,291 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,437 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,848 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,890 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,528 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,418 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes fair value measurements by level at December 31, 2022, for assets and liabilities measured at fair value on a recurring basis ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:53.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level I</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level II</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level III</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,074 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,328 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term time deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,326 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,938 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,307 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted deposits:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury securities and obligations of U.S. government corporations and agencies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restricted deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">564 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets at fair value</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,007 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,591 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,598 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 15853000000 0 0 15853000000 156000000 0 0 156000000 0 9853000000 0 9853000000 0 3291000000 0 3291000000 0 198000000 0 198000000 0 1437000000 0 1437000000 0 1086000000 0 1086000000 0 981000000 0 981000000 248000000 2000000 0 250000000 404000000 16848000000 0 17252000000 312000000 0 0 312000000 321000000 0 0 321000000 0 34000000 0 34000000 0 4000000 0 4000000 0 642000000 0 642000000 633000000 680000000 0 1313000000 16890000000 17528000000 0 34418000000 12074000000 0 0 12074000000 366000000 5000000 0 371000000 0 9328000000 0 9328000000 0 3165000000 0 3165000000 0 204000000 0 204000000 0 1326000000 0 1326000000 0 1046000000 0 1046000000 0 862000000 0 862000000 3000000 2000000 0 5000000 369000000 15938000000 0 16307000000 256000000 0 0 256000000 308000000 0 0 308000000 0 33000000 0 33000000 0 4000000 0 4000000 0 616000000 0 616000000 564000000 653000000 0 1217000000 13007000000 16591000000 0 29598000000 716000000 698000000 Goodwill and Intangible Assets<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 2023 the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,194 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,771 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,812 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,836 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in goodwill by operating segment ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2021</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,194 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,771 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and purchase accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,077 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,533)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reallocation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,812 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Translation impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,198 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,424 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,836 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10194000000 1592000000 5424000000 2561000000 19771000000 0 0 0 1077000000 1077000000 0 0 0 1533000000 1533000000 4000000 0 0 -4000000 0 0 0 0 370000000 370000000 0 0 0 -133000000 -133000000 10198000000 1592000000 5424000000 1598000000 18812000000 0 0 0 24000000 24000000 10198000000 1592000000 5424000000 1622000000 18836000000 Medical Claims Liability<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Operations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 2023 the Company updated its segment structure. Prior year information has been adjusted to reflect the change in segment reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the three months ended March 31, 2023 ($ in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,246 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,010 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,434 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,988 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,834 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,513 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,133 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,604 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,676 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,477 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,752 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,504 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the three months ended March 31, 2022 ($ in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2022, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,046 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,662 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,060 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,932 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,944 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,259 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables related to medical claims are included in premium and trade receivables. Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum health benefits ratio (HBR) and other return of premium programs, the Company recorded $159 million and $67 million as a reduction to premium revenue in the three months ended March 31, 2023 and 2022, respectively.</span></div>Incurred but not reported (IBNR) plus expected development on reported claims as of March 31, 2023 was $11,271 million. Total IBNR plus expected development on reported claims represents estimates for claims incurred but not reported, development on reported claims, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services, and other relevant factors. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the three months ended March 31, 2023 ($ in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.812%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2023</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,921 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,745 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2023, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,246 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,431 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,902 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,719 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,813 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,163 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,177 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,571 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(803)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,137)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,010 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,434 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,679 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,988 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,541 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,502 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,834 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,145 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,174 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,513 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,133 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,604 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,676 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2023, net</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,477 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,752 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,306 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,504 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in medical claims liability for the three months ended March 31, 2022 ($ in millions): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, January 1, 2022</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,845 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,243 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, January 1, 2022, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,822 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,286 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,289 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,098 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,423 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">751 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,561 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(514)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,046 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,022 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">690 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,398 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,643 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,662 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,665 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,298 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,060 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, March 31, 2022, net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,932 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,247 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: Reinsurance recoverable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,944 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,957 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,259 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11253000000 3431000000 1921000000 140000000 16745000000 7000000 0 19000000 0 26000000 11246000000 3431000000 1902000000 140000000 16719000000 20813000000 5163000000 4177000000 418000000 30571000000 -803000000 -155000000 -172000000 -7000000 -1137000000 20010000000 5008000000 4005000000 411000000 29434000000 12679000000 2988000000 2541000000 294000000 18502000000 6834000000 2145000000 1063000000 132000000 10174000000 19513000000 5133000000 3604000000 426000000 28676000000 11743000000 3306000000 2303000000 125000000 17477000000 9000000 0 18000000 0 27000000 11752000000 3306000000 2321000000 125000000 17504000000 9845000000 2286000000 2014000000 98000000 14243000000 23000000 0 0 0 23000000 9822000000 2286000000 2014000000 98000000 14220000000 0 0 0 249000000 249000000 19289000000 5098000000 3423000000 751000000 28561000000 -514000000 -52000000 -149000000 -8000000 -723000000 18775000000 5046000000 3274000000 743000000 27838000000 12022000000 2674000000 2012000000 690000000 17398000000 5643000000 1624000000 1319000000 76000000 8662000000 17665000000 4298000000 3331000000 766000000 26060000000 10932000000 3034000000 1957000000 324000000 16247000000 12000000 0 0 0 12000000 10944000000 3034000000 1957000000 324000000 16259000000 -159000000 -67000000 11271000000 Affordable Care Act <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affordable Care Act established risk spreading premium stabilization programs as well as a minimum annual medical loss ratio (MLR) and cost sharing reductions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's net receivables (payables) for each of the programs are as follows ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment receivable</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">887 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk adjustment payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum medical loss ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(176)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost sharing reduction payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 887000000 838000000 1556000000 780000000 176000000 103000000 89000000 99000000 Debt <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,320 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,223 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the Company's total debt, approximately 12% is variable rate debt. Approximately 11% uses the London Interbank Offered Rate (LIBOR) as a reference rate pursuant to the terms of the Company Credit Facility and approximately 1% uses the Sterling Overnight Index Average (SONIA) as a reference rate. The debt agreements that may be impacted by the discontinuation of LIBOR have provisions included that are sufficient for the Company to transition from the existing LIBOR rates to the prevailing successor market rates as necessary. The document governing the Company Credit Facility includes provisions to convert from LIBOR to the Secured Overnight Financing Rate (SOFR) at the time LIBOR ceases to be published.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,500 million 4.25% Senior Notes due December 15, 2027</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,300 million 2.45% Senior Notes due July 15, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3,500 million 4.625% Senior Notes due December 15, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,277 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,000 million 3.375% Senior Notes due February 15, 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 3.00% Senior Notes due October 15, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,200 million 2.50% Senior Notes due March 1, 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,300 million 2.625% Senior Notes due August 1, 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,673 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan facility</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,320 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,020 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,223 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,938 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2500000000 0.0425 2393000000 2393000000 2300000000 0.0245 2303000000 2303000000 3500000000 0.04625 3277000000 3277000000 2000000000 0.03375 2000000000 2000000000 2200000000 0.0300 2200000000 2200000000 2200000000 0.0250 2200000000 2200000000 1300000000 0.02625 1300000000 1300000000 15673000000 15673000000 2169000000 2183000000 359000000 58000000 260000000 253000000 141000000 147000000 18320000000 18020000000 97000000 82000000 18223000000 17938000000 0.12 0.11 0.01 Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfMy0xLTEtMS01MTI4MzA_783fed1c-02c1-431e-a722-7cb1d4c86e26">2,578</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfMy0zLTEtMS01MTI4MzA_853035ae-05ae-4b17-bf54-ac31ed5a3567">2,554</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNi0xLTEtMS01MTI4MzA_7a4b92c6-0c5f-4883-8953-23db2aa27d48">177</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNi0zLTEtMS01MTI4MzA_d104caf9-c9a4-4f8f-8c46-eeddbe595094">180</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNy0xLTEtMS01MTI4MzA_688f6be3-3b3e-4d3f-8b8c-980cb953f774">3,144</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNy0zLTEtMS01MTI4MzA_d9bb9525-f87d-487e-8bd8-d3dc205100bd">3,133</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, the weighted average remaining lease term for the Company was 20.5 years. The average remaining lease term of the Circle Health portfolio is 27.0 years. Excluding Circle Health, the company's portfolio average remaining lease term is 8.5 years. The lease liabilities as of March 31, 2023 reflect a weighted average discount rate of 5.7%.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the right-of-use (ROU) assets and lease liabilities ($ in millions):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROU assets (recorded within other long-term assets)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfMy0xLTEtMS01MTI4MzA_783fed1c-02c1-431e-a722-7cb1d4c86e26">2,578</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfMy0zLTEtMS01MTI4MzA_853035ae-05ae-4b17-bf54-ac31ed5a3567">2,554</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term (recorded within accounts payable and accrued expenses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNi0xLTEtMS01MTI4MzA_7a4b92c6-0c5f-4883-8953-23db2aa27d48">177</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNi0zLTEtMS01MTI4MzA_d104caf9-c9a4-4f8f-8c46-eeddbe595094">180</span> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term (recorded within other long-term liabilities)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNy0xLTEtMS01MTI4MzA_688f6be3-3b3e-4d3f-8b8c-980cb953f774">3,144</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmM2YmYyODIxODZmNzQ1NTY5ODE2YjVlMzQyNmU3M2U5L3NlYzpjNmJmMjgyMTg2Zjc0NTU2OTgxNmI1ZTM0MjZlNzNlOV83MC9mcmFnOjA0ZGRhZjAwM2M3MjRmZmY4MDI0MWJmMDNkNzIyYTY1L3RhYmxlOmMyNDU1ZjUxNTI2ZDQ2Y2JhMTU5MmZkYWUzODg1YmYxL3RhYmxlcmFuZ2U6YzI0NTVmNTE1MjZkNDZjYmExNTkyZmRhZTM4ODViZjFfNy0zLTEtMS01MTI4MzA_d9bb9525-f87d-487e-8bd8-d3dc205100bd">3,133</span> </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,313 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2578000000 2554000000 177000000 180000000 3144000000 3133000000 3321000000 3313000000 P20Y6M P27Y P8Y6M 0.057 Stockholders' Equity <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Board of Directors has authorized a stock repurchase program of the Company's common stock from time to time on the open market or through privately negotiated transactions. In 2022, the Company's Board of Directors authorized increases under the program including $3,000 million in June 2022 and an additional $2,000 million in December 2022. With these increases, the Company is authorized to repurchase up to $6,000 million, inclusive of past authorizations. As of March 31, 2023, the Company had a remaining amount of $2,429 million available under the Company's stock repurchase program. In April 2023, the Company repurchased an additional 3 million shares for $200 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,548 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Shares repurchased for income tax withholding are shares withheld in connection with employee stock plans to meet applicable tax withholding requirements. These shares are typically included in the Company's treasury stock. 3000000000 2000000000 6000000000 2429000000 3000000 200000000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents the Company's share repurchase activity ($ in millions, shares in thousands):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:33.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.910%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share buybacks</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax withholding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share repurchases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,548 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4852000 377000000 0 0 696000 46000000 846000 71000000 5548000 423000000 846000 71000000 Earnings Per Share <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553,845 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,658 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of diluted earnings per common share for the three months ended March 31, 2023 and 2022 excludes 1,606 thousand shares and 923 thousand shares, respectively, related to anti-dilutive stock options, restricted stock, and restricted stock units.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the calculation of basic and diluted net earnings per common share ($ in millions, except per share data in dollars and shares in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings attributable to Centene Corporation</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing per share amounts:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,230 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock equivalents (as determined by applying the treasury stock method) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,428 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares and potential dilutive common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553,845 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,658 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings per common share attributable to Centene Corporation:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.04 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:10.8pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The reduction in common stock equivalents is primarily driven by the distribution of long-term stock awards to the estate of the Company's former CEO during the first quarter of 2023, which were fully dilutive prior to their distribution.</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1130000000 849000000 550779000 583230000 3066000 7428000 553845000 590658000 2.05 1.46 2.04 1.44 1606000 923000 Segment Information <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In early 2023, and in conjunction with the Company's updated strategic plan, executive leadership realignment, and corresponding 2023 divestitures, the Company has revised the way it manages the business, evaluates performance, and allocates resources, resulting in an updated segment structure comprised of (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. Prior year information has been adjusted to reflect the change in segment reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid, Medicare, and Commercial segments represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams, and the type of information presented to the Company's chief operating decision-maker to evaluate all results of operations. The Company does not report total assets by segment since this is not a metric used to allocate resources or evaluate segment performance.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended March 31, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,227 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,825 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,227 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,952 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,164 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,867)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,867)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,164 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,889 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended March 31, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,074 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,074 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,185 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,775 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended March 31, 2023, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,227 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,825 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,227 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,952 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,164 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,867)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,867)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,164 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,252 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,889 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,010 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,008 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,005 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,247 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,648 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment information for the three months ended March 31, 2022, is as follows ($ in millions):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicaid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercial</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other/Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,889 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,343 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium and service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,121 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,074 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,185 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,074 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,757 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,222 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,185 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,775 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,046 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> Gross margin represents premium and service revenues less medical costs and cost of services.</span></div></td></tr></table></div> 22227000000 5876000000 5252000000 470000000 33825000000 0 0 0 1127000000 1127000000 22227000000 5876000000 5252000000 1597000000 34952000000 3937000000 0 0 0 3937000000 26164000000 5876000000 5252000000 1597000000 38889000000 0 0 0 3867000000 3867000000 0 0 0 -3867000000 -3867000000 26164000000 5876000000 5252000000 1597000000 38889000000 20010000000 5008000000 4005000000 411000000 29434000000 0 0 0 870000000 870000000 2217000000 868000000 1247000000 316000000 4648000000 21121000000 5757000000 4132000000 879000000 31889000000 0 0 0 2343000000 2343000000 21121000000 5757000000 4132000000 3222000000 34232000000 2953000000 0 0 0 2953000000 24074000000 5757000000 4132000000 3222000000 37185000000 0 0 0 6450000000 6450000000 0 0 0 -6450000000 -6450000000 24074000000 5757000000 4132000000 3222000000 37185000000 18775000000 5046000000 3274000000 743000000 27838000000 0 0 0 1988000000 1988000000 2346000000 711000000 858000000 491000000 4406000000 Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is routinely subjected to legal and regulatory proceedings in the normal course of business. These matters can include, without limitation:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">periodic compliance and other reviews and investigations by various federal and state regulatory agencies with respect to requirements applicable to the Company's business, including, without limitation, those related to payment of out-of-network claims, submissions to the Centers for Medicare and Medicaid Services (CMS) related to risk adjustment payments, or the False Claims Act, the calculation of minimum MLR and rebates related thereto, submissions to state agencies related to payments or state false claims acts, pre-authorization penalties, timely review of grievances and appeals, timely and accurate payment of claims, cybersecurity issues, including those related to the Company's or the Company's third party vendors' information systems, and the Health Insurance Portability and Accountability Act of 1996 and other federal and state fraud, waste and abuse laws;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation arising out of general business activities, such as tax matters, disputes related to healthcare benefits coverage or reimbursement, putative securities class actions, and medical malpractice, privacy, real estate, intellectual property and employment-related claims; and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes regarding reinsurance arrangements, claims arising out of the acquisition or divestiture of various assets, class actions, and claims relating to the performance of contractual and non-contractual obligations to providers, members, employer groups and others, including, but not limited to, the alleged failure to properly pay claims and challenges to the manner in which the Company processes claims, claims related to network adequacy and claims alleging that the Company has engaged in unfair business practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, these matters may result in awards of damages, fines or penalties, which could be substantial, and/or could require changes to the Company's business. The Company intends to vigorously defend itself against legal and regulatory proceedings to which it is currently a party; however, these proceedings are subject to many uncertainties. In some of the cases pending against the Company, substantial non-economic or punitive damages are being sought. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records reserves and accrues costs for certain legal proceedings and regulatory matters to the extent that it determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. While such reserves and accrued costs reflect the Company's best estimate of the probable loss for such matters, the recorded amounts may differ materially from the actual amount of any such losses. In some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal and regulatory proceedings, which may be exacerbated by various factors, including but not limited to, they may involve indeterminate claims for monetary damages or may involve fines, penalties or punitive damages; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; involve a large number of parties, claimants or regulatory bodies; are in the early stages of the proceedings; involve a number of separate proceedings and/or a wide range of potential outcomes; or result in a change of business practices. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, amounts accrued for legal proceedings and regulatory matters were not material, except for the reserve estimate as described below with respect to claims or potential claims involving services provided by Envolve Pharmacy Solutions, Inc. (Envolve), as the Company's pharmacy benefits management (PBM) subsidiary. It is possible that in a particular quarter or annual period the Company's financial condition, results of operations, cash flow and/or liquidity could be materially adversely affected by an ultimate unfavorable resolution of or development in legal and/or regulatory proceedings, including as described below. Except for the discussion below, the Company believes that the ultimate outcome of any of the regulatory and legal proceedings that are currently pending against it should not have a material adverse effect on financial condition, results of operations, cash flow, or liquidity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 20, 2015, the Company's California subsidiary, Health Net of California, Inc. (Health Net California), was named as a defendant in a California taxpayer action filed in Los Angeles County Superior Court, captioned as Michael D. Myers v. State Board of Equalization, Dave Jones, Insurance Commissioner of the State of California, Betty T. Yee, Controller of the State of California, et al., Los Angeles Superior Court Case No. BS158655. This action is brought under a California statute that permits an individual taxpayer to sue a governmental agency when the taxpayer believes the agency has failed to enforce governing law. Plaintiff contends that Health Net California, a California licensed Health Care Service Plan (HCSP), is an "insurer" for purposes of taxation despite acknowledging it is not an "insurer" under regulatory law. Under California law, "insurers" must pay a gross premiums tax (GPT), calculated as 2.35% on gross premiums. As a licensed HCSP, Health Net California has paid the California Corporate Franchise Tax (CFT), the tax generally paid by California businesses. Plaintiff contends that Health Net California must pay the GPT rather than the CFT. Plaintiff seeks a writ of mandate directing the California taxing agencies to collect the GPT, and seeks an order requiring Health Net California to pay GPT, interest and penalties for a period dating to eight years prior to the October 2015 filing of the complaint. This lawsuit is being coordinated with similar lawsuits filed against other entities (collectively, Related Actions). In March 2018, the Court overruled the Company's demurrer seeking to dismiss the complaint and denied the Company's motion to strike allegations seeking retroactive relief. In August 2018, the trial court stayed all the Related Actions pending determination of a writ of mandate by the California Court of Appeals in two of the Related Actions. In March 2019, the California Court of Appeals denied the writ of mandate. The defendants in those Related Actions sought review by the California Supreme Court, which declined to review the matter. Upon the return of the matter to the Los Angeles County Superior Court, motions for summary judgment were scheduled. Health Net California's motion for summary judgment was heard by the Court in March 2020. In March 2020, the Court granted Health Net California's motion for summary judgment. In September 2020, the plaintiff appealed the Court's decision. The Company intends to continue its vigorous defense against these claims; however, this matter is subject to many uncertainties, and an adverse outcome in this matter could potentially have a materially adverse impact on the Company's financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in April 2021, several lawsuits have been filed against the Company and its subsidiaries, alleging that the defendants failed to prevent Health Net members' personal and health data from being exposed in connection with a data breach involving Accellion's File Transfer Appliance. The Company denies any wrongdoing, and at a mediation in September 2021, the Company reached a settlement with plaintiffs in three of the pending class actions which, if approved by court, should resolve most or all of the pending litigation related to this matter. In addition, claims related to these lawsuits are anticipated to be covered in part by the Company's insurance carrier. As a result, while these matters are subject to many uncertainties, the Company does not believe that an adverse outcome in these matters is likely to have a materially adverse impact on the Company's financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Benefits Management Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11, 2021, the State of Ohio filed a civil action against the Company and the Company's subsidiaries, Buckeye Health Plan Community Solutions, Inc. and Envolve, in Franklin County Court of Common Pleas, captioned as Ohio Department of Medicaid, et al. v. Centene Corporation, et al. The complaint alleged breaches of contract with the Ohio Department of Medicaid relating to the provision of PBM services and violations of Ohio law relating to such contracts, including among other things, by (i) seeking payment for services already reimbursed, (ii) not accurately disclosing to the Ohio Department of Medicaid the true cost of the PBM services and (iii) inflating dispensing fees for prescription drugs. The plaintiffs sought an undisclosed sum of money in damages, penalties, and possible termination of the contract with Buckeye Health Plan. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has reached no-fault agreements with the Attorneys General, including Ohio, to resolve claims and/or allegations made by the states related to services previously provided by Envolve. As a result of the settlement, the Ohio Attorney General's litigation against the Company was dismissed. Additionally, the Company is in discussions to bring final resolution to similar concerns in other affected states. Consistent with those discussions, the Company recorded a reserve estimate of $1,250 million in the second quarter of 2021 related to this issue, inclusive of the above settlements and rebates that the Company determined in the course of the matter are payable across products. Additional claims, reviews or investigations relating to the Company's historical PBM business across products may be brought by other states, the federal government, or shareholder litigants, and there is no guarantee the Company will have the ability to settle such claims with other states within the reserve estimate the Company has recorded and on other acceptable terms, or at all. This matter is subject to many uncertainties, and an adverse outcome in this matter could have an adverse impact on the Company's financial condition, results of operations and cash flows.</span></div> 3 1250000000 EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 302 262 1 false 59 0 false 6 false false R1.htm 0000001 - Document - Cover Sheet http://www.centene.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS) Statements 5 false false R6.htm 0000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Statements 6 false false R7.htm 0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 7 false false R8.htm 0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 8 false false R9.htm 0000009 - Disclosure - Organization and Operations Sheet http://www.centene.com/role/OrganizationandOperations Organization and Operations Notes 9 false false R10.htm 0000010 - Disclosure - Acquisitions and Divestitures Sheet http://www.centene.com/role/AcquisitionsandDivestitures Acquisitions and Divestitures Notes 10 false false R11.htm 0000011 - Disclosure - Short-term and Long-term Investments, Restricted Deposits Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits Short-term and Long-term Investments, Restricted Deposits Notes 11 false false R12.htm 0000012 - Disclosure - Fair Value Measurements Sheet http://www.centene.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 0000013 - Disclosure - Goodwill and Intangible Assets Sheet http://www.centene.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 13 false false R14.htm 0000014 - Disclosure - Medical Claims Liability Sheet http://www.centene.com/role/MedicalClaimsLiability Medical Claims Liability Notes 14 false false R15.htm 0000015 - Disclosure - Affordable Care Act Sheet http://www.centene.com/role/AffordableCareAct Affordable Care Act Notes 15 false false R16.htm 0000016 - Disclosure - Debt Sheet http://www.centene.com/role/Debt Debt Notes 16 false false R17.htm 0000017 - Disclosure - Leases Sheet http://www.centene.com/role/Leases Leases Notes 17 false false R18.htm 0000018 - Disclosure - Stockholders' Equity Sheet http://www.centene.com/role/StockholdersEquity Stockholders' Equity Notes 18 false false R19.htm 0000019 - Disclosure - Earnings Per Share Sheet http://www.centene.com/role/EarningsPerShare Earnings Per Share Notes 19 false false R20.htm 0000020 - Disclosure - Segment Information Sheet http://www.centene.com/role/SegmentInformation Segment Information Notes 20 false false R21.htm 0000021 - Disclosure - Contingencies Sheet http://www.centene.com/role/Contingencies Contingencies Notes 21 false false R22.htm 0000022 - Disclosure - Organization and Operations (Policies) Sheet http://www.centene.com/role/OrganizationandOperationsPolicies Organization and Operations (Policies) Policies 22 false false R23.htm 0000023 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables Short-term and Long-term Investments, Restricted Deposits (Tables) Tables http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits 23 false false R24.htm 0000024 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.centene.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.centene.com/role/FairValueMeasurements 24 false false R25.htm 0000025 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.centene.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.centene.com/role/GoodwillandIntangibleAssets 25 false false R26.htm 0000026 - Disclosure - Medical Claims Liability (Tables) Sheet http://www.centene.com/role/MedicalClaimsLiabilityTables Medical Claims Liability (Tables) Tables http://www.centene.com/role/MedicalClaimsLiability 26 false false R27.htm 0000027 - Disclosure - Affordable Care Act (Tables) Sheet http://www.centene.com/role/AffordableCareActTables Affordable Care Act (Tables) Tables http://www.centene.com/role/AffordableCareAct 27 false false R28.htm 0000028 - Disclosure - Debt (Tables) Sheet http://www.centene.com/role/DebtTables Debt (Tables) Tables http://www.centene.com/role/Debt 28 false false R29.htm 0000029 - Disclosure - Leases (Tables) Sheet http://www.centene.com/role/LeasesTables Leases (Tables) Tables http://www.centene.com/role/Leases 29 false false R30.htm 0000030 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.centene.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.centene.com/role/StockholdersEquity 30 false false R31.htm 0000031 - Disclosure - Earnings Per Share (Tables) Sheet http://www.centene.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.centene.com/role/EarningsPerShare 31 false false R32.htm 0000032 - Disclosure - Segment Information (Tables) Sheet http://www.centene.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.centene.com/role/SegmentInformation 32 false false R33.htm 0000033 - Disclosure - Acquisitions and Divestitures -Divestiture (Details) Sheet http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails Acquisitions and Divestitures -Divestiture (Details) Details 33 false false R34.htm 0000034 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details) Details 34 false false R35.htm 0000035 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails Short-term and Long-term Investments, Restricted Deposits - Narrative (Details) Details http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables 35 false false R36.htm 0000036 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details) Details 36 false false R37.htm 0000037 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Sheet http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details) Details 37 false false R38.htm 0000038 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 38 false false R39.htm 0000039 - Disclosure - Fair Value Measurements - Narrative (Details) Sheet http://www.centene.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements - Narrative (Details) Details 39 false false R40.htm 0000040 - Disclosure - Goodwill and Intangible Assets (Details) Sheet http://www.centene.com/role/GoodwillandIntangibleAssetsDetails Goodwill and Intangible Assets (Details) Details http://www.centene.com/role/GoodwillandIntangibleAssetsTables 40 false false R41.htm 0000041 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details) Details 41 false false R42.htm 0000042 - Disclosure - Medical Claims Liability - Narrative (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails Medical Claims Liability - Narrative (Details) Details 42 false false R43.htm 0000043 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Sheet http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details) Details 43 false false R44.htm 0000044 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.centene.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 44 false false R45.htm 0000045 - Disclosure - Debt - Narrative (Details) Sheet http://www.centene.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 45 false false R46.htm 0000046 - Disclosure - Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) Sheet http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details) Details 46 false false R47.htm 0000047 - Disclosure - Leases - Narrative (Details) Sheet http://www.centene.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 47 false false R48.htm 0000048 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.centene.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 48 false false R49.htm 0000049 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details) Sheet http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails Stockholders' Equity - Share Repurchase Activity (Details) Details 49 false false R50.htm 0000050 - Disclosure - Earnings Per Share (Details) Sheet http://www.centene.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.centene.com/role/EarningsPerShareTables 50 false false R51.htm 0000051 - Disclosure - Segment Information (Details) Sheet http://www.centene.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.centene.com/role/SegmentInformationTables 51 false false R52.htm 0000052 - Disclosure - Contingencies (Details) Sheet http://www.centene.com/role/ContingenciesDetails Contingencies (Details) Details http://www.centene.com/role/Contingencies 52 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 1 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. cnc-20230331.htm 4 cnc-20230331.htm a2023033110-qexhibit101.htm a2023033110-qexhibit102.htm a2023033110-qexhibit103.htm a2023033110-qexhibit311.htm a2023033110-qexhibit312.htm a2023033110-qexhibit321.htm a2023033110-qexhibit322.htm cnc-20230331.xsd cnc-20230331_cal.xml cnc-20230331_def.xml cnc-20230331_lab.xml cnc-20230331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cnc-20230331.htm": { "axisCustom": 0, "axisStandard": 21, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 1021, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 302, "dts": { "calculationLink": { "local": [ "cnc-20230331_cal.xml" ] }, "definitionLink": { "local": [ "cnc-20230331_def.xml" ] }, "inline": { "local": [ "cnc-20230331.htm" ] }, "labelLink": { "local": [ "cnc-20230331_lab.xml" ] }, "presentationLink": { "local": [ "cnc-20230331_pre.xml" ] }, "schema": { "local": [ "cnc-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 435, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 6, "http://xbrl.sec.gov/dei/2022": 5, "total": 11 }, "keyCustom": 25, "keyStandard": 237, "memberCustom": 24, "memberStandard": 34, "nsprefix": "cnc", "nsuri": "http://www.centene.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://www.centene.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Acquisitions and Divestitures", "menuCat": "Notes", "order": "10", "role": "http://www.centene.com/role/AcquisitionsandDivestitures", "shortName": "Acquisitions and Divestitures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Short-term and Long-term Investments, Restricted Deposits", "menuCat": "Notes", "order": "11", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits", "shortName": "Short-term and Long-term Investments, Restricted Deposits", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "12", "role": "http://www.centene.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Goodwill and Intangible Assets", "menuCat": "Notes", "order": "13", "role": "http://www.centene.com/role/GoodwillandIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InsuranceDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Medical Claims Liability", "menuCat": "Notes", "order": "14", "role": "http://www.centene.com/role/MedicalClaimsLiability", "shortName": "Medical Claims Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InsuranceDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:AffordableCareActDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Affordable Care Act", "menuCat": "Notes", "order": "15", "role": "http://www.centene.com/role/AffordableCareAct", "shortName": "Affordable Care Act", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:AffordableCareActDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Debt", "menuCat": "Notes", "order": "16", "role": "http://www.centene.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Leases", "menuCat": "Notes", "order": "17", "role": "http://www.centene.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Stockholders' Equity", "menuCat": "Notes", "order": "18", "role": "http://www.centene.com/role/StockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "19", "role": "http://www.centene.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "ia00f4c5ab95e424d930f6d590a1231a7_I20221231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Segment Information", "menuCat": "Notes", "order": "20", "role": "http://www.centene.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Contingencies", "menuCat": "Notes", "order": "21", "role": "http://www.centene.com/role/Contingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Organization and Operations (Policies)", "menuCat": "Policies", "order": "22", "role": "http://www.centene.com/role/OrganizationandOperationsPolicies", "shortName": "Organization and Operations (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Short-term and Long-term Investments, Restricted Deposits (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables", "shortName": "Short-term and Long-term Investments, Restricted Deposits (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.centene.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Goodwill and Intangible Assets (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Medical Claims Liability (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.centene.com/role/MedicalClaimsLiabilityTables", "shortName": "Medical Claims Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Affordable Care Act (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.centene.com/role/AffordableCareActTables", "shortName": "Affordable Care Act (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Debt (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.centene.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.centene.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Stockholders' Equity (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.centene.com/role/StockholdersEquityTables", "shortName": "Stockholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.centene.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Segment Information (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.centene.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnSaleOfBusiness", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Acquisitions and Divestitures -Divestiture (Details)", "menuCat": "Details", "order": "33", "role": "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "shortName": "Acquisitions and Divestitures -Divestiture (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "iea884e89e69e4e33a2dc0ddc6d9cbaf2_I20230110", "decimals": "-6", "lang": "en-US", "name": "cnc:DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "menuCat": "Details", "order": "34", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - By Investment Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "menuCat": "Details", "order": "35", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "menuCat": "Details", "order": "36", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Fair Value of Available-For-Sale Investments with Gross Unrealized Losses by Investment Type and Length of Time (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i6d0694e855a0422b9eefd42e709def5a_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "menuCat": "Details", "order": "37", "role": "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "shortName": "Short-term and Long-term Investments, Restricted Deposits - Contractual Maturities of Short-Term and Long-Term Investments and Restricted Deposits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i6d0694e855a0422b9eefd42e709def5a_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "menuCat": "Details", "order": "38", "role": "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "shortName": "Fair Value Measurements - Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Fair Value Measurements - Narrative (Details)", "menuCat": "Details", "order": "39", "role": "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:LifeInsuranceContractsAndEquityInvestmentsFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "ia00f4c5ab95e424d930f6d590a1231a7_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Goodwill and Intangible Assets (Details)", "menuCat": "Details", "order": "40", "role": "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i86f7dc22b96843ceaeab95328bfe6298_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "ia00f4c5ab95e424d930f6d590a1231a7_I20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "menuCat": "Details", "order": "41", "role": "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "shortName": "Medical Claims Liability - Schedule of Change in Medical Claims Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i86f7dc22b96843ceaeab95328bfe6298_I20211231", "decimals": "-6", "lang": "en-US", "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Medical Claims Liability - Narrative (Details)", "menuCat": "Details", "order": "42", "role": "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails", "shortName": "Medical Claims Liability - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "menuCat": "Details", "order": "43", "role": "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails", "shortName": "Affordable Care Act - Net Receivables (Payables) for Each of the Ongoing Programs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "cnc:ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:AffordableCareActRiskAdjustmentReceivable", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:SeniorNotesTotal", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Debt - Schedule of Debt (Details)", "menuCat": "Details", "order": "44", "role": "http://www.centene.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:SeniorNotesTotal", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i567ff38dc0b740aeb9b424778d843491_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Debt - Narrative (Details)", "menuCat": "Details", "order": "45", "role": "http://www.centene.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i567ff38dc0b740aeb9b424778d843491_D20230101-20230331", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details)", "menuCat": "Details", "order": "46", "role": "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails", "shortName": "Leases - Right-of-use (ROU) Assets and Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Leases - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://www.centene.com/role/LeasesNarrativeDetails", "shortName": "Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i904f8dd28f68428490281259237ece51_I20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "iac71913a457743e68ab097023ef5be63_D20221201-20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Stockholders' Equity - Narrative (Details)", "menuCat": "Details", "order": "48", "role": "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "shortName": "Stockholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "iac71913a457743e68ab097023ef5be63_D20221201-20221231", "decimals": "-6", "first": true, "lang": "en-US", "name": "cnc:StockRepurchaseProgramIncreaseAuthorizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockValueAcquiredCostMethod", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Stockholders' Equity - Share Repurchase Activity (Details)", "menuCat": "Details", "order": "49", "role": "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails", "shortName": "Stockholders' Equity - Share Repurchase Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i689158c3fd0c458cb8ebf8d114be1a16_D20230101-20230331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "menuCat": "Statements", "order": "5", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Earnings Per Share (Details)", "menuCat": "Details", "order": "50", "role": "http://www.centene.com/role/EarningsPerShareDetails", "shortName": "Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Segment Information (Details)", "menuCat": "Details", "order": "51", "role": "http://www.centene.com/role/SegmentInformationDetails", "shortName": "Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "ia818bd08e6814abb8cb84dece723de6c_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Contingencies (Details)", "menuCat": "Details", "order": "52", "role": "http://www.centene.com/role/ContingenciesDetails", "shortName": "Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "ia818bd08e6814abb8cb84dece723de6c_I20210930", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:LossContingencyPendingClaimsNumber", "reportCount": 1, "unique": true, "unitRef": "claim", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "if5ac48f357b2441aaafb35646db3e51c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "menuCat": "Statements", "order": "6", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "if5ac48f357b2441aaafb35646db3e51c_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "ia00f4c5ab95e424d930f6d590a1231a7_I20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i97d1469e82014457b515740ed2cb02e9_I20221231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "8", "role": "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": "-6", "lang": "en-US", "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Organization and Operations", "menuCat": "Notes", "order": "9", "role": "http://www.centene.com/role/OrganizationandOperations", "shortName": "Organization and Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "cnc-20230331.htm", "contextRef": "i01faef958e3a4797bc5277f911a882d1_D20230101-20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 59, "tag": { "cnc_A1300Million2625SeniorNotesDueAugust2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$1,300 Million 2.625% Senior Notes due August 2031", "label": "$1,300 Million 2.625% Senior Notes due August 2031 [Member]", "terseLabel": "$1,300 million 2.625% Senior Notes due August 1, 2031" } } }, "localname": "A1300Million2625SeniorNotesDueAugust2031Member", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2200Million250SeniorNotesDueMarch2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,200 Million 2.50% Senior Notes due March 2031", "label": "$2,200 Million 2.50% Senior Notes due March 2031 [Member]", "terseLabel": "$2,200 million 2.50% Senior Notes due March 1, 2031" } } }, "localname": "A2200Million250SeniorNotesDueMarch2031Member", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2200Million300SeniorNotesDueOctober2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,200 Million 3.00% Senior Notes Due October 2030", "label": "$2,200 Million 3.00% Senior Notes Due October 2030 [Member]", "terseLabel": "$2,200 million 3.00% Senior Notes due October 15, 2030" } } }, "localname": "A2200Million300SeniorNotesDueOctober2030Member", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2200Million375SeniorNotesDueFebruary2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,200 Million 3.75% Senior Notes Due February 2030", "label": "$2,200 Million 3.75% Senior Notes Due February 2030 [Member]", "terseLabel": "$2,000 million 3.375% Senior Notes due February 15, 2030" } } }, "localname": "A2200Million375SeniorNotesDueFebruary2030Member", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A2300Million245SeniorNotsDueJuly2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$2,300 Million 2.45% Senior Nots due July 2028", "label": "$2,300 Million 2.45% Senior Nots due July 2028 [Member]", "terseLabel": "$2,300 million 2.45% Senior Notes due July 15, 2028" } } }, "localname": "A2300Million245SeniorNotsDueJuly2028Member", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_A3500Million4625SeniorNotesDueDecember2029Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "$3,500 Million 4.625% Senior Notes due December 2029", "label": "$3,500 Million 4.625% Senior Notes due December 2029 [Member]", "terseLabel": "$3,500 million 4.625% Senior Notes due December 15, 2029" } } }, "localname": "A3500Million4625SeniorNotesDueDecember2029Member", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_AffordableCareActAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affordable Care Act [Abstract]", "label": "Affordable Care Act [Abstract]", "terseLabel": "Affordable Care Act [Abstract]" } } }, "localname": "AffordableCareActAbstract", "nsuri": "http://www.centene.com/20230331", "xbrltype": "stringItemType" }, "cnc_AffordableCareActCostSharingReductionsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act Cost Sharing Reductions, Payable", "label": "Affordable Care Act Cost Sharing Reductions, Payable", "negatedLabel": "Cost sharing reduction payable" } } }, "localname": "AffordableCareActCostSharingReductionsPayable", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affordable Care Act Disclosure [Text Block]", "label": "Affordable Care Act Disclosure [Text Block]", "terseLabel": "Affordable Care Act" } } }, "localname": "AffordableCareActDisclosureTextBlock", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AffordableCareAct" ], "xbrltype": "textBlockItemType" }, "cnc_AffordableCareActMinimumMedicalLossRatio": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Minimum Medical Loss Ratio", "label": "Affordable Care Act Minimum Medical Loss Ratio", "negatedTerseLabel": "Minimum medical loss ratio" } } }, "localname": "AffordableCareActMinimumMedicalLossRatio", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActReinsurancePayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act Reinsurance, Payable", "label": "Affordable Care Act Reinsurance Payable", "negatedLabel": "Risk adjustment payable" } } }, "localname": "AffordableCareActReinsurancePayable", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AffordableCareActRiskAdjustmentReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Affordable Care Act, Risk Adjustment Receivable", "label": "Affordable Care Act, Risk Adjustment Receivable", "terseLabel": "Risk adjustment receivable" } } }, "localname": "AffordableCareActRiskAdjustmentReceivable", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AffordableCareActNetReceivablesPayablesforEachoftheOngoingProgramsDetails" ], "xbrltype": "monetaryItemType" }, "cnc_AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts Recorded As An Adjustment To Premium Revenues Related To Minimum HBR and Return Of Premium Programs", "label": "Amounts Recorded As An Adjustment to Premium Revenues Related to Minimum HBR and Return of Premium Programs", "negatedTerseLabel": "Amounts recorded as an adjustment to premium revenues related to minimum HBR and return of premium programs" } } }, "localname": "AmountsRecordedAsAnAdjustmentToPremiumRevenuesRelatedToMinimumHBRAndReturnOfPremiumPrograms", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_CenturionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centurion", "label": "Centurion [Member]", "terseLabel": "Centurion" } } }, "localname": "CenturionMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "domainItemType" }, "cnc_CircleHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Circle Health", "label": "Circle Health [Member]", "terseLabel": "Circle Health" } } }, "localname": "CircleHealthMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_CommercialSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial Segment", "label": "Commercial Segment [Member]", "terseLabel": "Commercial" } } }, "localname": "CommercialSegmentMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cnc_DebtSecuritiesAvailableForSaleNumberOfPositions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Securities, Available -for-Sale, Number of Positions", "label": "Debt Securities, Available -for-Sale, Number of Positions", "terseLabel": "Total investment positions" } } }, "localname": "DebtSecuritiesAvailableForSaleNumberOfPositions", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "integerItemType" }, "cnc_DebtTotalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Total", "label": "Debt Total [Member]", "terseLabel": "Debt Total" } } }, "localname": "DebtTotalMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High", "label": "Disposal Group, Including Discontinued Operations, Consideration, Contingent Consideration, Range of Outcomes, Value High", "terseLabel": "Contingent consideration on disposal (up to)" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationsConsiderationContingentConsiderationRangeOfOutcomesValueHigh", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "cnc_EmployeeStockCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Stock Compensation Plan", "label": "Employee Stock Compensation Plan [Member]", "terseLabel": "Employee Stock Compensation Plan" } } }, "localname": "EmployeeStockCompensationPlanMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "domainItemType" }, "cnc_ExcludingCircleHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Excluding Circle Health", "label": "Excluding Circle Health [Member]", "terseLabel": "Excluding Circle Health" } } }, "localname": "ExcludingCircleHealthMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions", "label": "Fair Value, Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Input Definitions [Table Text Block]", "terseLabel": "Assets and Liabilities, Based Upon Observable or Unobservable Inputs, Level Input Definitions" } } }, "localname": "FairValueAssetsAndLiabilitiesBasedUponObservableOrUnobservableInputsInputDefinitionsTableTextBlock", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "cnc_FinanceLeaseLiabilityAndOther": { "auth_ref": [], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": 2.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease Liability And Other", "label": "Finance Lease Liability And Other", "terseLabel": "Finance leases and other" } } }, "localname": "FinanceLeaseLiabilityAndOther", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "cnc_FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]", "label": "Four Point Two Five Percent Senior Notes, Due In Twenty Twenty Seven [Member]", "terseLabel": "$2,500 million 4.25% Senior Notes due December 15, 2027" } } }, "localname": "FourPointTwoFivePercentSeniorNotesDueInTwentyTwentySevenMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_GainLossOnExtinguishmentOfDebtIncludingCashPortion": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion", "label": "Gain (Loss) on Extinguishment of Debt , Including Cash Portion", "terseLabel": "Debt extinguishment" } } }, "localname": "GainLossOnExtinguishmentOfDebtIncludingCashPortion", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "cnc_InvestmentSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Securities", "label": "Investment Securities [Member]", "terseLabel": "Investment Securities" } } }, "localname": "InvestmentSecuritiesMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost": { "auth_ref": [], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost", "label": "Investments, Debt Securities, Equity Method Investments And Other, Amortized Cost", "totalLabel": "Total, Amortized Cost" } } }, "localname": "InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue": { "auth_ref": [], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 3.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investments, Debt Securities, Equity Securities And Other, Fair Value", "label": "Investments, Debt Securities, Equity Securities And Other, Fair Value", "totalLabel": "Total, Fair Value" } } }, "localname": "InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration", "label": "Investments Recorded At Fair Value That Carry Rating Of A AA Plus, Weighted Average, Duration", "terseLabel": "Investments recorded at fair value that carry rating of AAA Plus, weighted average (in years)" } } }, "localname": "InvestmentsRecordedAtFairValueThatCarryRatingOfAAAPlusWeightedAverageDuration", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "durationItemType" }, "cnc_LifeInsuranceContractsAndEquityInvestmentsFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Life Insurance Contracts And Equity Investments, Fair Value", "label": "Life Insurance Contracts And Equity Investments, Fair Value", "terseLabel": "Aggregate carrying amount of life insurance contracts and equity investments, fair value" } } }, "localname": "LifeInsuranceContractsAndEquityInvestmentsFairValue", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)", "label": "London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR) And Sterling Overnight Index Average (SONIA)" } } }, "localname": "LondonInterbankOfferedRateLIBORAndSterlingOvernightIndexAverageSONIAMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_MagellanSpecialtyHealthMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Magellan Specialty Health", "label": "Magellan Specialty Health [Member]", "terseLabel": "Magellan Specialty Health" } } }, "localname": "MagellanSpecialtyHealthMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "domainItemType" }, "cnc_MedicaidSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medicaid Segment", "label": "Medicaid Segment [Member]", "terseLabel": "Medicaid" } } }, "localname": "MedicaidSegmentMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cnc_MedicareSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medicare Segment", "label": "Medicare Segment [Member]", "terseLabel": "Medicare" } } }, "localname": "MedicareSegmentMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cnc_PremiumTaxExpense": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Premium tax expense, similar assessments and provider pass through payments.", "label": "Premium Tax Expense", "terseLabel": "Premium tax expense" } } }, "localname": "PremiumTaxExpense", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "cnc_PremiumTaxRevenue": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 }, "http://www.centene.com/role/SegmentInformationDetails": { "order": 1.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Premium tax revenue, similar assessments and provider pass through payments.", "label": "Premium Tax Revenue", "terseLabel": "Premium tax" } } }, "localname": "PremiumTaxRevenue", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "cnc_RatedSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rated Securities [Member]", "label": "Rated Securities [Member]", "terseLabel": "Rated Securities" } } }, "localname": "RatedSecuritiesMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_RestrictedCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Cash Equivalents [Member]", "label": "Restricted Cash Equivalents [Member]", "terseLabel": "Restricted cash equivalents" } } }, "localname": "RestrictedCashEquivalentsMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "domainItemType" }, "cnc_RestrictedCertificatesOfDepositMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted certificates of deposit [member]", "label": "Restricted Certificates Of Deposit [Member]", "terseLabel": "Restricted certificates of deposit" } } }, "localname": "RestrictedCertificatesOfDepositMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "domainItemType" }, "cnc_ReturnofPremiumPayable": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Return of Premium Payable", "label": "Return of Premium Payable", "terseLabel": "Return of premium payable" } } }, "localname": "ReturnofPremiumPayable", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "cnc_ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Receivables (Payables) Related to the Affordable Care Act Programs", "label": "Schedule Of Receivables (Payables) Related To The Affordable Care Act Programs [Table Text Block]", "terseLabel": "Schedule of net receivables (payables) related to the Affordable Care Act Programs" } } }, "localname": "ScheduleOfReceivablesPayablesRelatedToTheAffordableCareActProgramsTableTextBlock", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/AffordableCareActTables" ], "xbrltype": "textBlockItemType" }, "cnc_SeniorNotesTotal": { "auth_ref": [], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": 3.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Senior Notes, Total", "label": "Senior Notes, Total", "totalLabel": "Total senior notes" } } }, "localname": "SeniorNotesTotal", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "cnc_SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture", "label": "Shares Issued, Value, Acquisitions, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Fair value of unvested equity awards in connection with acquisition" } } }, "localname": "SharesIssuedValueAcquisitionsShareBasedPaymentArrangementAfterForfeiture", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short-term and long-term investments and restricted deposits by investment type", "label": "Short Term And Long Term Investments And Restricted Deposits By Investment Type [Table Text Block]", "terseLabel": "Short-term and long-term investments and restricted deposits by investment type" } } }, "localname": "ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlock", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "xbrltype": "textBlockItemType" }, "cnc_SterlingOvernightIndexAverageSONIAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sterling Overnight Index Average (SONIA)", "label": "Sterling Overnight Index Average (SONIA) [Member]", "terseLabel": "Sterling Overnight Index Average (SONIA)" } } }, "localname": "SterlingOvernightIndexAverageSONIAMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "cnc_StockRepurchaseProgramIncreaseAuthorizedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Repurchase Program, Increase, Authorized Amount", "label": "Stock Repurchase Program, Increase, Authorized Amount", "terseLabel": "Stock repurchase program, increase to authorized amount" } } }, "localname": "StockRepurchaseProgramIncreaseAuthorizedAmount", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "cnc_TermLoanCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Credit Agreement [Member]", "label": "Term Loan Credit Agreement [Member]", "terseLabel": "Term loan facility" } } }, "localname": "TermLoanCreditAgreementMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "cnc_TotalPremiumAndServiceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total Premium and Service", "label": "Total Premium and Service [Member]", "terseLabel": "Premium and service revenues" } } }, "localname": "TotalPremiumAndServiceMember", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "cnc_TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation": { "auth_ref": [], "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "order": 2.0, "parentTag": "us-gaap_TreasuryStockSharesAcquired", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation", "label": "Treasury Stock, Shares, Acquired, Excluding Shares Withheld For Tax Withholding Obligation", "terseLabel": "Share buybacks (in shares)" } } }, "localname": "TreasuryStockSharesAcquiredExcludingSharesWithheldForTaxWithholdingObligation", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "sharesItemType" }, "cnc_TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes": { "auth_ref": [], "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "order": 2.0, "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes", "label": "Treasury Stock, Value, Acquired, Cost Method, Excluding Shares Withheld For Tax Purposes", "terseLabel": "Share buybacks" } } }, "localname": "TreasuryStockValueAcquiredCostMethodExcludingSharesWithheldForTaxPurposes", "nsuri": "http://www.centene.com/20230331", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r598" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r599" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r600" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r596" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r595" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r597" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.centene.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r258", "r295", "r313", "r314", "r315", "r316", "r317", "r319", "r323", "r379", "r380", "r381", "r382", "r384", "r385", "r387", "r389", "r390", "r649", "r650" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r258", "r295", "r313", "r314", "r315", "r316", "r317", "r319", "r323", "r379", "r380", "r381", "r382", "r384", "r385", "r387", "r389", "r390", "r649", "r650" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r325", "r532", "r581", "r591", "r646", "r647", "r651", "r688" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r325", "r532", "r581", "r591", "r646", "r647", "r651", "r688" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r34", "r36", "r37", "r227", "r547", "r559", "r560" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive earnings (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r33", "r37", "r146", "r499", "r555", "r556", "r605", "r606", "r607", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Earnings (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r17" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r448", "r449", "r450", "r618", "r619", "r620", "r680" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "order": 1.0, "parentTag": "us-gaap_TreasuryStockValueAcquiredCostMethod", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "terseLabel": "Income tax withholding" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r132", "r133", "r446" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "verboseLabel": "Stock compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllOtherSegmentsMember": { "auth_ref": [ "r291", "r313", "r314", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.", "label": "Other Segments [Member]", "terseLabel": "Other", "verboseLabel": "Other/Eliminations" } } }, "localname": "AllOtherSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r64", "r97", "r99" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of acquired intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "verboseLabel": "Anti-dilutive restricted stock and restricted stock units excluded from the calculation of diluted earnings (loss) per common share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r582", "r624" ], "lang": { "en-us": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset-backed securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r64", "r101" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r164", "r188", "r221", "r256", "r303", "r315", "r321", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r462", "r467", "r480", "r590", "r649", "r650", "r684" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r215", "r229", "r256", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r462", "r467", "r480", "r590", "r649", "r650", "r684" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r151" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r78" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r79" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale [Abstract]", "terseLabel": "Investments:" } } }, "localname": "AvailableForSaleSecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]", "terseLabel": "Unrealized Losses" } } }, "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": { "auth_ref": [ "r84" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "terseLabel": "Five years through ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": { "auth_ref": [ "r80", "r333", "r543" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10", "terseLabel": "Five years through ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "auth_ref": [ "r83" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "One year through five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r80", "r332", "r542" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five", "terseLabel": "One year through five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": { "auth_ref": [ "r85" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 4.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10", "terseLabel": "Greater than ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": { "auth_ref": [ "r80", "r334", "r544" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 4.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10", "terseLabel": "Greater than ten years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]", "terseLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r82" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One", "terseLabel": "One year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r80", "r331", "r541" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One", "terseLabel": "One year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": { "auth_ref": [ "r335" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 5.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost", "terseLabel": "Asset-backed securities" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": { "auth_ref": [ "r86", "r545" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": 5.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.", "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value", "terseLabel": "Asset-backed securities" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BankTimeDepositsMember": { "auth_ref": [ "r177" ], "lang": { "en-us": { "role": { "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.", "label": "Bank Time Deposits [Member]", "terseLabel": "Short-term time deposits", "verboseLabel": "Short-term time deposits" } } }, "localname": "BankTimeDepositsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "verboseLabel": "Organization and Operations" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r66", "r217", "r568" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Member]", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r60", "r66", "r68" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "terseLabel": "The following table provides a reconciliation of cash, cash equivalents, and restricted cash and cash equivalents reported within the Consolidated Balance Sheets to the totals above:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r60", "r156" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r182" ], "lang": { "en-us": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates of Deposit [Member]", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r224", "r225", "r226", "r256", "r274", "r278", "r280", "r282", "r289", "r290", "r343", "r379", "r382", "r383", "r384", "r390", "r391", "r419", "r420", "r422", "r426", "r433", "r480", "r566", "r601", "r614", "r621" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r126", "r127", "r128", "r129" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommercialMortgageBackedSecuritiesMember": { "auth_ref": [ "r86", "r653" ], "lang": { "en-us": { "role": { "documentation": "Securities collateralized by commercial real estate mortgage loans.", "label": "Commercial Mortgage-Backed Securities [Member]", "terseLabel": "Commercial mortgage-backed securities", "verboseLabel": "Commercial mortgage-backed securities" } } }, "localname": "CommercialMortgageBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r28", "r173", "r194" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r107", "r374", "r375", "r565", "r648" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/Contingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r618", "r619", "r680" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)", "verboseLabel": "Par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r120" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16", "r590" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value; authorized 800,000 shares; 614,355 issued and 551,714 outstanding at March\u00a031, 2023, and 607,847 issued and 550,754 outstanding at December\u00a031, 2022" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r39", "r236", "r238", "r247", "r537", "r551" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive earnings attributable to Centene Corporation" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r140", "r141", "r149", "r236", "r238", "r246", "r536", "r550" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedTerseLabel": "Comprehensive (earnings) loss attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r139", "r149", "r236", "r238", "r245", "r535", "r549" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive earnings" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r71", "r72", "r154", "r155", "r328", "r564" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r71", "r72", "r154", "r155", "r328", "r561", "r564" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r71", "r72", "r154", "r155", "r328", "r564", "r690" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r71", "r72", "r154", "r155", "r328" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Percentage of investments in rated securities carry an investment grade rating by nationally recognized statistical rating organizations" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r71", "r72", "r154", "r155", "r328", "r564" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r435", "r436", "r439" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Unearned revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateDebtSecuritiesMember": { "auth_ref": [ "r582", "r584", "r689" ], "lang": { "en-us": { "role": { "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.", "label": "Corporate Debt Securities [Member]", "terseLabel": "Corporate securities" } } }, "localname": "CorporateDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r46", "r532" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of services" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r43" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditAvailabilityConcentrationRiskMember": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that borrowing or credit line availability under commitments from one or more lenders is to a selected benchmark, such as total debt, segment debt. Risk is the materially adverse effects that funds which may be needed for operations or for a specific purpose will not be available on terms that are acceptable to an entity, if at all.", "label": "Credit Availability Concentration Risk [Member]", "terseLabel": "Credit Availability Concentration Risk" } } }, "localname": "CreditAvailabilityConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r171", "r196" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt and Lease Obligation", "totalLabel": "Total debt" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r114", "r254", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r408", "r415", "r416", "r418" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r12", "r13", "r14", "r165", "r166", "r185", "r258", "r392", "r393", "r394", "r395", "r396", "r398", "r404", "r405", "r406", "r407", "r409", "r410", "r411", "r412", "r413", "r414", "r491", "r576", "r577", "r578", "r579", "r580", "r615" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r158", "r160", "r392", "r491", "r577", "r578" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r25", "r393" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r26", "r258", "r392", "r393", "r394", "r395", "r396", "r398", "r404", "r405", "r406", "r407", "r409", "r410", "r411", "r412", "r413", "r414", "r491", "r576", "r577", "r578", "r579", "r580", "r615" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r26", "r121", "r122", "r123", "r124", "r157", "r158", "r160", "r183", "r258", "r392", "r393", "r394", "r395", "r396", "r398", "r404", "r405", "r406", "r407", "r409", "r410", "r411", "r412", "r413", "r414", "r417", "r491", "r576", "r577", "r578", "r579", "r580", "r615" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": { "auth_ref": [ "r330", "r350", "r351", "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss", "terseLabel": "Accrued interest income" } } }, "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": { "auth_ref": [ "r630" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 4.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquityMethodInvestmentsAndOtherAmortizedCost", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss", "totalLabel": "Amortized Cost" } } }, "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": { "auth_ref": [ "r340", "r355", "r573" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer", "terseLabel": "Fair Value, 12 Months or More" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": { "auth_ref": [ "r340", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss", "negatedLabel": "12 Months or More" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": { "auth_ref": [ "r340", "r355", "r573" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months", "terseLabel": "Fair Value, Less Than 12 Months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": { "auth_ref": [ "r340", "r355" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss", "negatedLabel": "Less Than 12 Months" } } }, "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": { "auth_ref": [ "r630" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 3.0, "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest", "terseLabel": "Fair Value", "totalLabel": "Fair Value" } } }, "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities, Available-for-Sale [Table]", "terseLabel": "Debt Securities, Available-for-sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": { "auth_ref": [ "r338", "r573", "r631" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]", "terseLabel": "Fair value of available-for-sale investments with gross unrealized losses by investment type and length of time" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": { "auth_ref": [ "r339", "r353" ], "lang": { "en-us": { "role": { "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.", "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions", "terseLabel": "Positions from which gross unrealized losses were generated" } } }, "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Available-for-Sale, Amortized Cost [Abstract]", "terseLabel": "Debt Securities" } } }, "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r64", "r134", "r454", "r458", "r459", "r617" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r451", "r452" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepositsMember": { "auth_ref": [ "r178" ], "lang": { "en-us": { "role": { "documentation": "Amounts held on account by the entity representing a liability to the depositor. Deposits may take various forms (for example, demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits) and may be categorized in multiple ways (such as, foreign and domestic, interest and noninterest bearing).", "label": "Deposits [Member]", "terseLabel": "Restricted Deposits", "verboseLabel": "Restricted deposits" } } }, "localname": "DepositsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r64", "r103" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r64", "r103" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r102", "r105" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Consideration", "terseLabel": "Consideration received on divestiture" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r585", "r586" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r248", "r264", "r265", "r266", "r267", "r268", "r272", "r274", "r280", "r281", "r282", "r286", "r473", "r474", "r538", "r552", "r570" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic earnings per common share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "verboseLabel": "Net earnings per common share attributable to Centene Corporation:" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]", "terseLabel": "Shares used in computing per share amounts:", "verboseLabel": "Weighted average number of common shares outstanding:" } } }, "localname": "EarningsPerShareBasicOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r248", "r264", "r265", "r266", "r267", "r268", "r274", "r280", "r281", "r282", "r286", "r473", "r474", "r538", "r552", "r570" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted earnings per common share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r283", "r284", "r285", "r287" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r481" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r120", "r210", "r239", "r240", "r241", "r259", "r260", "r261", "r263", "r269", "r271", "r288", "r344", "r434", "r448", "r449", "r450", "r455", "r456", "r472", "r482", "r483", "r484", "r485", "r486", "r488", "r499", "r555", "r556", "r557" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r93", "r304", "r602" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 3.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Private equity investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNi": { "auth_ref": [ "r222", "r479", "r569" ], "calculation": { "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 }, "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 2.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.", "label": "Equity Securities, FV-NI, Current", "terseLabel": "Equity securities" } } }, "localname": "EquitySecuritiesFvNi", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r92", "r186", "r592", "r593", "r594" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Equity Securities" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExternalCreditRatingByGroupingAxis": { "auth_ref": [ "r76", "r469", "r575", "r629" ], "lang": { "en-us": { "role": { "documentation": "Information by external rating classified as investment grade or non investment grade.", "label": "External Credit Rating by Grouping [Axis]", "terseLabel": "External Credit Rating by Grouping [Axis]" } } }, "localname": "ExternalCreditRatingByGroupingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ExternalCreditRatingByGroupingDomain": { "auth_ref": [ "r110", "r150" ], "lang": { "en-us": { "role": { "documentation": "External credit rating classified as investment grade or non-investment grade.", "label": "External Credit Rating by Grouping [Domain]", "terseLabel": "External Credit Rating by Grouping [Domain]" } } }, "localname": "ExternalCreditRatingByGroupingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ExternalCreditRatingInvestmentGradeMember": { "auth_ref": [ "r110", "r150" ], "lang": { "en-us": { "role": { "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote investment grade.", "label": "External Credit Rating, Investment Grade [Member]", "terseLabel": "External Credit Rating, Investment Grade" } } }, "localname": "ExternalCreditRatingInvestmentGradeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r475", "r476", "r478" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]", "terseLabel": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r151", "r153" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]", "terseLabel": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r406", "r440", "r441", "r442", "r443", "r444", "r445", "r476", "r504", "r505", "r506", "r577", "r578", "r582", "r583", "r584" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r406", "r440", "r445", "r476", "r504", "r582", "r583", "r584" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level I" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r406", "r440", "r445", "r476", "r505", "r577", "r578", "r582", "r583", "r584" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level II" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r406", "r440", "r441", "r442", "r443", "r444", "r445", "r476", "r506", "r577", "r578", "r582", "r583", "r584" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level III" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r406", "r440", "r441", "r442", "r443", "r444", "r445", "r504", "r505", "r506", "r577", "r578", "r582", "r583", "r584" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r336", "r337", "r345", "r346", "r347", "r348", "r349", "r354", "r356", "r357", "r417", "r431", "r470", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r573", "r625", "r626", "r627", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Schedule Of Investments And Restricted Deposits By Type [Axis]", "verboseLabel": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossOnSaleOfBusiness": { "auth_ref": [ "r466", "r613" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.", "label": "Gain (Loss) on Disposition of Business", "negatedLabel": "(Gain) on divestiture", "negatedTerseLabel": "Gain on disposition of business" } } }, "localname": "GainLossOnSaleOfBusiness", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r64", "r112", "r113" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "(Gain) loss on debt extinguishment" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r219", "r358", "r533", "r574", "r590", "r632", "r639" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "netLabel": "Goodwill", "periodEndLabel": "Goodwill, Balance ending", "periodStartLabel": "Goodwill, Balance beginning" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r361", "r574" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Acquisition and purchase accounting adjustments" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r365" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Translation impact" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r64", "r359", "r364", "r370", "r574" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "negatedLabel": "Impairments" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillTransfers": { "auth_ref": [ "r638" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Transfers", "terseLabel": "Reallocation" } } }, "localname": "GoodwillTransfers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": { "auth_ref": [ "r363", "r574" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Written off Related to Sale of Business Unit", "negatedTerseLabel": "Divestitures" } } }, "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r44", "r256", "r303", "r314", "r320", "r323", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r480", "r572", "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthCarePremiumMember": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Money received from insurance for service provided for maintenance, diagnosis and treatment of physical and mental health.", "label": "Health Care, Premium [Member]", "terseLabel": "Premium" } } }, "localname": "HealthCarePremiumMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Securities, Held-to-Maturity, Unrealized Loss Position, Fair Value [Abstract]", "terseLabel": "Fair Value" } } }, "localname": "HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r45", "r65", "r138", "r264", "r265", "r266", "r267", "r279", "r282" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "verboseLabel": "Earnings attributable to Centene Corporation" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r41", "r161", "r174", "r199", "r303", "r314", "r320", "r323", "r539", "r572" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before income tax" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r585", "r586" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "verboseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r0", "r1", "r2", "r3", "r4", "r5", "r6", "r7", "r8", "r9", "r10", "r105", "r106" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "verboseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r257", "r270", "r271", "r301", "r453", "r457", "r460", "r553" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r67" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r63" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r531", "r612" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Unearned revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": { "auth_ref": [ "r63" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in health care insurance liability balances during the period.", "label": "Increase (Decrease) in Health Care Insurance Liabilities", "terseLabel": "Medical claims liabilities" } } }, "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r63" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]", "terseLabel": "Changes in assets and liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPremiumsReceivable": { "auth_ref": [ "r63" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The change in the premium receivable balance on the balance sheet.", "label": "Increase (Decrease) in Premiums Receivable", "negatedLabel": "Premium and trade receivables" } } }, "localname": "IncreaseDecreaseInPremiumsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r275", "r276", "r277", "r282", "r447" ], "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "verboseLabel": "Common stock equivalents (as determined by applying the treasury stock method) (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InsuranceAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Insurance [Abstract]", "terseLabel": "Insurance [Abstract]" } } }, "localname": "InsuranceAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InsuranceDisclosureTextBlock": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.", "label": "Insurance Disclosure [Text Block]", "terseLabel": "Medical Claims Liability" } } }, "localname": "InsuranceDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiability" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r96", "r98" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r159", "r176", "r242", "r297", "r490" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r249", "r252", "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r295", "r313", "r314", "r315", "r316", "r317", "r319", "r323" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Eliminations" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentIncomeNonoperating": { "auth_ref": [ "r48" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.", "label": "Investment Income, Nonoperating", "terseLabel": "Investment and other income" } } }, "localname": "InvestmentIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Contractual maturities of short-term and long-term investments and restricted deposits" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Debt and Equity Securities [Abstract]", "terseLabel": "Investments, Debt and Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r475" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Total investments" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r92", "r162", "r181", "r209", "r567" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]", "verboseLabel": "Short-term and Long-term Investments, Restricted Deposits" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDeposits" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets held for their financial return, rather than for the entity's operations.", "label": "Investments [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseContractualTermAxis": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Information by contractual term of lease arrangement.", "label": "Lease Contractual Term [Axis]", "terseLabel": "Lease Contractual Term [Axis]" } } }, "localname": "LeaseContractualTermAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseContractualTermDomain": { "auth_ref": [ "r682" ], "lang": { "en-us": { "role": { "documentation": "Contractual term of lease arrangement.", "label": "Lease Contractual Term [Domain]", "terseLabel": "Lease Contractual Term [Domain]" } } }, "localname": "LeaseContractualTermDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r683" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "ROU Assets and Liabilities" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r256", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r463", "r467", "r468", "r480", "r571", "r649", "r684", "r685" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r168", "r192", "r590", "r616", "r628", "r681" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, redeemable noncontrolling interests and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r24", "r216", "r256", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r463", "r467", "r468", "r480", "r590", "r649", "r684", "r685" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r201", "r204" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.", "label": "Liability for Claims and Claims Adjustment Expense", "periodEndLabel": "Balance, March 31, 2023", "periodStartLabel": "Balance, January 1, 2023", "terseLabel": "Medical claims liability" } } }, "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions", "terseLabel": "Acquisitions" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]", "terseLabel": "Paid related to:" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": { "auth_ref": [ "r203" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year", "terseLabel": "Current year" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": { "auth_ref": [ "r203" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years", "terseLabel": "Prior years" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": { "auth_ref": [ "r202" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims", "totalLabel": "Total incurred" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]", "terseLabel": "Incurred related to:" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": { "auth_ref": [ "r184", "r201", "r204" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net", "periodEndLabel": "Balance, March 31, 2023, net", "periodStartLabel": "Balance, January 1, 2023, net" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]", "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]" } } }, "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LifeInsuranceCorporateOrBankOwnedAmount": { "auth_ref": [ "r94", "r603" ], "calculation": { "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails": { "order": 4.0, "parentTag": "cnc_InvestmentsDebtSecuritiesEquitySecuritiesAndOtherFairValue", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the amount that could be realized under a life insurance contract or contracts owned by the Entity as of the date of the statement of financial position. Such Entity-owned life insurance policies are commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).", "label": "Life Insurance, Corporate or Bank Owned, Amount", "terseLabel": "Life insurance contracts" } } }, "localname": "LifeInsuranceCorporateOrBankOwnedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r14", "r166", "r185" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": 1.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Credit facility" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationReserve": { "auth_ref": [ "r28", "r643" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.", "label": "Estimated Litigation Liability", "terseLabel": "Reserve estimate" } } }, "localname": "LitigationReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]", "terseLabel": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]", "terseLabel": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "negatedLabel": "Less: current portion", "terseLabel": "Current portion of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r223" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r218" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Long-Term Investments", "verboseLabel": "Long-term investments" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r26", "r111" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r108", "r109", "r376", "r377", "r378", "r644", "r645" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyPendingClaimsNumber": { "auth_ref": [ "r644", "r645" ], "lang": { "en-us": { "role": { "documentation": "Number of pending claims pertaining to a loss contingency.", "label": "Loss Contingency, Pending Claims, Number", "terseLabel": "Pending claims" } } }, "localname": "LossContingencyPendingClaimsNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "integerItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r11", "r135" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "terseLabel": "Acquisitions and Divestitures" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestitures" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r31", "r167", "r191", "r256", "r343", "r379", "r382", "r383", "r384", "r390", "r391", "r480" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "verboseLabel": "Nonredeemable noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDecreaseFromRedemptions": { "auth_ref": [ "r125", "r142", "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).", "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests", "negatedTerseLabel": "Purchase of redeemable noncontrolling interest" } } }, "localname": "MinorityInterestDecreaseFromRedemptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_MunicipalBondsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.", "label": "Municipal Bonds [Member]", "terseLabel": "Municipal securities" } } }, "localname": "MunicipalBondsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r251" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r251" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r60", "r62", "r65" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r42", "r65", "r175", "r198", "r214", "r234", "r237", "r241", "r256", "r262", "r264", "r265", "r266", "r267", "r270", "r271", "r279", "r303", "r314", "r320", "r323", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r474", "r480", "r572", "r649" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net earnings attributable to Centene Corporation" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Net earnings per common share attributable to Centene Corporation:", "verboseLabel": "Earnings attributable to Centene Corporation" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r144", "r148", "r234", "r237", "r270", "r271", "r607" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedTerseLabel": "(Earnings) loss attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r117", "r144", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net earnings (loss)" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Guidance Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r136", "r434", "r618", "r619", "r620" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r303", "r314", "r320", "r323", "r572" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Earnings from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r493" ], "calculation": { "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r493" ], "calculation": { "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Short-term (recorded within accounts payable and accrued expenses)" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r493" ], "calculation": { "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-term (recorded within other long-term liabilities)" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.", "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r492" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "ROU assets (recorded within other long-term assets)" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesRightofuseROUAssetsandLeaseLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r497", "r589" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate for operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r496", "r589" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "verboseLabel": "Weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/LeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r313", "r314", "r315", "r316", "r317", "r323" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r228", "r590" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "verboseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r220" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r32" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r40", "r120", "r235", "r238", "r244", "r482", "r487", "r488", "r534", "r548", "r605", "r606" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive earnings (loss), net of tax", "totalLabel": "Other comprehensive earnings (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": { "auth_ref": [ "r34", "r38", "r91", "r233" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax", "negatedTerseLabel": "Reclassification adjustment, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r230", "r232", "r341" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax", "terseLabel": "Change in unrealized gain (loss) on investments" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r230", "r232" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "totalLabel": "Change in unrealized gain (loss) on investments, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": { "auth_ref": [ "r35", "r231" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax", "negatedTerseLabel": "Change in unrealized gain (loss) on investments, tax effect", "verboseLabel": "Other comprehensive earning (loss), tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r65" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other adjustments, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestrictedAssetsNoncurrent": { "auth_ref": [ "r562", "r563" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other.", "label": "Other Restricted Assets, Noncurrent", "terseLabel": "Restricted deposits" } } }, "localname": "OtherRestrictedAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": { "auth_ref": [ "r61", "r203" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.", "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid", "totalLabel": "Total paid" } } }, "localname": "PaymentsForLossesAndLossAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r608", "r609" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedLabel": "Other investing activities, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r56" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Common stock repurchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r58" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedLabel": "Payments for debt extinguishment" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r51" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r53" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Purchases of investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r52" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r59" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Purchase of noncontrolling interest" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PendingLitigationMember": { "auth_ref": [ "r643" ], "lang": { "en-us": { "role": { "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.", "label": "Pending Litigation [Member]", "terseLabel": "Pending Litigation" } } }, "localname": "PendingLitigationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": { "auth_ref": [ "r200" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.", "label": "Policyholder Benefits and Claims Incurred, Net, Health", "terseLabel": "Medical costs" } } }, "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r15", "r419" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r15", "r419" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r15", "r590" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at March\u00a031, 2023 and December\u00a031, 2022" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PremiumsAndOtherReceivablesNet": { "auth_ref": [ "r197" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.", "label": "Premiums and Other Receivables, Net", "terseLabel": "Premium and trade receivables" } } }, "localname": "PremiumsAndOtherReceivablesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r49" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "terseLabel": "Proceeds from sale of business" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": { "auth_ref": [ "r49" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.", "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested", "terseLabel": "Divestiture proceeds, net of divested cash" } } }, "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r54" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "Proceeds from common stock issuances" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r55" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r610", "r611" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing activities, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [ "r50" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.", "label": "Proceeds from Sale, Maturity and Collection of Investments", "terseLabel": "Sales and maturities of investments" } } }, "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r214", "r234", "r237", "r250", "r256", "r262", "r270", "r271", "r303", "r314", "r320", "r323", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r461", "r464", "r465", "r474", "r480", "r539", "r572", "r587", "r588", "r607", "r649" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "totalLabel": "Net earnings", "verboseLabel": "Net earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEEARNINGSLOSS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r104", "r193", "r546", "r590" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, software and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r115", "r116", "r118", "r119" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "terseLabel": "Redeemable noncontrolling interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": { "auth_ref": [ "r201", "r204", "r686", "r687" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.", "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments", "periodEndLabel": "Plus: Reinsurance recoverable", "periodStartLabel": "Less: Reinsurance recoverable" } } }, "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r57" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedLabel": "Payments and repurchases of long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResidentialMortgageBackedSecuritiesMember": { "auth_ref": [ "r623", "r653" ], "lang": { "en-us": { "role": { "documentation": "Securities collateralized by residential real estate mortgage loans.", "label": "Residential Mortgage-Backed Securities [Member]", "terseLabel": "Residential mortgage-backed securities" } } }, "localname": "ResidentialMortgageBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r66", "r68", "r163", "r189", "r217" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash and cash equivalents, included in restricted deposits" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r125", "r190", "r558", "r560", "r590" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r210", "r259", "r260", "r261", "r263", "r269", "r271", "r344", "r448", "r449", "r450", "r455", "r456", "r472", "r555", "r557" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r294", "r295", "r313", "r318", "r319", "r325", "r326", "r328", "r437", "r438", "r532" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 }, "http://www.centene.com/role/SegmentInformationDetails": { "order": 2.0, "parentTag": "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Premium and service revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r294", "r295", "r313", "r318", "r319", "r325", "r326", "r328", "r437", "r438", "r532" ], "calculation": { "http://www.centene.com/role/SegmentInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "totalLabel": "Total external revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r243", "r256", "r294", "r295", "r313", "r318", "r319", "r325", "r326", "r328", "r343", "r379", "r380", "r382", "r383", "r384", "r386", "r388", "r390", "r391", "r480", "r539", "r649" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues", "totalLabel": "Total revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving credit agreement" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Available-for-Sale [Line Items]", "terseLabel": "Debt Securities, Available-for-sale [Line Items]", "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsContractualMaturitiesofShortTermandLongTermInvestmentsandRestrictedDepositsDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r81", "r86", "r87", "r88", "r89", "r90", "r179", "r180" ], "lang": { "en-us": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule of Available-for-Sale Securities [Table]", "terseLabel": "Schedule of Available-for-Sale Securities [Table]", "verboseLabel": "Schedule Of Investments And Restricted Deposits By Type [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Calculation of Basic and Diluted Net Earnings Per Common Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r475", "r476" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r574" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r574", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r641", "r642" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.", "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]", "terseLabel": "Schedule of change in medical claims liability" } } }, "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r73", "r74", "r75", "r95" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r73", "r74", "r75", "r95" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Segment Information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "auth_ref": [ "r126", "r127", "r128", "r129" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table Text Block]", "terseLabel": "Class of Treasury Stock" } } }, "localname": "ScheduleOfTreasuryStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r291", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r328", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r372", "r373", "r574", "r688" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r291", "r292", "r293", "r303", "r306", "r317", "r321", "r322", "r323", "r324", "r325", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]", "verboseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r307", "r308", "r309", "r310", "r311", "r312", "r326" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/OrganizationandOperationsPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r47" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorNotes": { "auth_ref": [ "r172", "r195" ], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "cnc_SeniorNotesTotal", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.", "label": "Senior Notes", "terseLabel": "Senior notes" } } }, "localname": "SeniorNotes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r63" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "order": 1.0, "parentTag": "us-gaap_TreasuryStockSharesAcquired", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "terseLabel": "Income tax withholding (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r169", "r170", "r187", "r604" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "terseLabel": "Short-term investments" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": { "auth_ref": [ "r206", "r207" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.", "label": "Short-Duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net", "terseLabel": "Short-duration insurance contracts, Incurred but not reported and expected development on reported claims" } } }, "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r212", "r291", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r323", "r328", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r371", "r372", "r373", "r574", "r688" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/GoodwillandIntangibleAssetsDetails", "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails", "http://www.centene.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r224", "r225", "r226", "r256", "r274", "r278", "r280", "r282", "r289", "r290", "r343", "r379", "r382", "r383", "r384", "r390", "r391", "r419", "r420", "r422", "r426", "r433", "r480", "r566", "r601", "r614", "r621" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r29", "r120", "r210", "r239", "r240", "r241", "r259", "r260", "r261", "r263", "r269", "r271", "r288", "r344", "r434", "r448", "r449", "r450", "r455", "r456", "r472", "r482", "r483", "r484", "r485", "r486", "r488", "r499", "r555", "r556", "r557" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r259", "r260", "r261", "r288", "r532" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r15", "r16", "r120", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued for employee benefit plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r15", "r16", "r125", "r131" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Common stock issued for employee benefit plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Stock repurchase program, remaining available" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r19", "r20", "r77", "r590", "r616", "r628", "r681" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Centene stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r136", "r137", "r147", "r210", "r211", "r240", "r259", "r260", "r261", "r263", "r269", "r344", "r434", "r448", "r449", "r450", "r455", "r456", "r472", "r482", "r483", "r488", "r499", "r556", "r557", "r616", "r628", "r681" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders' equity", "verboseLabel": "Stockholders' equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS", "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r130", "r255", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r432", "r434", "r471" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r489", "r500" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r489", "r500" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r489", "r500" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/AcquisitionsandDivestituresDivestitureDetails", "http://www.centene.com/role/StockholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r554" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.", "label": "Current Year Claims and Claims Adjustment Expense", "terseLabel": "Current year" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": { "auth_ref": [ "r554" ], "calculation": { "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.", "label": "Prior Year Claims and Claims Adjustment Expense", "terseLabel": "Prior years" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/MedicalClaimsLiabilityScheduleofChangeinMedicalClaimsLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r336", "r337", "r417", "r431", "r470", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r625", "r626", "r627", "r691", "r692", "r693", "r694", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Financial Instruments [Domain]", "terseLabel": "Financial Instruments [Domain]" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonMember": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockCommonMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "periodEndLabel": "Treasury stock (in shares)", "periodStartLabel": "Treasury stock (in shares)", "verboseLabel": "Treasury stock (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETSParenthetical", "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r30", "r126", "r129" ], "calculation": { "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedLabel": "Treasury stock, at cost (62,641 and 57,093 shares, respectively)" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r16", "r120", "r125" ], "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Common stock repurchases (in shares)", "totalLabel": "Common stock repurchases (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r120", "r125", "r126" ], "calculation": { "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Common stock repurchases", "terseLabel": "Common stock repurchases", "totalLabel": "Common stock repurchases" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY", "http://www.centene.com/role/StockholdersEquityNarrativeDetails", "http://www.centene.com/role/StockholdersEquityShareRepurchaseActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r540", "r582", "r689" ], "lang": { "en-us": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. Treasury securities and obligations of U.S. government corporations and agencies" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsbyLevelforAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsByInvestmentTypeDetails", "http://www.centene.com/role/ShorttermandLongtermInvestmentsRestrictedDepositsFairValueofAvailableForSaleInvestmentswithGrossUnrealizedLossesbyInvestmentTypeandLengthofTimeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [], "calculation": { "http://www.centene.com/role/DebtScheduleofDebtDetails_1": { "order": 4.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedTerseLabel": "Debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r273", "r282" ], "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average number of common shares and potential dilutive common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r272", "r282" ], "calculation": { "http://www.centene.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average number of common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.centene.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://www.centene.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "https://asc.fasb.org/topic&trid=2144416", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176304", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.16)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Subparagraph": "b.", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/subtopic&trid=2209399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(13)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.5)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.5)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(cc)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "944", "URI": "https://asc.fasb.org/topic&trid=2303980", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324412", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(23))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL121698322-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL120267856-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(25))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(d)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(21))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1403", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r595": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r596": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r597": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r598": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r599": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r648": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r69": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r691": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r692": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r693": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r694": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r695": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r696": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r697": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "325", "URI": "https://asc.fasb.org/extlink&oid=6384206&loc=d3e41899-111602", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 74 0001071739-23-000116-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001071739-23-000116-xbrl.zip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

H&%>H)==WF]L_F,=\ M+GI_]'.: ^&ZZ!PY'6QK>\CE%O\3YISPCF>HL2JHL&GX8N@+8]ECG7_6?"K> MH;3^Z#G(-Z"P"J!@#!,_J MN'+.G39%T/\:(_HQ6G[T;$8;Q#;1Y/Z(]%M$SO'3IM5#,V"^6RX28E[]3 JY M48UZS1>N)BYE$HS+4,,Q6FL4QGL5R*OTKF!A]$^N]5B3'3P_%-1@M;%(.WG :M#RVO;">T1:I9&:2L* MBO;)B*&GHMR_W7%WKL#UN[;Q?)3)"5$D6(6TIV0OZAA-2$'7'Z9)O)K;DQQN^9N M57>9U9(KFJ%' QGK$"M3:F?C'"!Y%HN0UC#=^H;7 MDP2-B[WQ<+(82FD=(/!DL?R\H* 0;\^DNBS&Q8R(I:YK5\>?T^;C:S=;6[C2 M.N:D5.N)N$\2-&[>LQL$ME/:R*7WUR'C"2[7VUJV*K>+ /*"H=J1PTC!0&]* MPKEG$"Q7H)U0M=\8(R=HAZ.KG5XV;IYR=(0-HY1^4!96IS64^T*.-@GJ@I7$ MO7>"<5#!V9H""^ "N3#.&VL38BQW:_Z^A:^'7C-N2K$W9!VMB [VSI=A_L^/ MTS.\3'==<"%CJ)V#$%"(Z@%@!I>U@Z*,YQJC4*QU">G#E.R$./W#(JZAFCH MVZ_G@ M%$$K*K H[Q:S'8W$G8G;"9?NA\?E,,KL *4GB[,S7*9O\R58$B4: \[H.IA, M('CO RCMA9)6"&=:%^#O2MM.&/4_/$8'4647YV^[G"_]I+0\QSJH%$GUZQ>%_OMB-EO\7DOVZ"]/ MB(WINA9U3@R/P;DL@?8D1GL'4^"DD>"SY$%'^H#YY\%S(X[&GU8T*"!W6P!C MH./PM;)8AUF;1,$=_N]()Z7SL_/-Y+B_+HF[O\^7&&95/+7$^655$GX,?TQ< MTC84[D%'72A"U1I"T F*Y-*H6'3@K3LP-B%\Y(Y-SXS\Y]=U!YO!H4S7Q7S- MM"TJ<(E(PLX"E/&U<%];DD%!)WCPS#3/F;4@?-QST.\%X(?K^MA+&L_@[SRV MB4U"#7.,H36,F\GH-@')7H((5B6!#F-NWM/L($K'/7+MRS]IHLT.S/+=2NR? MO_PVG1B9?*&N\,-R R-[4!EJVEO9;\"Q'Y;03\6XSV$90ND?*N%OP$F(MC7 =B1MW.WR^0 WA*9&+G&[$F'&+EX8'XSA:&S%QM /#-[S7 M"TY_#M/EIA/))!>5.3H-D15R4TM@X&/R("VRE+A7KICCL?D$!>,6.74!R%;Z M:8;"D>]Y_Q:6]3[]E^>\X'WOG:/<['Z:\^>_TBUI/ZX'\9"TH:VZ" X1$P4? MR17OA>3*M!^&U=^5;LY*C#9Z""R3&!(F\$YF2#Q@<2XF;FUC,?QX5[KWP=+A M5[KW4547)_@GBWFU&Q?-PJ:K?[[\^A+GZ?0L+/^YN03*R:J1I6<@>767;3#@ MN!'@0@E)9>6L:YV$^19-_9_-'P"&>T5,#?7201Q]GY]+;BXJOHH+)NM<:_93 M)'\WNYIH4B!RB>0*:Q%*^U0P0><< M(&C-0"$K4$,FX):QK W'Z'>)+!Y\>&_ .$9WBY:"[,#0O"8O=3D/LVT-!K$T MG7]Z^773/JL>DVP'J67FB@V0O:B7''."*#P'J[E$[6+0I?7I[;>IZO^4X?A- MK;%NND?;94]R%Q%5SF29[::#>(8@HH 2N4W1:'!E8OTW*:J?Q; M4#I0_MTY,KX6=CJ7&&M=[WA,T\I1*S2.WZ]::*&+ MA'G3:ZZ6:2F$%:!]/920LK:1< 9\818]VA 5;XS!'[]MY5Z0&K)MY3[:[ZSC1DE"%&L(]XL\M9W,]M?@1^U'.[XG7\XC74! MR'O.]SM:>%6+GY!/G*3(B^0#O(X15Y)'\!2J@2J)UEU(1MG6>;BGZ.G_X/Q M('PKHCU4)QWLRM^XG[S[362E3)+).L@J"5 ^1XA1&BC6)W*+N#/YF?HN[$U[ M_V=C;7 [BJZ[2=NLWF.JNLPOUE<%J!]/P_HD+)=?MXET4L&+%^]FYZM_X/33 MZ9I^E4PYK>I7YQN+CB>H_ M'7T<>L?58OUT)9X_.V\^M]OR^7/JTD)1IG,!>U&M;J[: ;1% %1 M6.*Y2$M^^K/:YQT)[S][]1S&>0@MCVR9GV;X/FM"RL *DW67V538.@C&*BC2 M>R94B?(N@!^>1;S?:_L/H8ZWKD-JXD>9SG>UV2SNJ>+&W_T^79\^T.T!5_'. M4+OZ6J37GB[*MLOTLUT%>1Y&1KE?,H*.GO_22K&9UT0SH*L7]YPO$!+Y,L64 M[*3(*8K6YTH]7EJ1#KDRVH.Q18(**8/GKEZ_B(4I7C+/K>_N_'B75O;!TN&7 M5O9150?N]F/G/G46$Y/D2PE&&ZM*'"%D+Z M^VBA S U/;)A!4N(@8'&6BJO.3GWVF00W+)B6?2V>;KWQS_.W0M00Q[G[J/= M#I#]]$ [CBI9:1BX+&EG,5K2SE*+>+B4*01I91&-H?J?90KA7CC9:PKA/DKK M ('?&&C'<\J)(90@*!C&X,%7+TT#A#XX.R> M9*SBFGB0S#E0GJ03A#0@1,9HI>44NS<&WL'CE;Z/F83'X.UH%74 LZ>F]0@6 MI:Y#HH*L9QFR]E(Q3-2./B0MGFUHWE;SV/%*W\>XPF- UTIA'6!O]XD\21-? M�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